Congress
. 2011 Jun; 22(8):1736-47.
doi: 10.1093/annonc/mdr304.

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

A Goldhirsch 1 W C Wood  A S Coates  R D Gelber  B Thürlimann  H-J Senn  Panel members  
Affiliations
  • PMID: 21709140
  •     80 References
  •     1142 citations

Abstract

The 12th St Gallen International Breast Cancer Conference (2011) Expert Panel adopted a new approach to the classification of patients for therapeutic purposes based on the recognition of intrinsic biological subtypes within the breast cancer spectrum. For practical purposes, these subtypes may be approximated using clinicopathological rather than gene expression array criteria. In general, systemic therapy recommendations follow the subtype classification. Thus, 'Luminal A' disease generally requires only endocrine therapy, which also forms part of the treatment of the 'Luminal B' subtype. Chemotherapy is considered indicated for most patients with 'Luminal B', 'Human Epidermal growth factor Receptor 2 (HER2) positive', and 'Triple negative (ductal)' disease, with the addition of trastuzumab in 'HER2 positive' disease. Progress was also noted in defining better tolerated local therapies in selected cases without loss of efficacy, such as accelerated radiation therapy and the omission of axillary dissection under defined circumstances. Broad treatment recommendations are presented, recognizing that detailed treatment decisions need to consider disease extent, host factors, patient preferences, and social and economic constraints.

Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), M Clarke, +9 authors, W C Wood.
Lancet, 2008 Jan 08; 371(9606). PMID: 18177773
Review.
Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.
Giuseppe Viale, Meredith M Regan, +16 authors, International Breast Cancer Study Group.
J Natl Cancer Inst, 2008 Jan 31; 100(3). PMID: 18230798
Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.
Maggie C U Cheang, David Voduc, +5 authors, Torsten O Nielsen.
Clin Cancer Res, 2008 Mar 05; 14(5). PMID: 18316557
Highly Cited.
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.
Cornelia Liedtke, Chafika Mazouni, +10 authors, Lajos Pusztai.
J Clin Oncol, 2008 Feb 06; 26(8). PMID: 18250347
Highly Cited.
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.
START Trialists' Group, S M Bentzen, +21 authors, J R Yarnold.
Lancet, 2008 Mar 22; 371(9618). PMID: 18355913    Free PMC article.
Highly Cited.
Epidemiology of basal-like breast cancer.
Robert C Millikan, Beth Newman, +13 authors, Charles M Perou.
Breast Cancer Res Treat, 2007 Jun 21; 109(1). PMID: 17578664    Free PMC article.
Highly Cited.
Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.
Paul L Nguyen, Alphonse G Taghian, +7 authors, Jay R Harris.
J Clin Oncol, 2008 Apr 17; 26(14). PMID: 18413639
Highly Cited.
Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes.
Christine Desmedt, Benjamin Haibe-Kains, +6 authors, Christos Sotiriou.
Clin Cancer Res, 2008 Aug 14; 14(16). PMID: 18698033
Highly Cited.
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.
Pratyaksha Wirapati, Christos Sotiriou, +10 authors, Mauro Delorenzi.
Breast Cancer Res, 2008 Jul 30; 10(4). PMID: 18662380    Free PMC article.
Highly Cited.
Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole.
Giuseppe Viale, Anita Giobbie-Hurder, +18 authors, Breast International Group Trial 1-98.
J Clin Oncol, 2008 Nov 05; 26(34). PMID: 18981464    Free PMC article.
Highly Cited.
Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
Michael Gnant, Brigitte Mlineritsch, +20 authors, C Marth.
N Engl J Med, 2009 Feb 14; 360(7). PMID: 19213681
Highly Cited.
Gene-expression signatures in breast cancer.
Christos Sotiriou, Lajos Pusztai.
N Engl J Med, 2009 Feb 21; 360(8). PMID: 19228622
Highly Cited. Review.
Supervised risk predictor of breast cancer based on intrinsic subtypes.
Joel S Parker, Michael Mullins, +17 authors, Philip S Bernard.
J Clin Oncol, 2009 Feb 11; 27(8). PMID: 19204204    Free PMC article.
Highly Cited.
Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial.
Judith Hugh, John Hanson, +11 authors, Charles Vogel.
J Clin Oncol, 2009 Feb 11; 27(8). PMID: 19204205    Free PMC article.
Highly Cited.
microRNA-205 regulates HER3 in human breast cancer.
Marilena V Iorio, Patrizia Casalini, +6 authors, Elda Tagliabue.
Cancer Res, 2009 Mar 12; 69(6). PMID: 19276373
Highly Cited.
Adjuvant chemotherapy in older women with early-stage breast cancer.
Hyman B Muss, Donald A Berry, +23 authors, CALGB Investigators.
N Engl J Med, 2009 May 15; 360(20). PMID: 19439741    Free PMC article.
Highly Cited.
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.
Maggie C U Cheang, Stephen K Chia, +10 authors, Torsten O Nielsen.
J Natl Cancer Inst, 2009 May 14; 101(10). PMID: 19436038    Free PMC article.
Highly Cited.
Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer.
James J Dignam, Vanja Dukic, +3 authors, Norman Wolmark.
Breast Cancer Res Treat, 2008 Oct 03; 116(3). PMID: 18830816    Free PMC article.
Control of mammary stem cell function by steroid hormone signalling.
Marie-Liesse Asselin-Labat, François Vaillant, +8 authors, Jane E Visvader.
Nature, 2010 Apr 13; 465(7299). PMID: 20383121
Highly Cited.
Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial.
Jayant S Vaidya, David J Joseph, +21 authors, Michael Baum.
Lancet, 2010 Jun 24; 376(9735). PMID: 20570343
Highly Cited.
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial.
Andrew Tutt, Mark Robson, +12 authors, James Carmichael.
Lancet, 2010 Jul 09; 376(9737). PMID: 20609467
Highly Cited.
Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons.
Umberto Veronesi, Roberto Orecchia, +13 authors, Patrick Maisonneuve.
Breast Cancer Res Treat, 2010 Aug 17; 124(1). PMID: 20711810
Implication of tumor microenvironment in the resistance to chemotherapy in breast cancer patients.
Fabrice Andre, Narjiss Berrada, Christine Desmedt.
Curr Opin Oncol, 2010 Sep 16; 22(6). PMID: 20842030
Review.
Evaluation of treatment-effect heterogeneity using biomarkers measured on a continuous scale: subpopulation treatment effect pattern plot.
Ann A Lazar, Bernard F Cole, Marco Bonetti, Richard D Gelber.
J Clin Oncol, 2010 Sep 15; 28(29). PMID: 20837942    Free PMC article.
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.
David N Krag, Stewart J Anderson, +12 authors, Norman Wolmark.
Lancet Oncol, 2010 Sep 25; 11(10). PMID: 20863759    Free PMC article.
Highly Cited.
Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study.
H Eidtmann, R de Boer, +7 authors, R Coleman.
Ann Oncol, 2010 May 07; 21(11). PMID: 20444845
Highly Cited.
A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer.
Torsten O Nielsen, Joel S Parker, +12 authors, Matthew J Ellis.
Clin Cancer Res, 2010 Sep 15; 16(21). PMID: 20837693    Free PMC article.
Highly Cited.
Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer.
Daniel Schramek, Andreas Leibbrandt, +13 authors, Josef M Penninger.
Nature, 2010 Oct 01; 468(7320). PMID: 20881962    Free PMC article.
Highly Cited.
RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.
Eva Gonzalez-Suarez, Allison P Jacob, +6 authors, William C Dougall.
Nature, 2010 Oct 01; 468(7320). PMID: 20881963
Highly Cited.
Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.
Andrea Decensi, Matteo Puntoni, +4 authors, Sara Gandini.
Cancer Prev Res (Phila), 2010 Oct 16; 3(11). PMID: 20947488
Highly Cited. Systematic Review.
Amenorrhea from breast cancer therapy--not a matter of dose.
Sandra M Swain, Jong-Hyeon Jeong, Norman Wolmark.
N Engl J Med, 2010 Dec 03; 363(23). PMID: 21121855
Phase II trial of combination of pegylated liposomal doxorubicin, cisplatin, and infusional 5-fluorouracil (CCF) plus trastuzumab as preoperative treatment for locally advanced and inflammatory breast cancer.
Rosalba Torrisi, Anna Cardillo, +8 authors, Marco Colleoni.
Clin Breast Cancer, 2010 Dec 15; 10(6). PMID: 21147693
Mechanisms of endocrine resistance in breast cancer.
C Kent Osborne, Rachel Schiff.
Annu Rev Med, 2010 Oct 05; 62. PMID: 20887199    Free PMC article.
Highly Cited. Review.
Deconstructing the molecular portraits of breast cancer.
Aleix Prat, Charles M Perou.
Mol Oncol, 2010 Dec 15; 5(1). PMID: 21147047    Free PMC article.
Highly Cited. Review.
Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer.
Takayuki Iwamoto, Giampaolo Bianchini, +14 authors, Lajos Pusztai.
J Natl Cancer Inst, 2010 Dec 31; 103(3). PMID: 21191116
Highly Cited.
Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.
Armando E Giuliano, Kelly K Hunt, +7 authors, Monica Morrow.
JAMA, 2011 Feb 10; 305(6). PMID: 21304082    Free PMC article.
Highly Cited.
Reproductive history and risk of three breast cancer subtypes defined by three biomarkers.
Amanda I Phipps, Diana S M Buist, +4 authors, Christopher I Li.
Cancer Causes Control, 2010 Dec 25; 22(3). PMID: 21184265    Free PMC article.
Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling.
Wei Tan, Weizhou Zhang, +4 authors, Michael Karin.
Nature, 2011 Feb 18; 470(7335). PMID: 21326202    Free PMC article.
Highly Cited.
Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer.
Amanda I Phipps, Rowan T Chlebowski, +10 authors, Christopher I Li.
Cancer Epidemiol Biomarkers Prev, 2011 Mar 03; 20(3). PMID: 21364029    Free PMC article.
Bevacizumab for advanced breast cancer: all tied up with a RIBBON?
Harold J Burstein.
J Clin Oncol, 2011 Mar 09; 29(10). PMID: 21383305
Trastuzumab plus anastrozole versus anastrozole alone for the treatment of postmenopausal women with human epidermal growth factor receptor 2-positive, hormone receptor-positive metastatic breast cancer: results from the randomized phase III TAnDEM study.
Bella Kaufman, John R Mackey, +9 authors, Alison Jones.
J Clin Oncol, 2009 Sep 30; 27(33). PMID: 19786670
Highly Cited.
Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20.
Gong Tang, Steven Shak, +6 authors, Norman Wolmark.
Breast Cancer Res Treat, 2011 Jan 12; 127(1). PMID: 21221771    Free PMC article.
Preventive therapy for breast cancer: a consensus statement.
Jack Cuzick, Andrea DeCensi, +9 authors, Heinz Zwierzina.
Lancet Oncol, 2011 Mar 29; 12(5). PMID: 21441069
Review.
Clinical Notice for American Society of Clinical Oncology-College of American Pathologists guideline recommendations on ER/PgR and HER2 testing in breast cancer.
M Elizabeth Hammond, Daniel F Hayes, Antonio C Wolff.
J Clin Oncol, 2011 Apr 20; 29(15). PMID: 21502545
Autologous fat transplantation in patients with breast cancer: "silencing" or "fueling" cancer recurrence?
Visnu Lohsiriwat, Giuseppe Curigliano, +2 authors, Jean Yves Petit.
Breast, 2011 Feb 08; 20(4). PMID: 21295982
Review.
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX.
S Aebi, Z Sun, +14 authors, A Goldhirsch.
Ann Oncol, 2011 Feb 02; 22(9). PMID: 21282282    Free PMC article.
Adjuvant therapies for special types of breast cancer.
Marco Colleoni, Leila Russo, Silvia Dellapasqua.
Breast, 2011 Nov 02; 20 Suppl 3. PMID: 22015285
Review.
Is gene array testing to be considered routine now?
Soonmyung Paik.
Breast, 2011 Nov 02; 20 Suppl 3. PMID: 22015300
Review.
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009.
A Goldhirsch, J N Ingle, +4 authors, Panel members.
Ann Oncol, 2009 Jun 19; 20(8). PMID: 19535820    Free PMC article.
Highly Cited.
Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer: final results of the FinHer Trial.
Heikki Joensuu, Petri Bono, +17 authors, Pirkko-Liisa Kellokumpu-Lehtinen.
J Clin Oncol, 2009 Nov 04; 27(34). PMID: 19884557
Highly Cited.
Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.
Carsten Denkert, Sibylle Loibl, +14 authors, Gunter von Minckwitz.
J Clin Oncol, 2009 Nov 18; 28(1). PMID: 19917869
Highly Cited.
Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy.
Tomasz Byrski, Jacek Gronwald, +10 authors, Steven Narod.
J Clin Oncol, 2009 Dec 17; 28(3). PMID: 20008645
Highly Cited.
Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial.
Kathy S Albain, William E Barlow, +18 authors, Breast Cancer Intergroup of North America.
Lancet, 2009 Dec 17; 374(9707). PMID: 20004966    Free PMC article.
Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort.
Luca Gianni, Wolfgang Eiermann, +17 authors, Jose Baselga.
Lancet, 2010 Feb 02; 375(9712). PMID: 20113825
Highly Cited.
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.
Kathy S Albain, William E Barlow, +20 authors, Breast Cancer Intergroup of North America.
Lancet Oncol, 2009 Dec 17; 11(1). PMID: 20005174    Free PMC article.
Highly Cited.
Long-term results of hypofractionated radiation therapy for breast cancer.
Timothy J Whelan, Jean-Philippe Pignol, +12 authors, Carolyn Freeman.
N Engl J Med, 2010 Feb 12; 362(6). PMID: 20147717
Highly Cited.
Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer.
Daniel P Silver, Andrea L Richardson, +19 authors, Judy E Garber.
J Clin Oncol, 2010 Jan 27; 28(7). PMID: 20100965    Free PMC article.
Highly Cited.
Lapatinib plus letrozole as first-line therapy for HER-2+ hormone receptor-positive metastatic breast cancer.
Lee S Schwartzberg, Lee S Schwarzberg, +4 authors, Stephen Johnston.
Oncologist, 2010 Feb 17; 15(2). PMID: 20156908    Free PMC article.
The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer.
Michael Knauer, Stella Mook, +7 authors, Laura J van 't Veer.
Breast Cancer Res Treat, 2010 Mar 06; 120(3). PMID: 20204499
The association between biological subtype and isolated regional nodal failure after breast-conserving therapy.
Jennifer Y Wo, Alphonse G Taghian, +7 authors, Jay R Harris.
Int J Radiat Oncol Biol Phys, 2010 Feb 23; 77(1). PMID: 20171798
Genetic/familial high-risk assessment: breast and ovarian.
Mary B Daly, Jennifer E Axilbund, +23 authors, National Comprehensive Cancer Network.
J Natl Compr Canc Netw, 2010 May 25; 8(5). PMID: 20495085
Highly Cited.
American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
M Elizabeth H Hammond, Daniel F Hayes, +29 authors, Antonio C Wolff.
J Clin Oncol, 2010 Apr 21; 28(16). PMID: 20404251    Free PMC article.
Highly Cited. Systematic Review.
Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer.
Sandra M Swain, Jong-Hyeon Jeong, +14 authors, Norman Wolmark.
N Engl J Med, 2010 Jun 04; 362(22). PMID: 20519679    Free PMC article.
Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies.
Fiona M Blows, Kristy E Driver, +40 authors, David Huntsman.
PLoS Med, 2010 Jun 04; 7(5). PMID: 20520800    Free PMC article.
Highly Cited.
Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silico based mechanism.
Gloria Fuentes, Maurizio Scaltriti, José Baselga, Chandra S Verma.
Breast Cancer Res, 2011 May 24; 13(3). PMID: 21600050    Free PMC article.
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group.
Mitch Dowsett, Torsten O Nielsen, +19 authors, International Ki-67 in Breast Cancer Working Group.
J Natl Cancer Inst, 2011 Oct 01; 103(22). PMID: 21960707    Free PMC article.
Highly Cited.
Molecular portraits of human breast tumours.
C M Perou, T Sørlie, +15 authors, D Botstein.
Nature, 2000 Aug 30; 406(6797). PMID: 10963602
Highly Cited.
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.
Marc L Citron, Donald A Berry, +18 authors, Larry Norton.
J Clin Oncol, 2003 Apr 02; 21(8). PMID: 12668651
Highly Cited.
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.
Torsten O Nielsen, Forrest D Hsu, +13 authors, Charles M Perou.
Clin Cancer Res, 2004 Aug 26; 10(16). PMID: 15328174
Highly Cited.
Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast.
U Veronesi, R Saccozzi, +12 authors, R Zucali.
N Engl J Med, 1981 Jul 02; 305(1). PMID: 7015141
Highly Cited.
Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer.
B Fisher, M Bauer, +7 authors, E Montague.
N Engl J Med, 1985 Mar 14; 312(11). PMID: 3883167
Highly Cited.
Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer.
F Jänicke, M Schmitt, +4 authors, H Graeff.
Breast Cancer Res Treat, 1993 Jan 01; 24(3). PMID: 8435475
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.
Martine J Piccart-Gebhart, Marion Procter, +30 authors, Herceptin Adjuvant (HERA) Trial Study Team.
N Engl J Med, 2005 Oct 21; 353(16). PMID: 16236737
Highly Cited.
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.
Edward H Romond, Edith A Perez, +22 authors, Norman Wolmark.
N Engl J Med, 2005 Oct 21; 353(16). PMID: 16236738
Highly Cited.
Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93.
International Breast Cancer Study Group, Marco Colleoni, +6 authors, Richard D Gelber.
J Clin Oncol, 2006 Mar 01; 24(9). PMID: 16505417
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.
Manfred Kaufmann, Gabriel N Hortobagyi, +17 authors, Gunter von Minckwitz.
J Clin Oncol, 2006 Apr 20; 24(12). PMID: 16622270
Highly Cited.
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Soonmyung Paik, Gong Tang, +11 authors, Norman Wolmark.
J Clin Oncol, 2006 May 25; 24(23). PMID: 16720680
Highly Cited.
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.
Antonio C Wolff, M Elizabeth H Hammond, +22 authors, College of American Pathologists.
J Clin Oncol, 2006 Dec 13; 25(1). PMID: 17159189
Highly Cited.
Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis.
Goran Bjelakovic, Dimitrinka Nikolova, +2 authors, Christian Gluud.
JAMA, 2007 Mar 01; 297(8). PMID: 17327526
Highly Cited. Systematic Review.
Trastuzumab--mechanism of action and use in clinical practice.
Clifford A Hudis.
N Engl J Med, 2007 Jul 06; 357(1). PMID: 17611206
Highly Cited. Review.
Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy.
Nils D Arvold, Alphonse G Taghian, +7 authors, Jay R Harris.
J Clin Oncol, 2011 Sep 09; 29(29). PMID: 21900114    Free PMC article.
Highly Cited.
Impact of multigene assays in early stage breast cancer.
Shelly S Lo, Kathy S Albain.
Oncologist, 2011 Oct 22; 16(11). PMID: 22016475    Free PMC article.
Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC-PACS 01 randomized trial.
Jocelyne Jacquemier, Jean-Marie Boher, +12 authors, François Bertucci.
Breast Cancer Res, 2011 Nov 03; 13(6). PMID: 22044691    Free PMC article.
Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review.
Elisabeth Luporsi, Fabrice André, +22 authors, Jean-Pierre Bellocq.
Breast Cancer Res Treat, 2011 Nov 04; 132(3). PMID: 22048814    Free PMC article.
Highly Cited. Review.
Treatment of HER2-positive breast cancer: current status and future perspectives.
Carlos L Arteaga, Mark X Sliwkowski, +3 authors, Luca Gianni.
Nat Rev Clin Oncol, 2011 Nov 30; 9(1). PMID: 22124364
Highly Cited. Review.
Epidermal growth factor receptor in breast carcinoma: association between gene copy number and mutations.
Ning Lv, Xiaoming Xie, +6 authors, Weidong Wei.
Diagn Pathol, 2011 Dec 03; 6. PMID: 22132735    Free PMC article.
New Clues to Breast Cancer Heterogeneity.
Kreipe Hans.
Breast Care (Basel), 2011 Dec 03; 6(4). PMID: 22135622    Free PMC article.
Practical implications of gene-expression-based assays for breast oncologists.
Aleix Prat, Matthew J Ellis, Charles M Perou.
Nat Rev Clin Oncol, 2011 Dec 07; 9(1). PMID: 22143140    Free PMC article.
Highly Cited. Review.
AGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011.
Christoph Thomssen, Anton Scharl, Nadia Harbeck.
Breast Care (Basel), 2011 Dec 14; 6(4). PMID: 22164127    Free PMC article.
Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.
Thomas Karn, Lajos Pusztai, +12 authors, Achim Rody.
PLoS One, 2012 Jan 06; 6(12). PMID: 22220191    Free PMC article.
Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper.
R Rizzoli, J J Body, +5 authors, European Society for Clinical and Economical aspects of Osteoporosis and Osteoarthritis (ESCEO).
Osteoporos Int, 2012 Jan 25; 23(11). PMID: 22270857
Gemcitabine and carboplatin for pretreated metastatic breast cancer: the predictive value of immunohistochemically defined subtypes.
Fabrizio Nelli, Luca Moscetti, +6 authors, Enzo Maria Ruggeri.
Int J Clin Oncol, 2012 Feb 22; 18(2). PMID: 22350024
ER-alpha-cDNA as part of a bicistronic transcript gives rise to high frequency, long term, receptor expressing cell clones.
Michal Shenfeld, Yafit Hachmo, +5 authors, Dan Canaani.
PLoS One, 2012 Mar 01; 7(2). PMID: 22363779    Free PMC article.
Use of neoadjuvant data to design adjuvant endocrine therapy trials for breast cancer.
Rodrigo Goncalves, Cynthia Ma, +2 authors, Matthew James Ellis.
Nat Rev Clin Oncol, 2012 Mar 01; 9(4). PMID: 22371132    Free PMC article.
Review.
Is there any role for new prognostic markers in breast cancer?
Agustí Barnadas.
Clin Transl Oncol, 2012 Mar 01; 14(3). PMID: 22374417
Review.
Hormonal therapy in breast cancer: a model disease for the personalization of cancer care.
Shannon Puhalla, Saveri Bhattacharya, Nancy E Davidson.
Mol Oncol, 2012 Mar 13; 6(2). PMID: 22406404    Free PMC article.
Review.
Correlations between diffusion-weighted imaging and breast cancer biomarkers.
Laura Martincich, Veronica Deantoni, +9 authors, Filippo Montemurro.
Eur Radiol, 2012 Mar 14; 22(7). PMID: 22411304
EGFR/HER-targeted therapeutics in ovarian cancer.
Jason A Wilken, Tayf Badri, +7 authors, Nita J Maihle.
Future Med Chem, 2012 Mar 16; 4(4). PMID: 22416774    Free PMC article.
Review.
Trends and Novel Approaches in Neoadjuvant Treatment of Breast Cancer.
Guenther G Steger, Rupert Bartsch.
Breast Care (Basel), 2012 Mar 16; 6(6). PMID: 22419895    Free PMC article.
Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data.
Arvydas Laurinavicius, Aida Laurinaviciene, +3 authors, Juozas Lazutka.
Diagn Pathol, 2012 Mar 20; 7. PMID: 22424533    Free PMC article.
Patients with positive axillary lymph nodes: how to use genomic assays.
Ruta Rao.
Curr Treat Options Oncol, 2012 Mar 20; 13(2). PMID: 22426945
Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer.
H R Ali, S-J Dawson, +3 authors, C Caldas.
Br J Cancer, 2012 Apr 28; 106(11). PMID: 22538974    Free PMC article.
Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study.
Stefania Gori, Matteo Clavarezza, +12 authors, Marco Venturini.
BMC Cancer, 2012 May 02; 12. PMID: 22545982    Free PMC article.
Pre-treatment hormonal receptor status and Ki67 index predict pathologic complete response to neoadjuvant trastuzumab/taxanes but not disease-free survival in HER2-positive breast cancer patients.
Guo-Chun Zhang, Xue-Ke Qian, +6 authors, Ning Liao.
Med Oncol, 2012 May 02; 29(5). PMID: 22547076
Results of the First Austrian Multidisciplinary Expert Panel on Controversies in Local Treatment of Breast Cancer.
Michael Knauer, Michael Gnant, Florian Fitzal.
Breast Care (Basel), 2012 May 04; 7(1). PMID: 22553475    Free PMC article.
Importance of assessing CK19 immunostaining in core biopsies in patients subjected to sentinel node study by OSNA.
Felip Vilardell, Anna Novell, +9 authors, Xavier Matias-Guiu.
Virchows Arch, 2012 May 05; 460(6). PMID: 22555942    Free PMC article.
Distribution, clinicopathologic features and survival of breast cancer subtypes in Southern China.
Cong Xue, Xi Wang, +7 authors, Zhongyu Yuan.
Cancer Sci, 2012 May 26; 103(9). PMID: 22625227    Free PMC article.
Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study.
Matteo Clavarezza, Giorgio Mustacchi, +13 authors, Marco Venturini.
BMC Cancer, 2012 Jun 08; 12. PMID: 22672524    Free PMC article.
AKT-aro and HER2-aro, models for de novo resistance to aromatase inhibitors; molecular characterization and inhibitor response studies.
Cynthie Wong, Xin Wang, +2 authors, Shiuan Chen.
Breast Cancer Res Treat, 2012 Jun 19; 134(2). PMID: 22706627    Free PMC article.
Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials.
J Huober, S Gelber, +7 authors, B Thürlimann.
Ann Oncol, 2012 Jun 19; 23(11). PMID: 22707751    Free PMC article.
Reproductive history and breast cancer risk.
Shunzo Kobayashi, Hiroshi Sugiura, +4 authors, Tatsuya Toyama.
Breast Cancer, 2012 Jun 20; 19(4). PMID: 22711317    Free PMC article.
Review.
Stromal genes add prognostic information to proliferation and histoclinical markers: a basis for the next generation of breast cancer gene signatures.
Dwain Mefford, Joel Mefford.
PLoS One, 2012 Jun 22; 7(6). PMID: 22719844    Free PMC article.
PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer.
A Prat, J S Parker, C Fan, C M Perou.
Breast Cancer Res Treat, 2012 Jul 04; 135(1). PMID: 22752290    Free PMC article.
A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer.
Martin Schuler, Ahmad Awada, +17 authors, Nadia Harbeck.
Breast Cancer Res Treat, 2012 Jul 06; 134(3). PMID: 22763464    Free PMC article.
Study on the skip metastasis of axillary lymph nodes in breast cancer and their relation with Gli1 expression.
Huan Wang, Xiao-Yun Mao, +3 authors, Ji-Guang Li.
Tumour Biol, 2012 Jul 17; 33(6). PMID: 22797820
Multi-institutional comparison of non-sentinel lymph node predictive tools in breast cancer patients with high predicted risk of further axillary metastasis.
Gábor Cserni, Rita Bori, +12 authors, Riccardo A Audisio.
Pathol Oncol Res, 2012 Jul 17; 19(1). PMID: 22798061
Impact of immunohistochemistry-based molecular subtype on chemosensitivity and survival in patients with breast cancer following neoadjuvant chemotherapy.
Changhoon Yoo, Jin-Hee Ahn, +6 authors, Gyungyub Gong.
J Breast Cancer, 2012 Jul 19; 15(2). PMID: 22807938    Free PMC article.
Survey of the application of the korean clinical practice recommendations on breast cancer treatment: the utility of the korean breast cancer society guidelines.
Geumhee Gwak, Hae Kyung Lee, +16 authors, Korea Breast Cancer Foundation.
J Breast Cancer, 2012 Jul 19; 15(2). PMID: 22807943    Free PMC article.
High-risk estrogen-receptor-positive breast cancer: identification and implications for therapy.
Rosemary L Balleine, Nicholas R Wilcken.
Mol Diagn Ther, 2012 Jul 21; 16(4). PMID: 22812573
Review.
Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype.
Masumi Yanagawa, Kenzo Ikemot, +6 authors, Kohsuke Sasaki.
BMC Res Notes, 2012 Jul 27; 5. PMID: 22830453    Free PMC article.
Breast cancer: Anastrozole and fulvestrant--combination to unlock efficacy.
Aron Goldhirsch, Richard D Gelber.
Nat Rev Clin Oncol, 2012 Sep 06; 9(10). PMID: 22949048
The molecular profile of luminal B breast cancer.
Chad J Creighton.
Biologics, 2012 Sep 08; 6. PMID: 22956860    Free PMC article.
Biological characteristics of interval cancers: a role for biomarkers in the breast cancer screening.
A Caldarella, D Puliti, +8 authors, E Paci.
J Cancer Res Clin Oncol, 2012 Sep 11; 139(2). PMID: 22961208
Higher cytoplasmic and nuclear poly(ADP-ribose) polymerase expression in familial than in sporadic breast cancer.
Marie-Luise Klauke, Nicoline Hoogerbrugge, +7 authors, Berit Maria Müller.
Virchows Arch, 2012 Sep 13; 461(4). PMID: 22968923
Accuracy validation of adjuvant! online in Taiwanese breast cancer patients--a 10-year analysis.
Kuo Yao-Lung, Chen Dar-Ren, Chang Tsai-Wang.
BMC Med Inform Decis Mak, 2012 Sep 19; 12. PMID: 22985190    Free PMC article.
Human epidermal growth factor receptor-2-positive breast cancer: does estrogen receptor status define two distinct subtypes?
I Vaz-Luis, E P Winer, N U Lin.
Ann Oncol, 2012 Oct 02; 24(2). PMID: 23022997    Free PMC article.
Review.
Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study.
Ines Vaz-Luis, Rebecca A Ottesen, +8 authors, Nancy U Lin.
Breast Cancer Res, 2012 Oct 03; 14(5). PMID: 23025714    Free PMC article.
Immunoglobulin kappa C predicts overall survival in node-negative breast cancer.
Zonglin Chen, Aslihan Gerhold-Ay, +13 authors, Marcus Schmidt.
PLoS One, 2012 Oct 03; 7(9). PMID: 23028600    Free PMC article.
EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer.
P Dubsky, M Filipits, +17 authors, Austrian Breast and Colorectal Cancer Study Group (ABCSG).
Ann Oncol, 2012 Oct 05; 24(3). PMID: 23035151    Free PMC article.
Open biomedical pluralism: formalising knowledge about breast cancer phenotypes.
Aleksandra Sojic, Oliver Kutz.
J Biomed Semantics, 2012 Oct 11; 3 Suppl 2. PMID: 23046572    Free PMC article.
Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice.
Domenico Angelucci, Nicola Tinari, +13 authors, Clara Natoli.
J Cancer Res Clin Oncol, 2012 Oct 12; 139(2). PMID: 23052698    Free PMC article.
[Translational research and diagnostics for breast cancer].
H H Kreipe.
Pathologe, 2012 Oct 16; 33 Suppl 2. PMID: 23064514
Review.
Patients' choice on axillary lymph node dissection following sentinel lymph node micrometastasis--first report on prospective use of a nomogram in very low risk patients.
Gábor Cserni, Istvánné Bezsenyi, László Markó.
Pathol Oncol Res, 2012 Oct 17; 19(2). PMID: 23070585
Update on triple-negative breast cancer: prognosis and management strategies.
Olivier Brouckaert, Hans Wildiers, Giuseppe Floris, Patrick Neven.
Int J Womens Health, 2012 Oct 17; 4. PMID: 23071421    Free PMC article.
A comprehensive morphological study for basal-like breast carcinomas with comparison to nonbasal-like carcinomas.
Asli Cakir, Ipek Isik Gonul, Omer Uluoglu.
Diagn Pathol, 2012 Oct 23; 7. PMID: 23082819    Free PMC article.
Impact of the american college of surgeons oncology group Z0011 criteria applied to a contemporary patient population.
Min Yi, Henry M Kuerer, +6 authors, Kelly K Hunt.
J Am Coll Surg, 2012 Nov 06; 216(1). PMID: 23122536    Free PMC article.
The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use.
W Eiermann, M Rezai, +13 authors, J Blohmer.
Ann Oncol, 2012 Nov 09; 24(3). PMID: 23136233    Free PMC article.
Association of a common genetic variant of the IGF-1 gene with event-free survival in patients with HER2-positive breast cancer.
Axel Muendlein, Alois H Lang, +8 authors, Michael Hubalek.
J Cancer Res Clin Oncol, 2012 Nov 28; 139(3). PMID: 23180020
Association between body mass index and breast cancer intrinsic subtypes in Japanese women.
Kosei Kimura, Satoru Tanaka, +4 authors, Kazuhisa Uchiyama.
Exp Ther Med, 2012 Nov 28; 4(3). PMID: 23181105    Free PMC article.
Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer.
Aleix Prat, Maggie Chon U Cheang, +8 authors, Charles M Perou.
J Clin Oncol, 2012 Dec 13; 31(2). PMID: 23233704    Free PMC article.
Highly Cited.
PTP1B expression is an independent positive prognostic factor in human breast cancer.
S Soysal, E C Obermann, +4 authors, S Muenst.
Breast Cancer Res Treat, 2012 Dec 18; 137(2). PMID: 23242616    Free PMC article.
Invasive breast cancer: a significant correlation between histological types and molecular subgroups.
A Caldarella, C Buzzoni, +8 authors, E Paci.
J Cancer Res Clin Oncol, 2012 Dec 28; 139(4). PMID: 23269487
Two different formulations with equivalent effect? Comparison of serum estradiol suppression with monthly goserelin and trimonthly leuprolide in breast cancer patients.
Adnan Aydiner, Leyla Kilic, +6 authors, Abdullah Igci.
Med Oncol, 2013 Jan 01; 30(1). PMID: 23275115
High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival.
Akimitsu Yamada, Takashi Ishikawa, +10 authors, Itaru Endo.
Breast Cancer Res Treat, 2013 Jan 05; 137(3). PMID: 23288347    Free PMC article.
Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients.
Katarzyna Pogoda, Anna Niwińska, Magdalena Murawska, Tadeusz Pieńkowski.
Med Oncol, 2013 Jan 08; 30(1). PMID: 23292831    Free PMC article.
Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement.
H A Azim, S Michiels, +9 authors, C Swanton.
Ann Oncol, 2013 Jan 23; 24(3). PMID: 23337633    Free PMC article.
Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial.
Paul E Goss, James N Ingle, +18 authors, Lois E Shepherd.
J Clin Oncol, 2013 Jan 30; 31(11). PMID: 23358971    Free PMC article.
Highly Cited.
High expression of LC3B is associated with progression and poor outcome in triple-negative breast cancer.
Hong Zhao, Maopeng Yang, +3 authors, Qingyuan Zhang.
Med Oncol, 2013 Feb 02; 30(1). PMID: 23371253
[Breast cancer. Individualized therapy concepts].
N Harbeck, R Wuerstlein.
Internist (Berl), 2013 Feb 02; 54(2). PMID: 23371261
HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer.
Carsten Denkert, Jens Huober, +14 authors, Michael Untch.
Breast Cancer Res, 2013 Feb 09; 15(1). PMID: 23391338    Free PMC article.
Recurrence risk in small, node-negative, early breast cancer: a multicenter retrospective analysis.
T Gamucci, A Vaccaro, +9 authors, P Vici.
J Cancer Res Clin Oncol, 2013 Feb 16; 139(5). PMID: 23411686    Free PMC article.
Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?
Olga Golubnitschaja, Kristina Yeghiazaryan, +5 authors, Hans H Schild.
EPMA J, 2013 Feb 20; 4(1). PMID: 23418957    Free PMC article.
ERM/Rho protein expression in ductal breast cancer: a 15 year follow-up.
Agnieszka Halon, Piotr Donizy, Pawel Surowiak, Rafal Matkowski.
Cell Oncol (Dordr), 2013 Feb 20; 36(3). PMID: 23420497    Free PMC article.
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
Viviana Galimberti, Bernard F Cole, +25 authors, International Breast Cancer Study Group Trial 23-01 investigators.
Lancet Oncol, 2013 Mar 16; 14(4). PMID: 23491275    Free PMC article.
Highly Cited.
EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like, and HER2 intrinsic subtypes of breast cancer.
S D Soysal, S Muenst, +7 authors, W E Gillanders.
Br J Cancer, 2013 Mar 23; 108(7). PMID: 23519058    Free PMC article.
Quantitative molecular analysis of sentinel lymph node may be predictive of axillary node status in breast cancer classified by molecular subtypes.
Simonetta Buglioni, Franco Di Filippo, +9 authors, Marcella Mottolese.
PLoS One, 2013 Mar 28; 8(3). PMID: 23533593    Free PMC article.
The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer.
Carina Strand, Martin Bak, +13 authors, Mårten Fernö.
Springerplus, 2013 Apr 06; 2(1). PMID: 23560250    Free PMC article.
Long-term analysis to objectify the tumour grading by means of automated microscopic image analysis of the nucleolar organizer regions (AgNORs) in the case of breast carcinoma.
Klaus-Jürgen Winzer, Joachim Bellach, Peter Hufnagl.
Diagn Pathol, 2013 Apr 10; 8. PMID: 23566354    Free PMC article.
Associations between body mass index and molecular subtypes as well as other clinical characteristics of breast cancer in Chinese women.
Fei-Yu Chen, Hui-Ying Ou, +3 authors, Li-Li Tang.
Ther Clin Risk Manag, 2013 Apr 12; 9. PMID: 23576872    Free PMC article.
Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype.
M Lazzeroni, A Guerrieri-Gonzaga, +12 authors, G Pruneri.
Br J Cancer, 2013 Apr 13; 108(8). PMID: 23579208    Free PMC article.
Comparison of automated and manual FISH for evaluation of HER2 gene status on breast carcinoma core biopsies.
Christian Ohlschlegel, Doris Kradolfer, Margreth Hell, Wolfram Jochum.
BMC Clin Pathol, 2013 Apr 23; 13. PMID: 23601823    Free PMC article.
Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer.
Clara Natoli, Patrizia Vici, +17 authors, Teresa Gamucci.
J Cancer Res Clin Oncol, 2013 Apr 23; 139(7). PMID: 23604446    Free PMC article.
Differential survival and recurrence patterns of patients operated for breast cancer according to the new immunohistochemical classification: analytical survey from 1997 to 2012.
Antonio García Fernández, Carol Chabrera, +9 authors, Nuria Giménez.
Tumour Biol, 2013 Apr 23; 34(4). PMID: 23605321
A comprehensive analysis of Aurora A; transcript levels are the most reliable in association with proliferation and prognosis in breast cancer.
Satoko Yamamoto, Mutsuko Yamamoto-Ibusuki, +2 authors, Hirotaka Iwase.
BMC Cancer, 2013 May 01; 13. PMID: 23627634    Free PMC article.
Molecular subtypes of breast cancer: metabolic correlation with ¹⁸F-FDG PET/CT.
Ana María García Vicente, Ángel Soriano Castrejón, +6 authors, Ana González Ageitos.
Eur J Nucl Med Mol Imaging, 2013 May 02; 40(9). PMID: 23632960
Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.
Raphael Richard, Isabelle Thomassin, +7 authors, Cedric de Bazelaire.
Eur Radiol, 2013 May 09; 23(9). PMID: 23652844
Collagen triple helix repeat containing-1 (CTHRC1) expression in invasive ductal carcinoma of the breast: the impact on prognosis and correlation to clinicopathologic features.
Joo Heon Kim, Tae-Hwa Baek, +7 authors, Kwang Dong Kim.
Pathol Oncol Res, 2013 May 10; 19(4). PMID: 23658133
Hedgehog related protein expression in breast cancer: gli-2 is associated with poor overall survival.
Soyoung Im, Hyun Joo Choi, +4 authors, Chang Suk Kang.
Korean J Pathol, 2013 May 15; 47(2). PMID: 23667370    Free PMC article.
Src homology phosphotyrosyl phosphatase-2 expression is an independent negative prognostic factor in human breast cancer.
Simone Muenst, Ellen C Obermann, +6 authors, Savas D Soysal.
Histopathology, 2013 May 16; 63(1). PMID: 23672411    Free PMC article.
Stiffness of tumours measured by shear-wave elastography correlated with subtypes of breast cancer.
Jung Min Chang, In Ae Park, +7 authors, Woo Kyung Moon.
Eur Radiol, 2013 May 16; 23(9). PMID: 23673574
Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry.
E C Inwald, M Klinkhammer-Schalke, +4 authors, O Ortmann.
Breast Cancer Res Treat, 2013 May 16; 139(2). PMID: 23674192    Free PMC article.
Highly Cited.
Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis.
Ke-Da Yu, Sheng Huang, +2 authors, Zhi-Ming Shao.
BMC Cancer, 2013 May 18; 13. PMID: 23679207    Free PMC article.
Systematic Review.
A decision impact, decision conflict and economic assessment of routine Oncotype DX testing of 146 women with node-negative or pNImi, ER-positive breast cancer in the U.K.
S Holt, G Bertelli, +12 authors, C J Phillips.
Br J Cancer, 2013 May 23; 108(11). PMID: 23695023    Free PMC article.
A simple and reproducible prognostic index in luminal ER-positive breast cancers.
I Castellano, L Chiusa, +9 authors, A Sapino.
Ann Oncol, 2013 May 28; 24(9). PMID: 23709174    Free PMC article.
Axillary lymph node status, adjusted for pathologic complete response in breast and axilla after neoadjuvant chemotherapy, predicts differential disease-free survival in breast cancer.
G C Zhang, Y F Zhang, +4 authors, M Yao.
Curr Oncol, 2013 Jun 06; 20(3). PMID: 23737688    Free PMC article.
PET/CT and breast cancer subtypes.
Laura Gilardi, Marco Colleoni, Giovanni Paganelli.
Eur J Nucl Med Mol Imaging, 2013 Jun 12; 40(9). PMID: 23748238
The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer.
S Muenst, S D Soysal, +3 authors, W E Gillanders.
Breast Cancer Res Treat, 2013 Jun 13; 139(3). PMID: 23756627    Free PMC article.
Highly Cited.
A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer.
Davide Serrano, Matteo Lazzeroni, +15 authors, Bernardo Bonanni.
Breast Cancer Res, 2013 Jun 22; 15(3). PMID: 23786776    Free PMC article.
[Breast cancer: current recommendations for pathologists on the basis of the S3 guidelines].
A Lebeau, H Kreipe, +2 authors, R Kreienberg.
Pathologe, 2013 Jun 25; 34(4). PMID: 23793365
The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients.
Salomon M Stemmer, Shmuel H Klang, +7 authors, Nicky Lieberman.
Breast Cancer Res Treat, 2013 Jun 27; 140(1). PMID: 23801158    Free PMC article.
Hormonal therapies in young breast cancer patients: when, what and for how long?
Alexandre Christinat, Simona Di Lascio, Olivia Pagani.
J Thorac Dis, 2013 Jul 03; 5 Suppl 1. PMID: 23819026    Free PMC article.
The EndoPredict Gene-Expression Assay in Clinical Practice - Performance and Impact on Clinical Decisions.
Berit Maria Müller, Elke Keil, +16 authors, Carsten Denkert.
PLoS One, 2013 Jul 05; 8(6). PMID: 23826382    Free PMC article.
Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response.
E H Lips, L Mulder, +5 authors, J Wesseling.
Breast Cancer Res Treat, 2013 Jul 06; 140(1). PMID: 23828499    Free PMC article.
CD44/CD24 as potential prognostic markers in node-positive invasive ductal breast cancer patients treated with adjuvant chemotherapy.
Agnieszka Adamczyk, Joanna A Niemiec, +3 authors, Janusz Ryś.
J Mol Histol, 2013 Jul 10; 45(1). PMID: 23835592
Drug resistance and the role of combination chemotherapy in improving patient outcomes.
Denise A Yardley.
Int J Breast Cancer, 2013 Jul 19; 2013. PMID: 23864953    Free PMC article.
A case of synchronous bilateral breast cancer with different pathological responses to neoadjuvant chemotherapy with different biological character.
Mitsuhiro Hayashi, Yutaka Yamamoto, Noboru Takata, Hirotaka Iwase.
Springerplus, 2013 Jul 23; 2(1). PMID: 23875131    Free PMC article.
Luminal breast cancer: from biology to treatment.
Michail Ignatiadis, Christos Sotiriou.
Nat Rev Clin Oncol, 2013 Jul 25; 10(9). PMID: 23881035
Review.
Succinate dehydrogenase expression in breast cancer.
Sewha Kim, Do Hee Kim, Woo-Hee Jung, Ja Seung Koo.
Springerplus, 2013 Jul 28; 2(1). PMID: 23888270    Free PMC article.
Relative and disease-free survival for breast cancer in relation to subtype: a population-based study.
Pamela Minicozzi, Francesca Bella, +10 authors, Milena Sant.
J Cancer Res Clin Oncol, 2013 Jul 31; 139(9). PMID: 23892409
Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX.
Otto Metzger-Filho, Zhuoxin Sun, +8 authors, Fatima Cardoso.
J Clin Oncol, 2013 Jul 31; 31(25). PMID: 23897954    Free PMC article.
Highly Cited.
Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients.
M J Engstrøm, S Opdahl, +5 authors, A M Bofin.
Breast Cancer Res Treat, 2013 Aug 01; 140(3). PMID: 23901018    Free PMC article.
Assignment of tumor subtype by genomic testing and pathologic-based approximations: implications on patient's management and therapy selection.
A Romero, A Prat, +9 authors, M Martín.
Clin Transl Oncol, 2013 Aug 03; 16(4). PMID: 23907291
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013.
A Goldhirsch, E P Winer, +5 authors, Panel members.
Ann Oncol, 2013 Aug 07; 24(9). PMID: 23917950    Free PMC article.
Highly Cited.
[Gene expression analysis in breast cancer. A new diagnostic tool in pathology].
C Denkert.
Pathologe, 2013 Aug 13; 34(5). PMID: 23934410
Review.
Clinical relevance of lymph node ratio in breast cancer patients with one to three positive lymph nodes.
S I Kim, S-H Cho, +5 authors, B-W Park.
Br J Cancer, 2013 Aug 15; 109(5). PMID: 23942073    Free PMC article.
Prognostic significance of ESR1 amplification and ESR1 PvuII, CYP2C19*2, UGT2B15*2 polymorphisms in breast cancer patients.
Aleksandra Markiewicz, Marzena Wełnicka-Jaśkiewicz, +4 authors, Anna J Zaczek.
PLoS One, 2013 Aug 21; 8(8). PMID: 23951298    Free PMC article.
Predictive value of sphingosine kinase 1 expression in neoadjuvant treatment of breast cancer.
Eugen Ruckhäberle, Thomas Karn, +9 authors, Gunter von Minckwitz.
J Cancer Res Clin Oncol, 2013 Aug 21; 139(10). PMID: 23955546
Preoperative core needle biopsy is accurate in determining molecular subtypes in invasive breast cancer.
Xiaosong Chen, Long Sun, +10 authors, Kunwei Shen.
BMC Cancer, 2013 Aug 21; 13. PMID: 23957561    Free PMC article.
SEOM clinical guidelines for the systemic treatment of early breast cancer 2013.
S Del Barco, E Ciruelos, +3 authors, SEOM.
Clin Transl Oncol, 2013 Aug 28; 15(12). PMID: 23979909
Review.
Survival Analysis Based on Clinicopathological Data from a Single Institution: Chemotherapy Intensity Would Be Enhanced in Patients with Positive Hormone Receptors and Positive HER2 in China Who Cannot Afford the Target Therapy.
Jianyi Li, Shi Jia, +3 authors, Rui Tian.
ISRN Oncol, 2013 Aug 29; 2013. PMID: 23984097    Free PMC article.
SU6668 suppresses proliferation of triple negative breast cancer cells through down-regulating MTDH expression.
Lu Wang, Zhaozhe Liu, +4 authors, Xiaodong Xie.
Cancer Cell Int, 2013 Aug 30; 13(1). PMID: 23984913    Free PMC article.
The prognostic significance of Wnt-5a expression in primary breast cancer is extended to premenopausal women.
Janna Sand-Dejmek, Roy Ehrnström, +2 authors, Lisa Ryden.
PLoS One, 2013 Aug 31; 8(8). PMID: 23990917    Free PMC article.
Value of pre-treatment biomarkers in prediction of response to neoadjuvant endocrine therapy for hormone receptor-positive postmenopausal breast cancer.
Min Ying, Yingjian He, +7 authors, Tao Ouyang.
Chin J Cancer Res, 2013 Sep 03; 25(4). PMID: 23997526    Free PMC article.
St. Gallen 2013: brief preliminary summary of the consensus discussion.
Nadia Harbeck, Christoph Thomssen, Michael Gnant.
Breast Care (Basel), 2013 Sep 04; 8(2). PMID: 24000280    Free PMC article.
Integrating genetic and genomic information into effective cancer care in diverse populations.
L Fashoyin-Aje, K Sanghavi, K Bjornard, J Bodurtha.
Ann Oncol, 2013 Sep 06; 24 Suppl 7. PMID: 24001763    Free PMC article.
Metabolic interaction between cancer cells and stromal cells according to breast cancer molecular subtype.
Junjeong Choi, Do Hee Kim, Woo Hee Jung, Ja Seung Koo.
Breast Cancer Res, 2013 Sep 12; 15(5). PMID: 24020991    Free PMC article.
Role of maximum standardized uptake value in fluorodeoxyglucose positron emission tomography/computed tomography predicts malignancy grade and prognosis of operable breast cancer: a multi-institute study.
Takayuki Kadoya, Kenjiro Aogi, +3 authors, Morihito Okada.
Breast Cancer Res Treat, 2013 Sep 13; 141(2). PMID: 24026860    Free PMC article.
Effect of chemotherapy for luminal a breast cancer.
Naotaka Uchida, Takako Suda, Kiyosuke Ishiguro.
Yonago Acta Med, 2013 Sep 14; 56(2). PMID: 24031152    Free PMC article.
Serum soluble CD14 is a potential prognostic indicator of recurrence of human breast invasive ductal carcinoma with Her2-enriched subtype.
Weifeng He, Yifan Tong, +4 authors, Jin Zhang.
PLoS One, 2013 Oct 03; 8(9). PMID: 24086515    Free PMC article.
Lymph node involvement in immunohistochemistry-based molecular classifications of breast cancer.
Nicholas K Howland, Teryn D Driver, +5 authors, Celia Chao.
J Surg Res, 2013 Oct 08; 185(2). PMID: 24095025    Free PMC article.
18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes.
Hye Ryoung Koo, Jeong Seon Park, +9 authors, Woo Kyung Moon.
Eur Radiol, 2013 Oct 08; 24(3). PMID: 24097303
Reliable PCR quantitation of estrogen, progesterone and ERBB2 receptor mRNA from formalin-fixed, paraffin-embedded tissue is independent of prior macro-dissection.
Trine Tramm, Guido Hennig, +5 authors, Jens Overgaard.
Virchows Arch, 2013 Oct 09; 463(6). PMID: 24100522
Evaluating the 21-gene assay Recurrence Score® as a predictor of clinical response to 24 weeks of neoadjuvant exemestane in estrogen receptor-positive breast cancer.
Takayuki Ueno, Norikazu Masuda, +12 authors, Masakazu Toi.
Int J Clin Oncol, 2013 Oct 09; 19(4). PMID: 24101215
Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer.
A N Seo, H J Lee, +6 authors, S Y Park.
Br J Cancer, 2013 Oct 17; 109(10). PMID: 24129232    Free PMC article.
Highly Cited.
Serum follicle-stimulating hormone level is associated with human epidermal growth factor receptor type 2 and Ki67 expression in post-menopausal females with breast cancer.
Jun Zhou, Yiding Chen, +3 authors, Suzhan Zhang.
Oncol Lett, 2013 Oct 19; 6(4). PMID: 24137476    Free PMC article.
Genomic instability: a stronger prognostic marker than proliferation for early stage luminal breast carcinomas.
Anne Vincent-Salomon, Vanessa Benhamo, +13 authors, Olivier Delattre.
PLoS One, 2013 Oct 22; 8(10). PMID: 24143191    Free PMC article.
Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer.
L S Rigter, C E Loo, +11 authors, S Rodenhuis.
Br J Cancer, 2013 Oct 24; 109(12). PMID: 24149178    Free PMC article.
Prognostic value of the nodal ratio and ki-67 expression in breast cancer patients treated with postmastectomy radiotherapy.
Tae Ryool Koo, Keun Yong Eom, +5 authors, In Ah Kim.
J Breast Cancer, 2013 Oct 25; 16(3). PMID: 24155756    Free PMC article.
Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study.
Wenjing Zhou, Karin Jirström, +6 authors, Fredrik Wärnberg.
BMC Cancer, 2013 Nov 01; 13. PMID: 24171825    Free PMC article.
Nuclear expression of snail is an independent negative prognostic factor in human breast cancer.
S Muenst, S Däster, +7 authors, S D Soysal.
Dis Markers, 2013 Nov 06; 35(5). PMID: 24191127    Free PMC article.
¹⁸F-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorations.
Alexandre Cochet, Inna Dygai-Cochet, +8 authors, François Brunotte.
Eur J Nucl Med Mol Imaging, 2013 Nov 08; 41(3). PMID: 24196916
Detection of internal mammary lymph node metastasis with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with stage III breast cancer.
Min Jung Seo, Jong Jin Lee, +8 authors, Dae Hyuk Moon.
Eur J Nucl Med Mol Imaging, 2013 Nov 08; 41(3). PMID: 24196918
The use of digital images improves reproducibility of the ki-67 labeling index as a proliferation marker in breast cancer.
András Vörös, Erika Csörgő, +3 authors, Gábor Cserni.
Pathol Oncol Res, 2013 Nov 10; 20(2). PMID: 24202856
An international Ki67 reproducibility study.
Mei-Yin C Polley, Samuel C Y Leung, +16 authors, International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group.
J Natl Cancer Inst, 2013 Nov 10; 105(24). PMID: 24203987    Free PMC article.
Highly Cited.
HER story: the next chapter in HER-2-directed therapy for advanced breast cancer.
Sunil Verma, Anil A Joy, +4 authors, Karen A Gelmon.
Oncologist, 2013 Nov 12; 18(11). PMID: 24212500    Free PMC article.
Review.
Clinical Significance of CK19 Negative Breast Cancer.
Mamiko Fujisue, Reiki Nishimura, +5 authors, Nobuyuki Arima.
Cancers (Basel), 2012 Jan 01; 5(1). PMID: 24216695    Free PMC article.
Heterogeneity of mesenchymal markers expression-molecular profiles of cancer cells disseminated by lymphatic and hematogenous routes in breast cancer.
Aleksandra Markiewicz, Magdalena Książkiewicz, +4 authors, Anna J Zaczek.
Cancers (Basel), 2013 Nov 13; 5(4). PMID: 24217115    Free PMC article.
Tumor-dependent increase of serum amino acid levels in breast cancer patients has diagnostic potential and correlates with molecular tumor subtypes.
Isabel Poschke, Yumeng Mao, Rolf Kiessling, Jana de Boniface.
J Transl Med, 2013 Nov 19; 11. PMID: 24237611    Free PMC article.
Advantages of one step nucleic acid amplification (OSNA) whole node assay in sentinel lymph node (SLN) analysis in breast cancer.
Ana Santaballa, Helena De La Cueva, +7 authors, Pilar Bello.
Springerplus, 2013 Nov 21; 2. PMID: 24255842    Free PMC article.
PTIP associated protein 1, PA1, is an independent prognostic factor for lymphnode negative breast cancer.
Takashi Takeshita, Mutsuko Yamamoto-Ibusuki, +5 authors, Hirotaka Iwase.
PLoS One, 2013 Nov 22; 8(11). PMID: 24260416    Free PMC article.
Calretinin expression in high-grade invasive ductal carcinoma of the breast is associated with basal-like subtype and unfavorable prognosis.
Ross J Taliano, Shaolei Lu, +5 authors, Evgeny Yakirevich.
Hum Pathol, 2013 Nov 23; 44(12). PMID: 24262018    Free PMC article.
St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases--aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial.
Anna-Karin Falck, Mårten Fernö, Pär-Ola Bendahl, Lisa Rydén.
BMC Cancer, 2013 Nov 28; 13. PMID: 24274821    Free PMC article.
Are breast cancer molecular classes predictive of survival in patients with long follow-up?
Danae Pracella, Serena Bonin, +4 authors, Giorgio Stanta.
Dis Markers, 2013 Nov 30; 35(6). PMID: 24288429    Free PMC article.
Subcellular localization of Mdm2 expression and prognosis of breast cancer.
Hyung Seok Park, Ji Min Park, +3 authors, Byeong-Woo Park.
Int J Clin Oncol, 2013 Dec 03; 19(5). PMID: 24292333
The prognostic value of mitotic activity index (MAI), phosphohistone H3 (PPH3), cyclin B1, cyclin A, and Ki67, alone and in combinations, in node-negative premenopausal breast cancer.
Marie Klintman, Carina Strand, +11 authors, Mårten Fernö.
PLoS One, 2013 Dec 11; 8(12). PMID: 24324728    Free PMC article.
Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer: a retrospective study.
Stine B Thorsen, Sarah Lt Christensen, +10 authors, Jan Stenvang.
BMC Cancer, 2013 Dec 18; 13. PMID: 24330623    Free PMC article.
Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients.
Branka Petricevic, Johannes Laengle, +6 authors, Michael Bergmann.
J Transl Med, 2013 Dec 18; 11. PMID: 24330813    Free PMC article.
Capecitabine maintenance therapy in patients with recurrent or metastatic breast cancer.
W Si, Y Y Zhu, +6 authors, J L Yang.
Braz J Med Biol Res, 2013 Dec 19; 46(12). PMID: 24345917    Free PMC article.
Semi-automated evaluation of Ki-67 index in invasive ductal carcinoma of the breast.
Cristian Suciu, Anca Muresan, +3 authors, Marius Raica.
Oncol Lett, 2013 Dec 19; 7(1). PMID: 24348830    Free PMC article.
Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials.
S Gandini, A Guerrieri-Gonzaga, +8 authors, A DeCensi.
Ann Oncol, 2013 Dec 20; 25(3). PMID: 24351403    Free PMC article.
Clinicopathological features and prognosis of pregnancy associated breast cancer - a matched case control study.
Lilla Madaras, Kristóf Attila Kovács, +7 authors, Janina Kulka.
Pathol Oncol Res, 2013 Dec 21; 20(3). PMID: 24357159
Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes.
D J E Peeters, P-J van Dam, +9 authors, L Y Dirix.
Br J Cancer, 2013 Dec 25; 110(2). PMID: 24366294    Free PMC article.
Partial breast irradiation techniques in early breast cancer.
Agata Kacprowska, Jacek Jassem.
Rep Pract Oncol Radiother, 2011 Jan 01; 16(6). PMID: 24376983    Free PMC article.
Review.
Hypofractionated radiotherapy for early breast cancer: Review of phase III studies.
Agata Kacprowska, Jacek Jassem.
Rep Pract Oncol Radiother, 2012 Jan 01; 17(2). PMID: 24377002    Free PMC article.
Review.
Tamoxifen versus tamoxifen plus doxorubicin and cyclophosphamide as adjuvant therapy for node-positive postmenopausal breast cancer: results of a Japan Clinical Oncology Group Study (JCOG9401).
Tadahiko Shien, Hiroji Iwata, +7 authors, Haruhiko Fukuda.
Int J Clin Oncol, 2014 Jan 08; 19(6). PMID: 24395447
Characteristics and clinical outcome of T1 breast cancer: a multicenter retrospective cohort study.
G Houvenaeghel, A Goncalves, +20 authors, B Esterni.
Ann Oncol, 2014 Jan 09; 25(3). PMID: 24399079    Free PMC article.
Prognostic value of CtIP/RBBP8 expression in breast cancer.
Isabel Soria-Bretones, Carmen Sáez, +2 authors, Pablo Huertas.
Cancer Med, 2014 Jan 10; 2(6). PMID: 24403251    Free PMC article.
Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in Spain.
Laia Domingo, Dolores Salas, +10 authors, INCA Study Group.
Breast Cancer Res, 2014 Jan 15; 16(1). PMID: 24410848    Free PMC article.
[Determination of proliferation in breast cancer by immunohistochemical detection of Ki-67].
M Christgen, W Winkens, H H Kreipe.
Pathologe, 2014 Jan 15; 35(1). PMID: 24414612
Cross-national comparison of medical costs shared by payers and patients: a study of postmenopausal women with early-stage breast cancer based on assumption case scenarios and reimbursement fees.
Shota Hamada, Shiro Hinotsu, +2 authors, Koji Kawakami.
Breast Care (Basel), 2014 Jan 15; 8(4). PMID: 24415981    Free PMC article.
Patient's Anastrozole Compliance to Therapy (PACT) Program: Baseline Data and Patient Characteristics from a Population-Based, Randomized Study Evaluating Compliance to Aromatase Inhibitor Therapy in Postmenopausal Women with Hormone-Sensitive Early Breast Cancer.
Nadia Harbeck, Maria Blettner, +9 authors, Rolf Kreienberg.
Breast Care (Basel), 2014 Jan 15; 8(2). PMID: 24419247    Free PMC article.
The G protein-coupled estrogen receptor (GPER) is expressed in two different subcellular localizations reflecting distinct tumor properties in breast cancer.
Eleftherios P Samartzis, Aurelia Noske, +3 authors, Patrick Imesch.
PLoS One, 2014 Jan 15; 9(1). PMID: 24421881    Free PMC article.
Are synchronous and metachronous bilateral breast cancers different? An immunohistochemical analysis aimed at intrinsic tumor phenotype.
Elżbieta Senkus, Jolanta Szade, +5 authors, Jacek Jassem.
Int J Clin Exp Pathol, 2014 Jan 16; 7(1). PMID: 24427357    Free PMC article.
Effect Modification of Hormonal Therapy by p53 Status in Invasive Breast Cancer.
Sei Hyun Ahn, Hwa Jung Kim, +6 authors, Jong Won Lee.
J Breast Cancer, 2014 Jan 24; 16(4). PMID: 24454460    Free PMC article.
Differences and homologies of chromosomal alterations within and between breast cancer cell lines: a clustering analysis.
Milena Rondón-Lagos, Ludovica Verdun Di Cantogno, +8 authors, Anna Sapino.
Mol Cytogenet, 2014 Jan 25; 7(1). PMID: 24456987    Free PMC article.
Deregulation of the phosphatase, PP2A is a common event in breast cancer, predicting sensitivity to FTY720.
Shawn Baldacchino, Christian Saliba, +3 authors, Godfrey Grech.
EPMA J, 2014 Jan 28; 5(1). PMID: 24460909    Free PMC article.
The protective effect of parity in hormone receptor-positive, Ki-67 expressing breast cancer.
Se Kyung Lee, Seok Won Kim, +3 authors, Seok Jin Nam.
World J Surg, 2014 Feb 01; 38(5). PMID: 24481994
Molecular tests as prognostic factors in breast cancer.
Marc J van de Vijver.
Virchows Arch, 2014 Feb 04; 464(3). PMID: 24487789
Review.
Differences in breast carcinoma immunohistochemical subtypes between immigrant Arab and European women.
Fanny Preat, Philippe Simon, Jean-Christophe Noel.
Diagn Pathol, 2014 Feb 06; 9. PMID: 24495621    Free PMC article.
Prognostic value of Ki-67 in breast cancer patients with positive axillary lymph nodes: a retrospective cohort study.
Feng-yan Li, San-gang Wu, +5 authors, Zhen-yu He.
PLoS One, 2014 Feb 06; 9(2). PMID: 24498305    Free PMC article.
Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics.
Carol Sweeney, Philip S Bernard, +11 authors, Bette J Caan.
Cancer Epidemiol Biomarkers Prev, 2014 Feb 14; 23(5). PMID: 24521995    Free PMC article.
Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes.
Bette J Caan, Carol Sweeney, +8 authors, Philip S Bernard.
Cancer Epidemiol Biomarkers Prev, 2014 Feb 14; 23(5). PMID: 24521998    Free PMC article.
Long-term outcome of neoadjuvant endocrine therapy with aromatase inhibitors in elderly women with hormone receptor-positive breast cancer.
Antonino Grassadonia, Marta Di Nicola, +14 authors, Ettore Cianchetti.
Ann Surg Oncol, 2014 Feb 14; 21(5). PMID: 24522992    Free PMC article.
Genomic profiling in luminal breast cancer.
Oleg Gluz, Daniel Hofmann, +3 authors, Nadia Harbeck.
Breast Care (Basel), 2014 Feb 20; 8(6). PMID: 24550749    Free PMC article.
Review.
Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma.
Tatsuo Masubuchi, Yuichiro Tada, +8 authors, Toshitaka Nagao.
Int J Clin Oncol, 2014 Feb 21; 20(1). PMID: 24553861
Estrogen receptor α-coupled Bmi1 regulation pathway in breast cancer and its clinical implications.
Huali Wang, Haijing Liu, +10 authors, Bo Zhang.
BMC Cancer, 2014 Feb 25; 14. PMID: 24559156    Free PMC article.
Questioning the role of axillary node dissection in sentinel node positive early stage breast cancer in the South Eastern Cancer Centre.
O O Mohamed, P M Neary, C Fiuza-Castineira, G T O'Donoghue.
Ir J Med Sci, 2014 Mar 04; 184(1). PMID: 24585071
Effect of age and biological subtype on the risk and timing of brain metastasis in breast cancer patients.
Man-Hsin Hung, Chun-Yu Liu, +12 authors, Ling-Ming Tseng.
PLoS One, 2014 Mar 04; 9(2). PMID: 24586742    Free PMC article.
HER-3 expression in HER-2-amplified breast carcinoma.
Jacek Czopek, Janusz Pawlęga, +3 authors, Krzysztof Okoń.
Contemp Oncol (Pozn), 2013 Jan 01; 17(5). PMID: 24596534    Free PMC article.
Prognostic value of gene signatures and proliferation in lymph-node-negative breast cancer.
Kristin Jonsdottir, Jörg Assmus, +4 authors, Emiel A M Janssen.
PLoS One, 2014 Mar 07; 9(3). PMID: 24599057    Free PMC article.
Relationship of CK8/18 expression pattern to breast cancer immunohistochemical subtyping in Egyptian patients.
Hayam A Aiad, Rehab M Samaka, +3 authors, Islam M Miligy.
Ecancermedicalscience, 2014 Mar 08; 8. PMID: 24605136    Free PMC article.
Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial.
H Bonnefoi, S Litière, +18 authors, EORTC 10994/BIG 1-00 Study investigators.
Ann Oncol, 2014 Mar 13; 25(6). PMID: 24618153    Free PMC article.
Multi-gene fluorescence in situ hybridization to detect cell cycle gene copy number aberrations in young breast cancer patients.
Chunyan Li, Jingchao Bai, +9 authors, J Zhang.
Cell Cycle, 2014 Mar 14; 13(8). PMID: 24621502    Free PMC article.
Baseline staging tests based on molecular subtype is necessary for newly diagnosed breast cancer.
Xuesong Chen, Lichun Sun, +8 authors, Xiaoqun Dong.
J Exp Clin Cancer Res, 2014 Mar 19; 33. PMID: 24628817    Free PMC article.
Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression.
Janna K Mouw, Yoshihiro Yui, +10 authors, Valerie M Weaver.
Nat Med, 2014 Mar 19; 20(4). PMID: 24633304    Free PMC article.
Highly Cited.
Quantum dot-based immunofluorescent imaging of Ki67 and identification of prognostic value in HER2-positive (non-luminal) breast cancer.
Jin-Zhong Sun, Chuang Chen, +3 authors, Sheng-Rong Sun.
Int J Nanomedicine, 2014 Mar 22; 9. PMID: 24648732    Free PMC article.
Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials (Review).
Mei Hong Zhang, Hong Tao Man, +2 authors, Shi Liang Ma.
Biomed Rep, 2014 Mar 22; 2(1). PMID: 24649067    Free PMC article.
Frequent MYC coamplification and DNA hypomethylation of multiple genes on 8q in 8p11-p12-amplified breast carcinomas.
T Z Parris, A Kovács, +5 authors, K Helou.
Oncogenesis, 2014 Mar 26; 3. PMID: 24662924    Free PMC article.
High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial.
G Viale, L Slaets, +11 authors, TRANSBIG Consortium & the MINDACT Investigators.
Ann Oncol, 2014 Mar 29; 25(4). PMID: 24667714    Free PMC article.
The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients.
S Krenn-Pilko, U Langsenlehner, +5 authors, T Langsenlehner.
Br J Cancer, 2014 Mar 29; 110(10). PMID: 24675383    Free PMC article.
Highly Cited.
p40 (ΔNp63) expression in breast disease and its correlation with p63 immunohistochemistry.
Sang Kyum Kim, Woo Hee Jung, Ja Seung Koo.
Int J Clin Exp Pathol, 2014 Apr 04; 7(3). PMID: 24696720    Free PMC article.
A case of invasive micropapillary carcinoma of the breast involving extensive lymph node metastasis.
Kenji Taketani, Eriko Tokunaga, +7 authors, Yoshihiko Maehara.
World J Surg Oncol, 2014 Apr 09; 12. PMID: 24708742    Free PMC article.
A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue.
Arvydas Laurinavicius, Benoit Plancoulaine, +8 authors, Catherine Bor.
Breast Cancer Res, 2014 Apr 09; 16(2). PMID: 24708745    Free PMC article.
Potential of antibody-drug conjugates and novel therapeutics in breast cancer management.
Georgios D Lianos, Konstantinos Vlachos, +3 authors, Dimitrios H Roukos.
Onco Targets Ther, 2014 Apr 09; 7. PMID: 24711706    Free PMC article.
Review.
Age Does not Matter, Biology of Both Cancer and Patient Does.
Matti S Aapro.
Breast Care (Basel), 2012 Dec 01; 7(6). PMID: 24715823    Free PMC article.
Invasive breast carcinomas of no special type with osteoclast-like giant cells frequently have a luminal phenotype.
Shuling Zhou, Lin Yu, +2 authors, Wentao Yang.
Virchows Arch, 2014 Apr 15; 464(6). PMID: 24728734
Early and delayed prediction of axillary lymph node neoadjuvant response by (18)F-FDG PET/CT in patients with locally advanced breast cancer.
Ana María García Vicente, Ángel Soriano Castrejón, +5 authors, Ruth Espinosa Aunión.
Eur J Nucl Med Mol Imaging, 2014 Apr 20; 41(7). PMID: 24744045
Patterns and Biologic Features of p53 Mutation Types in Korean Breast Cancer Patients.
Hyung Won Kim, Hak Min Lee, +3 authors, Joon Jeong.
J Breast Cancer, 2014 Apr 20; 17(1). PMID: 24744791    Free PMC article.
Zonal difference and prognostic significance of foxp3 regulatory T cell infiltration in breast cancer.
Sewha Kim, Anbok Lee, +5 authors, Sun Hee Sung.
J Breast Cancer, 2014 Apr 20; 17(1). PMID: 24744792    Free PMC article.
A cross-sectional survey of the diagnosis and management of bone metastasis in breast cancer patients in Turkey.
Ali Arican, Tulin Bozkurt, +17 authors, Bahadir Pekin.
Support Care Cancer, 2014 Apr 23; 22(10). PMID: 24752566    Free PMC article.
Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer: Short version - AWMF Registry No.: 032-045OL AWMF-Register-Nummer: 032-045OL - Kurzversion 3.0, Juli 2012.
R Kreienberg, U-S Albert, +3 authors, A Wöckel.
Geburtshilfe Frauenheilkd, 2014 Apr 29; 73(6). PMID: 24771925    Free PMC article.
Multigene Assays for Classification, Prognosis, and Prediction in Breast Cancer: a Critical Review on the Background and Clinical Utility.
P Sinn, S Aulmann, +6 authors, A Schneeweiss.
Geburtshilfe Frauenheilkd, 2014 Apr 29; 73(9). PMID: 24771945    Free PMC article.
Can ki-67 play a role in prediction of breast cancer patients' response to neoadjuvant chemotherapy?
Juhasz-Böss Ingolf, Mavrova Russalina, +6 authors, Herr Daniel.
Biomed Res Int, 2014 May 02; 2014. PMID: 24783217    Free PMC article.
Future directions for the early detection of recurrent breast cancer.
Erika J Schneble, Lindsey J Graham, +10 authors, Robert F Setlik.
J Cancer, 2014 May 03; 5(4). PMID: 24790657    Free PMC article.
Review.
Measures of outcome in metastatic breast cancer: insights from a real-world scenario.
Marta Bonotto, Lorenzo Gerratana, +9 authors, Fabio Puglisi.
Oncologist, 2014 May 06; 19(6). PMID: 24794159    Free PMC article.
In breast cancer patients sentinel lymph node metastasis characteristics predict further axillary involvement.
Ildiko Illyes, Anna-Maria Tokes, +8 authors, Janina Kulka.
Virchows Arch, 2014 May 09; 465(1). PMID: 24809673
Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer.
S Muenst, A R Schaerli, +9 authors, S D Soysal.
Breast Cancer Res Treat, 2014 May 21; 146(1). PMID: 24842267    Free PMC article.
Highly Cited.
Cdc20 and securin overexpression predict short-term breast cancer survival.
H Karra, H Repo, +6 authors, P Kronqvist.
Br J Cancer, 2014 May 24; 110(12). PMID: 24853182    Free PMC article.
Different methods of pretreatment Ki-67 labeling index evaluation in core biopsies of breast cancer patients treated with neoadjuvant chemotherapy and their relation to response to therapy.
András Vörös, Erika Csörgő, +5 authors, Gábor Cserni.
Pathol Oncol Res, 2014 May 27; 21(1). PMID: 24859973
Relationship between chemotherapy and prognosis in different subtypes of node-negative breast cancer.
Xia Liu, Yong Guan, +5 authors, Yun Niu.
Tumour Biol, 2014 May 28; 35(9). PMID: 24863944
The mTOR inhibitor rapamycin synergizes with a fatty acid synthase inhibitor to induce cytotoxicity in ER/HER2-positive breast cancer cells.
Chen Yan, Huang Wei, +4 authors, Han Sheng.
PLoS One, 2014 May 29; 9(5). PMID: 24866893    Free PMC article.
Increased MTHFD2 expression is associated with poor prognosis in breast cancer.
Feng Liu, Yang Liu, +4 authors, Guoqiang Zhang.
Tumour Biol, 2014 May 30; 35(9). PMID: 24870594
TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group.
Charlotte Levin Tykjær Jørgensen, Christina Bjerre, +5 authors, Dorte L Nielsen.
BMC Cancer, 2014 Jun 03; 14. PMID: 24884504    Free PMC article.
Implications of differences in expression of sarcosine metabolism-related proteins according to the molecular subtype of breast cancer.
Ja Kyung Yoon, Do Hee Kim, Ja Seung Koo.
J Transl Med, 2014 Jun 03; 12. PMID: 24884785    Free PMC article.
Lin28B expression correlates with aggressive clinicopathological characteristics in breast invasive ductal carcinoma.
Ruilian Xie, Yanru Wang, +4 authors, Xiaoxiang Guan.
Cancer Biother Radiopharm, 2014 Jun 03; 29(5). PMID: 24885919    Free PMC article.
Factors associated to persistence with hormonal therapy in women with breast cancer.
Cláudia Brito, Margareth Crisóstomo Portela, Mauricio Teixeira Leite de Vasconcellos.
Rev Saude Publica, 2014 Jun 05; 48(2). PMID: 24897050    Free PMC article.
Prognostic value of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in breast cancer.
Joohyun Woo, Heejung Park, +3 authors, Woosung Lim.
PLoS One, 2014 Jun 11; 9(6). PMID: 24914806    Free PMC article.
Luminal breast cancer classification according to proliferative indices: clinicopathological characteristics and short-term survival analysis.
Yan Sun, Gang Nie, +3 authors, Haibo Wang.
Med Oncol, 2014 Jun 18; 31(7). PMID: 24935624
Aromatase inhibitors-induced bone loss in early breast cancer.
Jean-Jacques Body.
Bonekey Rep, 2012 Jan 01; 1. PMID: 24936287    Free PMC article.
Sorafenib-based therapy in HER2-negative advanced breast cancer: Results from a retrospective pooled analysis of randomized controlled trials.
Qi-Xing Tan, Qing-Hong Qin, +2 authors, Chang-Yuan Wei.
Exp Ther Med, 2014 Jun 19; 7(5). PMID: 24940450    Free PMC article.
Local treatment of the axilla in early breast cancer: concepts from the national surgical adjuvant breast and bowel project B-04 to the planned intergroup sentinel mamma trial.
Toralf Reimer, Steffi Hartmann, Angrit Stachs, Bernd Gerber.
Breast Care (Basel), 2014 Jun 20; 9(2). PMID: 24944550    Free PMC article.
Review.
Breast cancer and pregnancy: a comparative analysis of a Chilean cohort.
César Sánchez, Francisco Acevedo, +4 authors, Mauricio Camus.
Ecancermedicalscience, 2014 Jun 20; 8. PMID: 24944576    Free PMC article.
Increased copy number of the DLX4 homeobox gene in breast axillary lymph node metastasis.
Clarissa Torresan, Márcia M C Oliveira, +9 authors, Luciane R Cavalli.
Cancer Genet, 2014 Jun 21; 207(5). PMID: 24947980    Free PMC article.
Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes.
Patrick Maisonneuve, Davide Disalvatore, +10 authors, Aron Goldhirsch.
Breast Cancer Res, 2014 Jun 22; 16(3). PMID: 24951027    Free PMC article.
Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers.
Carol A Parise, Vincent Caggiano.
J Cancer Epidemiol, 2014 Jun 24; 2014. PMID: 24955090    Free PMC article.
Highly Cited.
Breast cancer molecular subtypes of Uygur and Han in Xinjiang of China.
Cheng-Hui Wang, Jun-Zhi Li, Wei Zhang.
Int J Clin Exp Med, 2014 Jun 24; 7(4). PMID: 24955192    Free PMC article.
High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process.
Silvia Grassilli, Federica Brugnoli, +10 authors, Valeria Bertagnolo.
Oncotarget, 2014 Jun 26; 5(12). PMID: 24962430    Free PMC article.
A functional interplay between ZNF217 and estrogen receptor alpha exists in luminal breast cancers.
Nhan T Nguyen, Julie A Vendrell, +8 authors, Pascale A Cohen.
Mol Oncol, 2014 Jun 29; 8(8). PMID: 24973012    Free PMC article.
Triple negative tumors accumulate significantly less methylglyoxal specific adducts than other human breast cancer subtypes.
Barbara Chiavarina, Marie-Julie Nokin, +10 authors, Akeila Bellahcène.
Oncotarget, 2014 Jul 01; 5(14). PMID: 24978626    Free PMC article.
Differential expression of enzymes associated with serine/glycine metabolism in different breast cancer subtypes.
Sang Kyum Kim, Woo Hee Jung, Ja Seung Koo.
PLoS One, 2014 Jul 01; 9(6). PMID: 24979213    Free PMC article.
The efficacy of molecular subtyping in predicting postoperative recurrence in breast-conserving therapy: a 15-study meta-analysis.
Jing Chen, Peng Jiang, +7 authors, Shui Wang.
World J Surg Oncol, 2014 Jul 16; 12. PMID: 25022995    Free PMC article.
The three receptor tyrosine kinases c-KIT, VEGFR2 and PDGFRα, closely spaced at 4q12, show increased protein expression in triple-negative breast cancer.
Sara Jansson, Pär-Ola Bendahl, +4 authors, Lisa Rydén.
PLoS One, 2014 Jul 16; 9(7). PMID: 25025175    Free PMC article.
Mapping lymph nodes in cancer management - role of (99m)Tc-tilmanocept injection.
Christoph Tausch, Astrid Baege, Christoph Rageth.
Onco Targets Ther, 2014 Jul 17; 7. PMID: 25028560    Free PMC article.
Review.
Yes-associated protein (YAP) is differentially expressed in tumor and stroma according to the molecular subtype of breast cancer.
Sang Kyum Kim, Woo Hee Jung, Ja Seung Koo.
Int J Clin Exp Pathol, 2014 Jul 18; 7(6). PMID: 25031743    Free PMC article.
Expression of autophagy related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma.
Yoon Jin Cha, Yon Hee Kim, Nam Hoon Cho, Ja Seung Koo.
Int J Clin Exp Pathol, 2014 Jul 18; 7(6). PMID: 25031766    Free PMC article.
An improved axillary staging system using the OSNA assay does not modify the therapeutic management of breast cancer patients.
Miguel Alonso Ruano, Eugeni Lopez-Bonet, +5 authors, Javier A Menendez.
Sci Rep, 2014 Jul 19; 4. PMID: 25034150    Free PMC article.
Major clinical research advances in gynecologic cancer in 2013.
Dong Hoon Suh, Jae-Weon Kim, +2 authors, Kyung-Hun Lee.
J Gynecol Oncol, 2014 Jul 22; 25(3). PMID: 25045437    Free PMC article.
Review.
Long-term survival analysis of korean breast cancer patients at a single center: improving outcome over time.
Sung Gwe Ahn, Hak Min Lee, +2 authors, Hy-De Lee.
Yonsei Med J, 2014 Jul 23; 55(5). PMID: 25048474    Free PMC article.
Whole-body total lesion glycolysis measured on fluorodeoxyglucose positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer.
Yoko Satoh, Atsushi Nambu, Tomoaki Ichikawa, Hiroshi Onishi.
BMC Cancer, 2014 Jul 23; 14. PMID: 25048880    Free PMC article.
Diagnostic tests based on gene expression profile in breast cancer: from background to clinical use.
Laura Zanotti, Alberto Bottini, +2 authors, Maria Rosa Cappelletti.
Tumour Biol, 2014 Jul 23; 35(9). PMID: 25048969
Review.
Expression of metabolism-related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma.
Yon Hee Kim, Woo Hee Jung, Ja Seung Koo.
Tumour Biol, 2014 Jul 24; 35(10). PMID: 25053597
Selective androgen receptor modulators (SARMs) negatively regulate triple-negative breast cancer growth and epithelial:mesenchymal stem cell signaling.
Ramesh Narayanan, Sunjoo Ahn, +4 authors, James T Dalton.
PLoS One, 2014 Jul 30; 9(7). PMID: 25072326    Free PMC article.
Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer.
Yoshiya Horimoto, Atsushi Arakawa, +7 authors, Mitsue Saito.
BMC Cancer, 2014 Jul 31; 14. PMID: 25073969    Free PMC article.
Non-coding polymorphisms in nucleotide binding domain 1 in ABCC1 gene associate with transcript level and survival of patients with breast cancer.
Tereza Kunická, Radka Václavíková, +9 authors, Pavel Souček.
PLoS One, 2014 Aug 01; 9(7). PMID: 25078270    Free PMC article.
How transferable are recommendations of the era of treating conventionally defined breast cancer for the era of molecularly characterised breast cancer?
Robert Königsberg, Christian Dittrich.
Gland Surg, 2012 Nov 01; 1(3). PMID: 25083440    Free PMC article.
Trends and present treatment patterns of early breast cancer in Southwest China.
Qiancheng Hu, Ting Luo, +5 authors, Hong Zheng.
Pathol Oncol Res, 2014 Aug 07; 21(2). PMID: 25096396
Spanish Mediterranean diet and other dietary patterns and breast cancer risk: case-control EpiGEICAM study.
A Castelló, M Pollán, +20 authors, GEICAM researchers.
Br J Cancer, 2014 Aug 08; 111(7). PMID: 25101568    Free PMC article.
Clinicopathologic subtypes and compromise of lymph nodes in patients with breast cancer.
B Jaime Jans, M Nicolás Escudero, +3 authors, A Mauricio Camus.
Ecancermedicalscience, 2014 Aug 13; 8. PMID: 25114720    Free PMC article.
Targeting autophagy in breast cancer.
Paola Maycotte, Andrew Thorburn.
World J Clin Oncol, 2014 Aug 13; 5(3). PMID: 25114840    Free PMC article.
Review.
Biological subtypes of breast cancer: Prognostic and therapeutic implications.
Ozlem Yersal, Sabri Barutca.
World J Clin Oncol, 2014 Aug 13; 5(3). PMID: 25114856    Free PMC article.
Highly Cited. Review.
How many etiological subtypes of breast cancer: two, three, four, or more?
William F Anderson, Philip S Rosenberg, +2 authors, Mark E Sherman.
J Natl Cancer Inst, 2014 Aug 15; 106(8). PMID: 25118203    Free PMC article.
Highly Cited. Review.
Acid ceramidase is associated with an improved prognosis in both DCIS and invasive breast cancer.
Nicole Sänger, Eugen Ruckhäberle, +7 authors, Thomas Karn.
Mol Oncol, 2014 Aug 19; 9(1). PMID: 25131496    Free PMC article.
Neoadjuvant chemotherapy for different molecular breast cancer subtypes: a retrospective study in Russian population.
Nataliya Babyshkina, Elena Malinovskaya, +6 authors, Nadejda Cherdyntseva.
Med Oncol, 2014 Aug 21; 31(9). PMID: 25139196
Presence of CHD1L over-expression is associated with aggressive tumor biology and is a novel prognostic biomarker for patient survival in human breast cancer.
Jiayi Wu, Yu Zong, +7 authors, Li Zhu.
PLoS One, 2014 Aug 26; 9(8). PMID: 25153161    Free PMC article.
PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors.
Maoyu Peng, Rajyasree Emmadi, +9 authors, Angela L Tyner.
Oncotarget, 2014 Aug 26; 5(15). PMID: 25153721    Free PMC article.
[18F]-fluorodeoxyglucose positron emission tomography can contribute to discriminate patients with poor prognosis in hormone receptor-positive breast cancer.
Sung Gwe Ahn, Minkyung Lee, +6 authors, Joon Jeong.
PLoS One, 2014 Aug 29; 9(8). PMID: 25167062    Free PMC article.
Progesterone receptor status and Ki-67 index may predict early relapse in luminal B/HER2 negative breast cancer patients: a retrospective study.
Yu Zong, Li Zhu, +7 authors, Kunwei Shen.
PLoS One, 2014 Aug 30; 9(8). PMID: 25170613    Free PMC article.
Geographic differences in the distribution of molecular subtypes of breast cancer in Brazil.
Filomena M Carvalho, Lívia M Bacchi, +2 authors, Carlos E Bacchi.
BMC Womens Health, 2014 Sep 02; 14. PMID: 25174527    Free PMC article.
Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancer.
R Lattanzio, R Ghasemi, +7 authors, M Piantelli.
Oncogenesis, 2014 Sep 02; 3. PMID: 25178039    Free PMC article.
Molecular subtyping predicts pathologic tumor response in early-stage breast cancer treated with neoadjuvant docetaxel plus capecitabine with or without trastuzumab chemotherapy.
Soley Bayraktar, Melanie Royce, +2 authors, Stefan Glück.
Med Oncol, 2014 Sep 05; 31(10). PMID: 25186065
Ovarian Ablation Using Goserelin Improves Survival of Premenopausal Patients with Stage II/III Hormone Receptor-Positive Breast Cancer without Chemotherapy-Induced Amenorrhea.
Juan Zhou, San-Gang Wu, +5 authors, Zhen-Yu He.
Cancer Res Treat, 2014 Sep 05; 47(1). PMID: 25187267    Free PMC article.
Immunohistochemical study of nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 in invasive breast carcinoma of no special type.
Krzysztof Symonowicz, Kamila Duś-Szachniewicz, +5 authors, Piotr Ziółkowski.
Exp Ther Med, 2014 Sep 05; 8(4). PMID: 25187794    Free PMC article.
Expression of a novel peptide derived from PCNA damages DNA and reverses cisplatin resistance.
Robert G Lingeman, Robert J Hickey, Linda H Malkas.
Cancer Chemother Pharmacol, 2014 Sep 06; 74(5). PMID: 25190177    Free PMC article.
HER2-positive endometrial cancer subtype carries poor prognosis.
Sylwia Lapińska-Szumczyk, Anna Supernat, +5 authors, Anna J Zaczek.
Clin Transl Sci, 2014 Sep 10; 7(6). PMID: 25201050    Free PMC article.
Impact of intrinsic subtype on predicting axillary lymph node metastasis in breast cancer.
Masataka Sawaki, Ai Idota, +7 authors, Hiroji Iwata.
Oncol Lett, 2014 Sep 10; 8(4). PMID: 25202396    Free PMC article.
Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers.
Hang Zhang, Xiyong Liu, +7 authors, Yun Yen.
BMC Cancer, 2014 Sep 13; 14. PMID: 25213022    Free PMC article.
Contrast enhanced computed tomography is indicative for angiogenesis pattern and display prognostic significance in breast cancer.
Jianyi Li, Yang Zhang, +3 authors, Jiao Guo.
BMC Cancer, 2014 Sep 17; 14. PMID: 25224155    Free PMC article.
Relation between radiographic BI-RADS scores and triple negativity in patients with ductal carcinomas.
Murat Oktay, Nilay Aydın Oktay, +5 authors, Burhan Yazıcı.
Int J Clin Exp Med, 2014 Sep 19; 7(8). PMID: 25232431    Free PMC article.
The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre.
Terri Patricia McVeigh, Lauren M Hughes, +4 authors, Michael J Kerin.
Eur J Cancer, 2014 Sep 23; 50(16). PMID: 25240289    Free PMC article.
HER-2 positive breast cancer is associated with an increased risk of positive cavity margins after initial lumpectomy.
Haixia Jia, Weijuan Jia, +14 authors, Fengxi Su.
World J Surg Oncol, 2014 Sep 23; 12. PMID: 25241216    Free PMC article.
Chemotherapy use and surgical treatment by receptor subtype in node-negative T1a and T1b female breast cancers, Iowa SEER Registry, 2010 to 2012.
Mary C Schroeder, Charles F Lynch, +2 authors, Alexandra Thomas.
Clin Breast Cancer, 2014 Sep 24; 15(1). PMID: 25245424    Free PMC article.
Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer.
Diego Caliari, Valentina Zappulli, +4 authors, Massimo Castagnaro.
BMC Vet Res, 2014 Sep 25; 10. PMID: 25249140    Free PMC article.
Difference between Luminal A and Luminal B Subtypes According to Ki-67, Tumor Size, and Progesterone Receptor Negativity Providing Prognostic Information.
Zorka Inic, Milan Zegarac, +6 authors, Snezana Jancic.
Clin Med Insights Oncol, 2014 Sep 25; 8. PMID: 25249766    Free PMC article.
Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial.
Andrea DeCensi, Matteo Puntoni, +15 authors, Michael N Pollak.
Breast Cancer Res Treat, 2014 Sep 26; 148(1). PMID: 25253174    Free PMC article.
Differential patterns of recurrence and specific survival between luminal A and luminal B breast cancer according to recent changes in the 2013 St Gallen immunohistochemical classification.
A García Fernández, C Chabrera, +11 authors, N Giménez.
Clin Transl Oncol, 2014 Oct 02; 17(3). PMID: 25270605
A study comparing two consecutive historical periods in breast cancer with a focus on surgical treatment, loco-regional recurrence, distant metastases and mortality.
A García-Fernández, C Chabrera, +11 authors, N Gimenez.
Clin Transl Oncol, 2014 Oct 02; 17(4). PMID: 25270606
MicroRNA expression as risk biomarker of breast cancer metastasis: a pilot retrospective case-cohort study.
Augusto L F Marino, Adriane F Evangelista, +6 authors, Marcia M C Marques.
BMC Cancer, 2014 Oct 04; 14. PMID: 25277099    Free PMC article.
Long-term outcomes following adjuvant endocrine therapy in breast cancer patients with a positive-to-negative change of hormone receptor status following neoadjuvant chemotherapy.
Jia Yi Wu, Wei Guo Chen, +5 authors, Kun Wei Shen.
Mol Clin Oncol, 2014 Oct 04; 2(6). PMID: 25279188    Free PMC article.
Risk factors for locoregional recurrence after postmastectomy radiotherapy in breast cancer patients with four or more positive axillary lymph nodes.
Q Li, S Wu, +6 authors, Z He.
Curr Oncol, 2014 Oct 11; 21(5). PMID: 25302039    Free PMC article.
Genetic polymorphism of ESR1 rs2881766 increases breast cancer risk in Korean women.
Byung Ho Son, Mi Kyung Kim, +5 authors, Sei Hyun Ahn.
J Cancer Res Clin Oncol, 2014 Oct 18; 141(4). PMID: 25323936
Breast Cancer 2012 - New Aspects.
H-C Kolberg, D Lüftner, +6 authors, S Kümmel.
Geburtshilfe Frauenheilkd, 2012 Jul 01; 72(7). PMID: 25324576    Free PMC article.
Post-mastectomy radiotherapy can improve survival in breast cancer patients aged 35 years or younger with four or more positive nodes but not in one to three positive nodes.
Sangang Wu, Qun Li, +4 authors, Zhenyu He.
Ther Clin Risk Manag, 2014 Oct 21; 10. PMID: 25328402    Free PMC article.
Overexpression of microRNA-200c predicts poor outcome in patients with PR-negative breast cancer.
Marie Tuomarila, Kaisa Luostari, +3 authors, Arto Mannermaa.
PLoS One, 2014 Oct 21; 9(10). PMID: 25329395    Free PMC article.
Crossover effects of estrogen receptor status on breast cancer-specific hazard rates by age and race.
Yu Ren, Dalliah M Black, +7 authors, Min Yi.
PLoS One, 2014 Oct 22; 9(10). PMID: 25333877    Free PMC article.
CD70: A Potential Target in Breast Cancer?
Camille Petrau, Marie Cornic, +5 authors, Florian Clatot.
J Cancer, 2014 Nov 05; 5(9). PMID: 25368676    Free PMC article.
An elevated peripheral blood lymphocyte-to-monocyte ratio predicts favorable response and prognosis in locally advanced breast cancer following neoadjuvant chemotherapy.
Xiao-Jian Ni, Xiao-Lan Zhang, +8 authors, Zhi-Ming Shao.
PLoS One, 2014 Nov 06; 9(11). PMID: 25372468    Free PMC article.
Evaluation of Ki67 expression across distinct categories of breast cancer specimens: a population-based study of matched surgical specimens, core needle biopsies and tissue microarrays.
Gøril Knutsvik, Ingunn M Stefansson, +4 authors, Lars A Akslen.
PLoS One, 2014 Nov 07; 9(11). PMID: 25375149    Free PMC article.
The clinical impact of 21-gene recurrence score on treatment decisions for patients with hormone receptor-positive early breast cancer in Korea.
Moo Hyun Lee, Wonshik Han, +7 authors, Eun Sook Lee.
Cancer Res Treat, 2014 Nov 11; 47(2). PMID: 25381828    Free PMC article.
Breast cancer arising within fibroadenoma: collective analysis of case reports in the literature and hints on treatment policy.
Yu-Ting Wu, Shou-Tung Chen, +5 authors, Hung-Wen Lai.
World J Surg Oncol, 2014 Nov 11; 12. PMID: 25382741    Free PMC article.
FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast.
Pavel Gromov, Jaime A Espinoza, +5 authors, Irina Gromova.
PLoS One, 2014 Nov 13; 9(11). PMID: 25389781    Free PMC article.
Distinct outcomes in patients with different molecular subtypes of inflammatory breast cancer.
Jingyu Zhou, Yi Yan, +5 authors, Lili Tang.
Saudi Med J, 2014 Nov 17; 35(11). PMID: 25399208    Free PMC article.
WWOX suppresses KLF5 expression and breast cancer cell growth.
Fei Ge, Wenlin Chen, +7 authors, Guosheng Ren.
Chin J Cancer Res, 2014 Nov 18; 26(5). PMID: 25400415    Free PMC article.
Association between molecular subtypes and lymph node status in invasive breast cancer.
Chengshuai Si, Yiting Jin, Hongying Wang, Qiang Zou.
Int J Clin Exp Pathol, 2014 Nov 18; 7(10). PMID: 25400761    Free PMC article.
Male breast carcinoma: a clinicopathological and immunohistochemical characterization study.
Ruoji Zhou, Lin Yu, +6 authors, Wentao Yang.
Int J Clin Exp Pathol, 2014 Nov 18; 7(10). PMID: 25400768    Free PMC article.
Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy.
Qi-Xing Tan, Qing-Hong Qin, +2 authors, Chang-Yuan Wei.
Int J Clin Exp Pathol, 2014 Nov 18; 7(10). PMID: 25400769    Free PMC article.
Current treatment of early breast cancer: adjuvant and neoadjuvant therapy.
Elizabeth Miller, Hee Jin Lee, +3 authors, Bora Lim.
F1000Res, 2014 Nov 18; 3. PMID: 25400908    Free PMC article.
Review.
Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients.
Patricia R Blank, Martin Filipits, +11 authors, Michael Gnant.
Pharmacoeconomics, 2014 Nov 19; 33(2). PMID: 25404424    Free PMC article.
Ki67 as a predictor of poor prognosis in patients with triple-negative breast cancer.
Haitao Li, Xinghua Han, +2 authors, Guomin Dong.
Oncol Lett, 2014 Dec 02; 9(1). PMID: 25435949    Free PMC article.
Human breast cancer and lymph node metastases express Gb3 and can be targeted by STxB-vectorized chemotherapeutic compounds.
Lev Stimmer, Sabrina Dehay, +5 authors, Ludger Johannes.
BMC Cancer, 2014 Dec 06; 14. PMID: 25476116    Free PMC article.
Objective consensus from decision trees.
Paul Martin Putora, Cedric M Panje, +3 authors, Ludwig Plasswilm.
Radiat Oncol, 2014 Dec 06; 9. PMID: 25476988    Free PMC article.
Kinome-wide functional screen identifies role of PLK1 in hormone-independent, ER-positive breast cancer.
Neil E Bhola, Valerie M Jansen, +11 authors, Carlos L Arteaga.
Cancer Res, 2014 Dec 07; 75(2). PMID: 25480943    Free PMC article.
Molecular Markers as Prognostic Factors in DCIS and Small Invasive Breast Cancers.
N Sänger, K Engels, +6 authors, T Karn.
Geburtshilfe Frauenheilkd, 2014 Dec 09; 74(11). PMID: 25484376    Free PMC article.
Site-specific metabolic phenotypes in metastatic breast cancer.
Hye Min Kim, Woo Hee Jung, Ja Seung Koo.
J Transl Med, 2014 Dec 17; 12. PMID: 25496516    Free PMC article.
A new tumor biomarker, serum protein peak at 3,144 m/z, in patients with node-positive breast cancer.
Z Chen, S Xu, +6 authors, X Wang.
Clin Transl Oncol, 2014 Dec 17; 17(6). PMID: 25511546    Free PMC article.
Association between Pathological Complete Response and Outcome Following Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients.
Sutima Luangdilok, Norasate Samarnthai, Krittiya Korphaisarn.
J Breast Cancer, 2014 Dec 31; 17(4). PMID: 25548587    Free PMC article.
Expression of sarcosine metabolism-related proteins according to metastatic site in breast cancer.
Yoon Jin Cha, Do Hee Kim, Woo Hee Jung, Ja Seung Koo.
Int J Clin Exp Pathol, 2015 Jan 01; 7(11). PMID: 25550822    Free PMC article.
New cell culture model for aromatase inhibitor-resistant breast cancer shows sensitivity to fulvestrant treatment and cross-resistance between letrozole and exemestane.
Stine Hole, Astrid M Pedersen, +3 authors, Anne E Lykkesfeldt.
Int J Oncol, 2015 Jan 28; 46(4). PMID: 25625755    Free PMC article.
Epithelial-mesenchymal transition markers in lymph node metastases and primary breast tumors - relation to dissemination and proliferation.
Aleksandra Markiewicz, Marzena Wełnicka-Jaśkiewicz, +4 authors, Anna J Żaczek.
Am J Transl Res, 2015 Jan 30; 6(6). PMID: 25628790    Free PMC article.
Methylation of tumor suppressor genes is related with copy number aberrations in breast cancer.
Rosa Murria, Sarai Palanca, +12 authors, Pascual Bolufer.
Am J Cancer Res, 2015 Jan 30; 5(1). PMID: 25628946    Free PMC article.
MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Paul Vilquin, Caterina F Donini, +5 authors, Pascale A Cohen.
Breast Cancer Res, 2015 Jan 31; 17. PMID: 25633049    Free PMC article.
Cardiac protective effects of dexrazoxane on animal cardiotoxicity model induced by anthracycline combined with trastuzumab is associated with upregulation of calpain-2.
Sheng Zhang, Tingting Meng, +2 authors, Jin Zhang.
Medicine (Baltimore), 2015 Jan 31; 94(4). PMID: 25634181    Free PMC article.
Regional Disease Control in Selected Patients with Sentinel Lymph Node Involvement and Omission of Axillary Lymph Node Dissection.
Gábor Cserni, Róbert Maráz.
Pathol Oncol Res, 2015 Feb 05; 21(4). PMID: 25648437
A randomized controlled study evaluating safety and efficacy of leuprorelin acetate every-3-months depot for 2 versus 3 or more years with tamoxifen for 5 years as adjuvant treatment in premenopausal patients with endocrine-responsive breast cancer.
Eiichi Shiba, Hiroko Yamashita, +5 authors, Tsukasa Fujimoto.
Breast Cancer, 2015 Feb 07; 23(3). PMID: 25655898    Free PMC article.
Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients.
Gul Alco, Atilla Bozdogan, +8 authors, Vahit Ozmen.
Oncol Lett, 2015 Feb 11; 9(3). PMID: 25663855    Free PMC article.
Systematization of Oncoplastic Surgery: Selection of Surgical Techniques and Patient-Reported Outcome in a Cohort of 1,035 Patients.
Mahdi Rezai, Sarah Knispel, +3 authors, Peter Kern.
Ann Surg Oncol, 2015 Feb 13; 22(11). PMID: 25672561    Free PMC article.
Using the Lymph Node Ratio to Evaluate the Prognosis of Stage II/III Breast Cancer Patients Who Received Neoadjuvant Chemotherapy and Mastectomy.
San-Gang Wu, Qun Li, +6 authors, Zhen-Yu He.
Cancer Res Treat, 2015 Feb 13; 47(4). PMID: 25672578    Free PMC article.
Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer.
Kenjiro Aogi, Takayuki Kadoya, +4 authors, Morihito Okada.
Breast Cancer Res Treat, 2015 Feb 24; 150(1). PMID: 25697596    Free PMC article.
An international study to increase concordance in Ki67 scoring.
Mei-Yin C Polley, Samuel C Y Leung, +28 authors, Torsten O Nielsen.
Mod Pathol, 2015 Feb 24; 28(6). PMID: 25698062
Highly Cited.
Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring.
Andrew McGuire, James A L Brown, Michael J Kerin.
Cancer Metastasis Rev, 2015 Feb 28; 34(1). PMID: 25721950    Free PMC article.
Highly Cited. Review.
In stage II/III lymph node-positive breast cancer patients less than 55 years of age, keratin 8 expression in lymph node metastases but not in the primary tumour is an indicator of better survival.
Serena Bonin, Danae Pracella, +2 authors, Giorgio Stanta.
Virchows Arch, 2015 Mar 01; 466(5). PMID: 25724181
Combining functional genomics strategies identifies modular heterogeneity of breast cancer intrinsic subtypes.
Nima Pouladi, Richard Cowper-Sallari, Jason H Moore.
BioData Min, 2014 Jan 01; 7. PMID: 25745517    Free PMC article.
Differential expression of lipid metabolism-related proteins in different breast cancer subtypes.
Sewha Kim, YuKyung Lee, Ja Seung Koo.
PLoS One, 2015 Mar 10; 10(3). PMID: 25751270    Free PMC article.
Outcome of Epstein-Barr virus-associated primary breast cancer.
Chafika Mazouni, Frédéric Fina, +3 authors, Pierre-Marie Martin.
Mol Clin Oncol, 2015 Mar 24; 3(2). PMID: 25798256    Free PMC article.
Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.
Tong Wang, Yuanyuan Ma, +3 authors, Ruifang Niu.
Tumour Biol, 2015 Mar 26; 36(8). PMID: 25804795
Folate receptor-α (FOLR1) expression and function in triple negative tumors.
Brian M Necela, Jennifer A Crozier, +16 authors, Edith A Perez.
PLoS One, 2015 Mar 31; 10(3). PMID: 25816016    Free PMC article.
Retrospective analysis of metastatic behaviour of breast cancer subtypes.
C Dilara Savci-Heijink, Hans Halfwerk, +3 authors, Marc J van de Vijver.
Breast Cancer Res Treat, 2015 Mar 31; 150(3). PMID: 25820592    Free PMC article.
Expression of sarcosine metabolism-related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma.
Yoon Jin Cha, Woo Hee Jung, Nam Hoon Cho, Ja Seung Koo.
Yonsei Med J, 2015 Apr 04; 56(3). PMID: 25837163    Free PMC article.
Optimal systemic therapy for early breast cancer in women: a clinical practice guideline.
A Eisen, G G Fletcher, +5 authors, members of the Early Breast Cancer Systemic Therapy Consensus Panel.
Curr Oncol, 2015 Apr 08; 22(Suppl 1). PMID: 25848340    Free PMC article.
High levels of DJ-1 protein and isoelectric point 6.3 isoform in sera of breast cancer patients.
Takahiko Kawate, Keiichi Iwaya, +16 authors, Norio Kohno.
Cancer Sci, 2015 Apr 14; 106(7). PMID: 25867058    Free PMC article.
Prediction of breast cancer survival using clinical and genetic markers by tumor subtypes.
Nan Song, Ji-Yeob Choi, +12 authors, Daehee Kang.
PLoS One, 2015 Apr 14; 10(4). PMID: 25867717    Free PMC article.
Prognostic value of tumor-associated macrophages according to histologic locations and hormone receptor status in breast cancer.
Jae Moon Gwak, Min Hye Jang, +2 authors, So Yeon Park.
PLoS One, 2015 Apr 18; 10(4). PMID: 25884955    Free PMC article.
Standardization for Ki-67 assessment in moderately differentiated breast cancer. A retrospective analysis of the SAKK 28/12 study.
Zsuzsanna Varga, Estelle Cassoly, +6 authors, Thomas Ruhstaller.
PLoS One, 2015 Apr 18; 10(4). PMID: 25885288    Free PMC article.
Correlation between (18)F-FDG uptake on PET/CT and prognostic factors in triple-negative breast cancer.
Hye Ryoung Koo, Jeong Seon Park, +3 authors, Woo Kyung Moon.
Eur Radiol, 2015 Apr 24; 25(11). PMID: 25903708
Five-year risk of interval-invasive second breast cancer.
Janie M Lee, Diana S M Buist, +6 authors, Rebecca A Hubbard.
J Natl Cancer Inst, 2015 Apr 24; 107(7). PMID: 25904721    Free PMC article.
Prognostic Relevance of Circulating Tumor Cells in Molecular Subtypes of Breast Cancer.
M Banys-Paluchowski, H Schneck, +7 authors, H Neubauer.
Geburtshilfe Frauenheilkd, 2015 Apr 29; 75(3). PMID: 25914415    Free PMC article.
An interobserver reproducibility analysis of Ki67 visual assessment in breast cancer.
Ruohong Shui, Baohua Yu, +2 authors, Wentao Yang.
PLoS One, 2015 May 02; 10(5). PMID: 25932921    Free PMC article.
Association between ¹⁸F-FDG uptake and molecular subtype of breast cancer.
Kazuhiro Kitajima, Kazuhito Fukushima, +6 authors, Shozo Hirota.
Eur J Nucl Med Mol Imaging, 2015 May 08; 42(9). PMID: 25947575
Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics.
Gi-Bang Koo, Michael J Morgan, +19 authors, You-Sun Kim.
Cell Res, 2015 May 09; 25(6). PMID: 25952668    Free PMC article.
Highly Cited.
Evaluation of human epidermal growth factor receptor 2 in breast cancer with a novel specific aptamer.
Ming Chu, Jia-Rui Kang, +6 authors, Yue-Dan Wang.
Cell Mol Immunol, 2015 May 12; 14(4). PMID: 25958844    Free PMC article.
Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration.
I Acerbi, L Cassereau, +7 authors, V M Weaver.
Integr Biol (Camb), 2015 May 12; 7(10). PMID: 25959051    Free PMC article.
Highly Cited.
Genotype/Phenotype correlations in patients with hereditary breast cancer.
Maike Wittersheim, Reinhard Büttner, Birgid Markiefka.
Breast Care (Basel), 2015 May 12; 10(1). PMID: 25960721    Free PMC article.
Review.
Om.breast cancer in very young women aged 25 year-old or below in the center of Tunisia and review of the literature.
Soumaya Ben Abdelkrim, Khadija Fathallah, +3 authors, Moncef Mokni.
Pathol Oncol Res, 2015 May 13; 21(3). PMID: 25962349
Review.
Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.
Erica T Warner, Rulla M Tamimi, +9 authors, Ann H Partridge.
J Clin Oncol, 2015 May 13; 33(20). PMID: 25964252    Free PMC article.
Highly Cited.
Lower Breast Cancer Risk among Women following the World Cancer Research Fund and American Institute for Cancer Research Lifestyle Recommendations: EpiGEICAM Case-Control Study.
Adela Castelló, Miguel Martín, +22 authors, EpiGEICAM Researchers.
PLoS One, 2015 May 16; 10(5). PMID: 25978407    Free PMC article.
Cyr61 as mediator of Src signaling in triple negative breast cancer cells.
María Pilar Sánchez-Bailón, Annarica Calcabrini, +6 authors, Jorge Martín-Pérez.
Oncotarget, 2015 May 20; 6(15). PMID: 25980494    Free PMC article.
The expression of CXCL13 and its relation to unfavorable clinical characteristics in young breast cancer.
Lujia Chen, Zhongxi Huang, +7 authors, Changsheng Ye.
J Transl Med, 2015 May 21; 13. PMID: 25990390    Free PMC article.
The influence of steroid receptor status on the cardiotoxicity risk in HER2-positive breast cancer patients receiving trastuzumab.
Joanna Huszno, Agnieszka Badora, Elżbieta Nowara.
Arch Med Sci, 2015 May 23; 11(2). PMID: 25995754    Free PMC article.
Targeting CD151 by lentivirus-mediated RNA interference inhibits luminal and basal-like breast cancer cell growth and invasion.
Ting Liu, Shaoqing wang, +2 authors, Yulin Li.
Mol Cell Biochem, 2015 May 25; 407(1-2). PMID: 26003442
Elevated expression of the retinoic acid-metabolizing enzyme CYP26C1 in primary breast carcinomas.
Makoto Osanai, Gang-Hong Lee.
Med Mol Morphol, 2015 May 27; 49(1). PMID: 26009309
Effects of age on the detection and management of breast cancer.
Andrew McGuire, James A L Brown, +2 authors, Michael J Kerin.
Cancers (Basel), 2015 May 27; 7(2). PMID: 26010605    Free PMC article.
Highly Cited. Review.
Macroscopic optical physiological parameters correlate with microscopic proliferation and vessel area breast cancer signatures.
So Hyun Chung, Michael D Feldman, +10 authors, Regine Choe.
Breast Cancer Res, 2015 May 28; 17. PMID: 26013572    Free PMC article.
Molecular Phenotype of Breast Cancer According to Time Since Last Pregnancy in a Large Cohort of Young Women.
Laura C Collins, Shari Gelber, +12 authors, Ann H Partridge.
Oncologist, 2015 May 31; 20(7). PMID: 26025931    Free PMC article.
PI3K mutations in breast cancer: prognostic and therapeutic implications.
Toru Mukohara.
Breast Cancer (Dove Med Press), 2015 Jun 02; 7. PMID: 26028978    Free PMC article.
Highly Cited. Review.
Expression of cancer-associated fibroblast-related proteins in adipose stroma of breast cancer.
Yoon Yang Jung, Yu Kyung Lee, Ja Seung Koo.
Tumour Biol, 2015 Jun 06; 36(11). PMID: 26044562
Identifying ultrasound and clinical features of breast cancer molecular subtypes by ensemble decision.
Lei Zhang, Jing Li, +7 authors, Jiawei Tian.
Sci Rep, 2015 Jun 06; 5. PMID: 26046791    Free PMC article.
Progesterone receptor loss identifies luminal-type local advanced breast cancer with poor survival in patients who fail to achieve a pathological complete response to neoadjuvant chemotherapy.
Sheng Chen, Liang Huang, Can-Ming Chen, Zhi-Ming Shao.
Oncotarget, 2015 Jun 09; 6(20). PMID: 26053183    Free PMC article.
The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study.
Signe Borgquist, Wenjing Zhou, +6 authors, Fredrik Wärnberg.
BMC Cancer, 2015 Jun 13; 15. PMID: 26062614    Free PMC article.
Immunohistochemical Predictors of Bone Metastases in Breast Cancer Patients.
Piotr Winczura, Katarzyna Sosińska-Mielcarek, +10 authors, Jacek Jassem.
Pathol Oncol Res, 2015 Jun 13; 21(4). PMID: 26062800    Free PMC article.
Difference between observed and expected number of involved lymph nodes reflects the metastatic potential of breast cancer independent to intrinsic subtype.
Ke-Da Yu, Yi-Zhou Jiang, Zhi-Ming Shao.
Oncotarget, 2015 Jun 14; 6(18). PMID: 26071479    Free PMC article.
Preclinical optimization of a broad-spectrum anti-bladder cancer tri-drug regimen via the Feedback System Control (FSC) platform.
Qi Liu, Cheng Zhang, +13 authors, Jingde Zhu.
Sci Rep, 2015 Jun 20; 5. PMID: 26088171    Free PMC article.
Positive Association of Fibroadenomatoid Change with HER2-Negative Invasive Breast Cancer: A Co-Occurrence Study.
Yaqin Chen, Anthony Bekhash, +9 authors, Hai Hu.
PLoS One, 2015 Jun 23; 10(6). PMID: 26098961    Free PMC article.
Differential immune cell densities in ductal carcinoma In-Situ and invasive breast cancer: Possible role of leukocytes in early stages of carcinogenesis.
Bushra Sikandar, Muhammad Asif Qureshi, +2 authors, Lubna Avesi.
Pak J Med Sci, 2015 Jun 24; 31(2). PMID: 26101474    Free PMC article.
Predictive Factors for Non-Sentinel Lymph Node Metastasis in the Case of Positive Sentinel Lymph Node Metastasis in Two or Fewer Nodes in Breast Cancer.
Chie Toshikawa, Yu Koyama, +11 authors, Toshifumi Wakai.
J Clin Med Res, 2015 Jul 01; 7(8). PMID: 26124908    Free PMC article.
Evaluation of the pathological response and prognosis following neoadjuvant chemotherapy in molecular subtypes of breast cancer.
Yue Zhao, Xiaoqiu Dong, +4 authors, Dongwei Zhang.
Onco Targets Ther, 2015 Jul 08; 8. PMID: 26150728    Free PMC article.
Differences in Clinical Outcomes between Luminal A and B Type Breast Cancers according to the St. Gallen Consensus 2013.
Hyo Jung Ahn, Soo Jin Jung, +2 authors, Hye-Kyoung Yoon.
J Breast Cancer, 2015 Jul 15; 18(2). PMID: 26155291    Free PMC article.
Basal ¹⁸F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography as a prognostic biomarker in patients with locally advanced breast cancer.
Ana María García Vicente, Ángel Soriano Castrejón, +4 authors, Ruth Espinosa Aunión.
Eur J Nucl Med Mol Imaging, 2015 Jul 15; 42(12). PMID: 26156534
The Clinicopathologic and Prognostic Value of Altered Chromosome 17 Centromere Copy Number in HER2 Fish Equivocal Breast Carcinomas.
Hongfei Ji, Qijia Xuan, +2 authors, Qingyuan Zhang.
PLoS One, 2015 Jul 15; 10(7). PMID: 26161550    Free PMC article.
Expression of cancer-associated fibroblast related proteins in metastatic breast cancer: an immunohistochemical analysis.
Hye Min Kim, Woo Hee Jung, Ja Seung Koo.
J Transl Med, 2015 Jul 15; 13. PMID: 26163388    Free PMC article.
Deregulated hepsin protease activity confers oncogenicity by concomitantly augmenting HGF/MET signalling and disrupting epithelial cohesion.
T A Tervonen, D Belitškin, +14 authors, J Klefström.
Oncogene, 2015 Jul 15; 35(14). PMID: 26165838
Evaluation of an Optimal Cut-Off Point for the Ki-67 Index as a Prognostic Factor in Primary Breast Cancer: A Retrospective Study.
Rumiko Tashima, Reiki Nishimura, +6 authors, Nobuyuki Arima.
PLoS One, 2015 Jul 16; 10(7). PMID: 26177501    Free PMC article.
Atlas of Cancer Signalling Network: a systems biology resource for integrative analysis of cancer data with Google Maps.
I Kuperstein, E Bonnet, +10 authors, A Zinovyev.
Oncogenesis, 2015 Jul 21; 4. PMID: 26192618    Free PMC article.
Application of a 70-Gene Expression Profile to Japanese Breast Cancer Patients.
Hideo Shimizu, Yoshiya Horimoto, +14 authors, Mitsue Saito.
Breast Care (Basel), 2015 Jul 22; 10(2). PMID: 26195940    Free PMC article.
Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer.
Yingbo Shao, Xianfu Sun, +2 authors, Hui Liu.
PLoS One, 2015 Jul 25; 10(7). PMID: 26207909    Free PMC article.
Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial.
Otto Metzger Filho, Anita Giobbie-Hurder, +12 authors, Aron Goldhirsch.
J Clin Oncol, 2015 Jul 29; 33(25). PMID: 26215945    Free PMC article.
Optimal approach in early breast cancer: Adjuvant and neoadjuvant treatment.
J Ribeiro, B Sousa, F Cardoso.
EJC Suppl, 2013 Sep 01; 11(2). PMID: 26217109    Free PMC article.
Review.
The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients.
Sabine Krenn-Pilko, Uwe Langsenlehner, +4 authors, Tanja Langsenlehner.
Tumour Biol, 2015 Jul 30; 37(1). PMID: 26219894
Diagnostic value of preoperative axillary lymph node ultrasound assessment in patients with breast cancer qualified for sentinel lymph node biopsy.
Tomasz Nowikiewicz, Adam Nowak, +2 authors, Wojciech Zegarski.
Wideochir Inne Tech Maloinwazyjne, 2015 Aug 05; 10(2). PMID: 26240616    Free PMC article.
Distinguishing Low-Risk Luminal A Breast Cancer Subtypes with Ki-67 and p53 Is More Predictive of Long-Term Survival.
Se Kyung Lee, Soo Youn Bae, +6 authors, Seok Jin Nam.
PLoS One, 2015 Aug 05; 10(8). PMID: 26241661    Free PMC article.
The Roles of the Learned Societies in Improving Quality of Life in the context of Globalisation.
Michael Baum.
Ann Med Surg (Lond), 2012 Jan 01; 1. PMID: 26257900    Free PMC article.
Breast Cancer in Elderly Caucasian Women-An Institution-Based Study of Correlation between Breast Cancer Prognostic Markers, TNM Stage, and Overall Survival.
Amila Orucevic, Matthew Curzon, +4 authors, John Bell.
Cancers (Basel), 2015 Aug 13; 7(3). PMID: 26264027    Free PMC article.
Evaluation of hormone receptor, human epidermal growth factor receptor-2 and Ki-67 with core needle biopsy and neoadjuvant chemotherapy effects in breast cancer patients.
Wen-Kai Ge, Ben Yang, +5 authors, Mei-Zhu Zheng.
Thorac Cancer, 2015 Aug 15; 6(1). PMID: 26273337    Free PMC article.
Essential medicines for breast cancer in low and middle income countries.
Y T Bazargani, A de Boer, +2 authors, Aukje K Mantel-Teeuwisse.
BMC Cancer, 2015 Aug 19; 15. PMID: 26283654    Free PMC article.
Do Recent Advances in Diagnostic and Therapeutic Procedures Negate the Benefit of Postmastectomy Radiotherapy in N1 Patients With a Low Risk of Locoregional Recurrence?
Jee Suk Chang, Jeongshim Lee, +7 authors, Yong Bae Kim.
Medicine (Baltimore), 2015 Aug 20; 94(33). PMID: 26287410    Free PMC article.
The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis.
Shu Chen Lin, Zhi Hua Gan, Yang Yao, Da Liu Min.
PLoS One, 2015 Aug 26; 10(8). PMID: 26305693    Free PMC article.
Clinical Significance of Microcalcifications Detection in Invasive Breast Carcinoma.
Yuki Hashimoto, Aya Murata, +8 authors, Yasuaki Hirooka.
Yonago Acta Med, 2015 Aug 26; 58(2). PMID: 26306060    Free PMC article.
Molecular biomarkers screened by next-generation RNA sequencing for non-sentinel lymph node status prediction in breast cancer patients with metastatic sentinel lymph nodes.
Feng Liang, Hongzhu Qu, +8 authors, Xiaopeng Hao.
World J Surg Oncol, 2015 Aug 28; 13. PMID: 26311227    Free PMC article.
Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen.
Tadanobu Nagaya, Kazuhide Sato, +3 authors, Hisataka Kobayashi.
PLoS One, 2015 Aug 28; 10(8). PMID: 26313651    Free PMC article.
Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse.
Ke-Da Yu, Xin Wang, +2 authors, Zhi-Ming Shao.
Oncotarget, 2015 Sep 01; 6(28). PMID: 26314842    Free PMC article.
Impact of immunohistochemistry-based molecular subtype on chemosensitivity and survival in Hispanic breast cancer patients following neoadjuvant chemotherapy.
Rodolfo Gómez, Carlos Andrés Ossa, +13 authors, Héctor García.
Ecancermedicalscience, 2015 Sep 01; 9. PMID: 26316883    Free PMC article.
Conference report from the 2015 OECI Oncology Days, Portugal, 22-24 June-tumour heterogeneity and next generation sequencing: morphology and technology.
Linda Cairns.
Ecancermedicalscience, 2015 Sep 01; 9. PMID: 26316886    Free PMC article.
Predicting Non-sentinel Lymph Node Metastasis in a Chinese Breast Cancer Population with 1-2 Positive Sentinel Nodes: Development and Assessment of a New Predictive Nomogram.
Jia-ying Chen, Jia-jian Chen, +7 authors, Jiong Wu.
World J Surg, 2015 Sep 02; 39(12). PMID: 26324157
Immunohistochemical, genetic and epigenetic profiles of hereditary and triple negative breast cancers. Relevance in personalized medicine.
Rosa Murria, Sarai Palanca, +14 authors, Pascual Bolufer.
Am J Cancer Res, 2015 Sep 04; 5(7). PMID: 26328265    Free PMC article.
Expression of Lipid Metabolism-Related Proteins in Metastatic Breast Cancer.
Yoon Yang Jung, Hye Min Kim, Ja Seung Koo.
PLoS One, 2015 Sep 04; 10(9). PMID: 26334757    Free PMC article.
Expression of p16 and pRB in invasive breast cancer.
Eunah Shin, Woo-Hee Jung, Ja-Seung Koo.
Int J Clin Exp Pathol, 2015 Sep 05; 8(7). PMID: 26339389    Free PMC article.
Clinicopathological classification and traditional prognostic indicators of breast cancer.
Jiehua Li, Zhibai Chen, Ka Su, Jian Zeng.
Int J Clin Exp Pathol, 2015 Sep 05; 8(7). PMID: 26339424    Free PMC article.
Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer.
Michael D Brooks, Monika L Burness, Max S Wicha.
Cell Stem Cell, 2015 Sep 05; 17(3). PMID: 26340526    Free PMC article.
Highly Cited. Review.
The Effect of Young Age in Hormone Receptor Positive Breast Cancer.
Minna K Lee, Leo A Varzi, +4 authors, Helena R Chang.
Biomed Res Int, 2015 Sep 10; 2015. PMID: 26351632    Free PMC article.
Prognostic role of PIK3CA mutations of cell-free DNA in early-stage triple negative breast cancer.
Takashi Takeshita, Yutaka Yamamoto, +5 authors, Hirotaka Iwase.
Cancer Sci, 2015 Sep 12; 106(11). PMID: 26353837    Free PMC article.
Prognostic effect analysis of molecular subtype on young breast cancer patients.
Hong-Liang Chen, Ang Ding, Fu-Wen Wang.
Chin J Cancer Res, 2015 Sep 12; 27(4). PMID: 26361413    Free PMC article.
4-IHC classification of breast cancer subtypes in a large cohort of a clinical cancer registry: use in clinical routine for therapeutic decisions and its effect on survival.
Elisabeth Christine Inwald, M Koller, +5 authors, O Ortmann.
Breast Cancer Res Treat, 2015 Sep 16; 153(3). PMID: 26369534    Free PMC article.
Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications.
Siker Kimbung, Anikó Kovács, +10 authors, Ingrid Hedenfalk.
Oncotarget, 2015 Sep 17; 6(32). PMID: 26375671    Free PMC article.
Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial.
E Munzone, A Giobbie-Hurder, +13 authors, International Breast Cancer Study Group and the BIG 1-98 Collaborative Group.
Ann Oncol, 2015 Sep 21; 26(12). PMID: 26387144    Free PMC article.
A Case Report of Adenoid Cystic Carcinoma of Breast- So Close Yet So Far from Triple Negative Breast Cancer.
Barath Raj Kumar, Naveen Padmanabhan, Gajasaraj Bose, Venkat Paneer.
J Clin Diagn Res, 2015 Sep 24; 9(7). PMID: 26393191    Free PMC article.
Radiation-induced lung damage promotes breast cancer lung-metastasis through CXCR4 signaling.
Lynn Feys, Benedicte Descamps, +6 authors, Olivier De Wever.
Oncotarget, 2015 Sep 24; 6(29). PMID: 26396176    Free PMC article.
Impact of updated HER2 testing guidelines in breast cancer--re-evaluation of HERA trial fluorescence in situ hybridization data.
Oliver C Stoss, Andreas Scheel, +6 authors, Josef Rüschoff.
Mod Pathol, 2015 Sep 26; 28(12). PMID: 26403781
The importance of tissue handling of surgically removed breast cancer for an accurate assessment of the Ki-67 index.
Nobuyuki Arima, Reiki Nishimura, +6 authors, Yasuo Toyozumi.
J Clin Pathol, 2015 Oct 01; 69(3). PMID: 26420767    Free PMC article.
Signatures of post-zygotic structural genetic aberrations in the cells of histologically normal breast tissue that can predispose to sporadic breast cancer.
Lars A Forsberg, Chiara Rasi, +27 authors, Jan P Dumanski.
Genome Res, 2015 Oct 03; 25(10). PMID: 26430163    Free PMC article.
Impact of immunohistological subtypes on the long-term prognosis of patients with metastatic breast cancer.
Kokoro Kobayashi, Yoshinori Ito, +8 authors, Kiyohiko Hatake.
Surg Today, 2015 Oct 16; 46(7). PMID: 26467559
Comparison of Clinicopathological Features and Treatment Results between Invasive Lobular Carcinoma and Ductal Carcinoma of the Breast.
Jun Su Park, Doo Ho Choi, +5 authors, Won Ho Kil.
J Breast Cancer, 2015 Oct 17; 18(3). PMID: 26472980    Free PMC article.
High Levels of Nucleolar Spindle-Associated Protein and Reduced Levels of BRCA1 Expression Predict Poor Prognosis in Triple-Negative Breast Cancer.
Li Chen, Liu Yang, +5 authors, Zhi-Ming Shao.
PLoS One, 2015 Oct 21; 10(10). PMID: 26485712    Free PMC article.
Correlation between conductivity and prognostic factors in invasive breast cancer using magnetic resonance electric properties tomography (MREPT).
Soo-Yeon Kim, Jaewook Shin, +4 authors, Jung Hyun Yoon.
Eur Radiol, 2015 Oct 27; 26(7). PMID: 26497503
Identifying patients at high risk of breast cancer recurrence: strategies to improve patient outcomes.
Yehoda M Martei, Jennifer M Matro.
Breast Cancer (Dove Med Press), 2015 Oct 28; 7. PMID: 26504408    Free PMC article.
Review.
Ki67/SATB1 ratio is an independent prognostic factor of overall survival in patients with early hormone receptor-positive invasive ductal breast carcinoma.
Arvydas Laurinavicius, Andrew R Green, +4 authors, Ian O Ellis.
Oncotarget, 2015 Oct 30; 6(38). PMID: 26512778    Free PMC article.
Association between Lymph Node Ratio and Disease Specific Survival in Breast Cancer Patients with One or Two Positive Lymph Nodes Stratified by Different Local Treatment Modalities.
Ruoxi Hong, Zhen Dai, Wenjie Zhu, Binghe Xu.
PLoS One, 2015 Oct 30; 10(10). PMID: 26513258    Free PMC article.
Defining lymphocyte-predominant breast cancer by the proportion of lymphocyte-rich stroma and its significance in routine histopathological diagnosis.
Haruo Ohtani, Kazuko Mori-Shiraishi, Morio Nakajima, Hamaichi Ueki.
Pathol Int, 2015 Nov 05; 65(12). PMID: 26530981    Free PMC article.
ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer.
Batoul Kaabi, Ghania Belaaloui, +4 authors, Hocine Bounecer.
Pathol Oncol Res, 2015 Nov 14; 22(2). PMID: 26563278
Identification of Differentially Expressed IGFBP5-Related Genes in Breast Cancer Tumor Tissues Using cDNA Microarray Experiments.
Mustafa Akkiprik, İrem Peker, +4 authors, Ayşe Özer.
Genes (Basel), 2015 Nov 17; 6(4). PMID: 26569312    Free PMC article.
HOXD13 methylation status is a prognostic indicator in breast cancer.
Zhenbin Zhong, Ming Shan, +5 authors, Da Pang.
Int J Clin Exp Pathol, 2015 Dec 01; 8(9). PMID: 26617782    Free PMC article.
Expression of Yes-associated protein (YAP) in metastatic breast cancer.
Hye Min Kim, Woo Hee Jung, Ja Seung Koo.
Int J Clin Exp Pathol, 2015 Dec 01; 8(9). PMID: 26617849    Free PMC article.
Prognostic significance of HOXD13 expression in human breast cancer.
Zhen-Bin Zhong, Ming Shan, +7 authors, Da Pang.
Int J Clin Exp Pathol, 2015 Dec 01; 8(9). PMID: 26617867    Free PMC article.
Associations and indications of Ki67 expression with clinicopathological parameters and molecular subtypes in invasive breast cancer: A population-based study.
Jinzhong Sun, Chuang Chen, +9 authors, Shengrong Sun.
Oncol Lett, 2015 Dec 02; 10(3). PMID: 26622743    Free PMC article.
Cell surface GRP78: A potential marker of good prognosis and response to chemotherapy in breast cancer.
Rinat Yerushalmi, Annat Raiter, Karen Nalbandyan, Britta Hardy.
Oncol Lett, 2015 Dec 02; 10(4). PMID: 26622810    Free PMC article.
Predictors of pathological complete response to neoadjuvant chemotherapy in stage II and III breast cancer: The impact of chemotherapeutic regimen.
Iheoma Y Nwaogu, Oluwadamilola M Fayanju, Donna B Jeffe, Julie A Margenthaler.
Mol Clin Oncol, 2015 Dec 02; 3(5). PMID: 26623062    Free PMC article.
Mutated Pathways as a Guide to Adjuvant Therapy Treatments for Breast Cancer.
Yang Liu, Zhenjun Hu, Charles DeLisi.
Mol Cancer Ther, 2015 Dec 03; 15(1). PMID: 26625895    Free PMC article.
Breast Cancer: State of the Art and New Findings.
C Melcher, C Scholz, +3 authors, W Janni.
Geburtshilfe Frauenheilkd, 2012 Mar 01; 72(3). PMID: 26640286    Free PMC article.
Biomarkers in Breast Cancer - An Update.
M Schmidt, P A Fasching, M W Beckmann, H Kölbl.
Geburtshilfe Frauenheilkd, 2012 Sep 01; 72(9). PMID: 26640290    Free PMC article.
Relapse profile of early breast cancer according to immunohistochemical subtypes: guidance for patient's follow up?
Nesrine Mejri, H Boussen, +3 authors, K Rahal.
Ther Adv Med Oncol, 2015 Dec 18; 7(3). PMID: 26674096    Free PMC article.
Correlation of clinicopathological outcomes with changes in IHC4 status after NACT in locally advanced breast cancers: do pre-NACT ER/PR status act as better prognosticators?
Sanjoy Chatterjee, Animesh Saha, +5 authors, Rosina Ahmed.
Breast Cancer (Dove Med Press), 2015 Dec 18; 7. PMID: 26677343    Free PMC article.
Recommendations from the EGAPP Working Group: does the use of Oncotype DX tumor gene expression profiling to guide treatment decisions improve outcomes in patients with breast cancer?
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group*.
Genet Med, 2015 Dec 19; 18(8). PMID: 26681310
The search for optimal cutoff points for apoptosis and proliferation rate in prognostification of early stage breast cancer patients treated with anthracyclines in adjuvant settings.
Beata Biesaga, Joanna Niemiec, +2 authors, Marek Ziobro.
Tumour Biol, 2015 Dec 22; 37(6). PMID: 26687650
The variation and clinical significance of hormone receptors and Her-2 status from primary to metastatic lesions in breast cancer patients.
Yan-Yun Zhu, Wen Si, +3 authors, Jun-Lan Yang.
Tumour Biol, 2015 Dec 22; 37(6). PMID: 26687919
The Values of Combined and Sub-Stratified Imaging Scores with Ultrasonography and Mammography in Breast Cancer Subtypes.
Tsun-Hou Chang, Hsian-He Hsu, +4 authors, Guo-Shiou Liao.
PLoS One, 2015 Dec 23; 10(12). PMID: 26689198    Free PMC article.
Identification of Risk Factors for Locoregional Recurrence in Breast Cancer Patients with Nodal Stage N0 and N1: Who Could Benefit from Post-Mastectomy Radiotherapy?
Eunjin Jwa, Kyung Hwan Shin, +5 authors, Young Hee Park.
PLoS One, 2015 Dec 23; 10(12). PMID: 26691445    Free PMC article.
Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium.
Emma H Allott, Stephanie M Cohen, +19 authors, Melissa A Troester.
Cancer Epidemiol Biomarkers Prev, 2015 Dec 30; 25(3). PMID: 26711328    Free PMC article.
ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells.
David Gallego-Ortega, Anita Ledger, +28 authors, Christopher J Ormandy.
PLoS Biol, 2015 Dec 31; 13(12). PMID: 26717410    Free PMC article.
Decreased Wnt5a Expression is a Poor Prognostic Factor in Triple-Negative Breast Cancer.
ZhenBin Zhong, Ming Shan, +3 authors, Da Pang.
Med Sci Monit, 2016 Jan 02; 22. PMID: 26721633    Free PMC article.
Prognostic impact of progesterone receptor status combined with body mass index in breast cancer patients treated with adjuvant aromatase inhibitor.
Masahiro Ohara, Etsushi Akimoto, +4 authors, Toshiyuki Itamoto.
Oncol Lett, 2016 Jan 02; 10(5). PMID: 26722327    Free PMC article.
Ki-67 is a prognostic marker for hormone receptor positive tumors.
M E Pérez-López, J García-Gómez, +3 authors, T García-Caballero.
Clin Transl Oncol, 2016 Jan 09; 18(10). PMID: 26742937    Free PMC article.
MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR.
Baotong Zhang, Ranran Zhao, +5 authors, Jin-Tang Dong.
Oncotarget, 2016 Jan 09; 7(5). PMID: 26744318    Free PMC article.
Characterization of MTAP Gene Expression in Breast Cancer Patients and Cell Lines.
Sarah Franco Vieira de Oliveira, Monica Ganzinelli, +9 authors, Enilze Maria de Souza Fonseca Ribeiro.
PLoS One, 2016 Jan 12; 11(1). PMID: 26751376    Free PMC article.
Developmental Insights into Breast Cancer Intratumoral Heterogeneity.
Mei Zhang, Jeffrey M Rosen.
Trends Cancer, 2016 Jan 12; 1(4). PMID: 26753176    Free PMC article.
Clinical verification of sensitivity to preoperative chemotherapy in cases of androgen receptor-expressing positive breast cancer.
Yuka Asano, Shinichiro Kashiwagi, +7 authors, Kosei Hirakawa.
Br J Cancer, 2016 Jan 13; 114(1). PMID: 26757422    Free PMC article.
Strong Expression of Hypoxia-Inducible Factor-1α (HIF-1α) Is Associated with Axl Expression and Features of Aggressive Tumors in African Breast Cancer.
Hawa Nalwoga, Lavina Ahmed, +2 authors, Lars A Akslen.
PLoS One, 2016 Jan 14; 11(1). PMID: 26760782    Free PMC article.
Geriatric oncology: problems with under-treatment within this population.
Divya Swaminathan, Vikram Swaminathan.
Cancer Biol Med, 2016 Jan 19; 12(4). PMID: 26779364    Free PMC article.
Review.
[Molecular classification of bladder cancer. Possible similarities to breast cancer].
R M Wirtz, V Fritz, R Stöhr, A Hartmann.
Pathologe, 2016 Jan 19; 37(1). PMID: 26780243
Review.
Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer.
Naoko Minatani, Mina Waraya, +11 authors, Masahiko Watanabe.
PLoS One, 2016 Jan 20; 11(1). PMID: 26785325    Free PMC article.
The inconsistency of molecular subtypes between primary foci and metastatic axillary lymph nodes in Luminal A breast cancer patients among Chinese women, an indication for chemotherapy?
Yadong Sun, Xiaofeng Liu, +8 authors, Jiaxiang Wang.
Tumour Biol, 2016 Jan 23; 37(7). PMID: 26790445
Fibroblast growth factor receptor-1 protein expression is associated with prognosis in estrogen receptor-positive/human epidermal growth factor receptor-2-negative primary breast cancer.
Mai Tomiguchi, Yutaka Yamamoto, +8 authors, Hirotaka Iwase.
Cancer Sci, 2016 Jan 24; 107(4). PMID: 26801869    Free PMC article.
Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer.
Jingdan Qiu, Xinying Xue, +4 authors, Ming Li.
J Cancer, 2016 Jan 29; 7(2). PMID: 26819640    Free PMC article.
Changes in intrinsic subtype of breast cancer during tumor progression in the same patient.
Chungyeul Kim, Jungjoo Lee, Wonyoung Lee, Aeree Kim.
Int J Clin Exp Pathol, 2016 Jan 30; 8(11). PMID: 26823864    Free PMC article.
Study design requirements for RNA sequencing-based breast cancer diagnostics.
Arvind Singh Mer, Daniel Klevebring, Henrik Grönberg, Mattias Rantalainen.
Sci Rep, 2016 Feb 03; 6. PMID: 26830453    Free PMC article.
¹⁸F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer.
Stefanie Avril, Raymond F Muzic, +3 authors, Norbert Avril.
J Nucl Med, 2016 Feb 03; 57 Suppl 1. PMID: 26834099    Free PMC article.
Review.
Quantum dots-based double imaging combined with organic dye imaging to establish an automatic computerized method for cancer Ki67 measurement.
Lin-Wei Wang, Ai-Ping Qu, +5 authors, Juan Liu.
Sci Rep, 2016 Feb 04; 6. PMID: 26839163    Free PMC article.
Outcomes of Triple-Negative Breast Cancers (TNBC) Compared with Non-TNBC: Does the Survival Vary for All Stages?
Gaurav Agarwal, Gitika Nanda, +4 authors, Narendra Krishnani.
World J Surg, 2016 Feb 05; 40(6). PMID: 26842691
St Gallen molecular subtypes in screening-detected and symptomatic breast cancer in a prospective cohort with long-term follow-up.
A K Falck, A Röme, +4 authors, L Rydén.
Br J Surg, 2016 Feb 10; 103(5). PMID: 26856820    Free PMC article.
Targeting metabolism in breast cancer: How far we can go?
Jing-Pei Long, Xiao-Na Li, Feng Zhang.
World J Clin Oncol, 2016 Feb 11; 7(1). PMID: 26862496    Free PMC article.
Review.
Dietary effects of mead acid on N-methyl-N-nitrosourea-induced mammary cancers in female Sprague-Dawley rats.
Yuichi Kinoshita, Katsuhiko Yoshizawa, +6 authors, Airo Tsubura.
Biomed Rep, 2016 Feb 13; 4(1). PMID: 26870330    Free PMC article.
Tamoxifen induces hepatotoxicity and changes to hepatocyte morphology at the early stage of endocrinotherapy in mice.
Fang-Fang Gao, Jia-Wei Lv, +4 authors, Lei Wei.
Biomed Rep, 2016 Feb 13; 4(1). PMID: 26870344    Free PMC article.
Interobserver Variability of Ki-67 Measurement in Breast Cancer.
Yul Ri Chung, Min Hye Jang, +3 authors, Korean Breast Pathology Ki-67 Study Group.
J Pathol Transl Med, 2016 Feb 16; 50(2). PMID: 26875758    Free PMC article.
Downregulation of miR-362-5p inhibits proliferation, migration and invasion of human breast cancer MCF7 cells.
Fang Ni, Zhaohua Gui, +4 authors, Siying Wang.
Oncol Lett, 2016 Feb 20; 11(2). PMID: 26893711    Free PMC article.
One-step nucleic acid amplification assay for intraoperative prediction of advanced axillary lymph node metastases in breast cancer patients with sentinel lymph node metastasis.
Michiyo Kubota, Yoshifumi Komoike, +6 authors, Kiyotaka Okuno.
Mol Clin Oncol, 2016 Feb 20; 4(2). PMID: 26893855    Free PMC article.
New insight on the biological role of p53 protein as a tumor suppressor: re-evaluation of its clinical significance in triple-negative breast cancer.
Min-Sun Jin, In Ae Park, +7 authors, Han Suk Ryu.
Tumour Biol, 2016 Feb 20; 37(8). PMID: 26894602
Low Concordance between Gene Expression Signatures in ER Positive HER2 Negative Breast Carcinoma Could Impair Their Clinical Application.
Enora Laas, Peter Mallon, +3 authors, Fabien Reyal.
PLoS One, 2016 Feb 20; 11(2). PMID: 26895349    Free PMC article.
Locoregional Recurrence by Tumor Biology in Breast Cancer Patients after Preoperative Chemotherapy and Breast Conservation Treatment.
Eunjin Jwa, Kyung Hwan Shin, +8 authors, Tae Hyun Kim.
Cancer Res Treat, 2016 Oct 19; 48(4). PMID: 26910473    Free PMC article.
Digital image analysis outperforms manual biomarker assessment in breast cancer.
Gustav Stålhammar, Nelson Fuentes Martinez, +9 authors, Johan Hartman.
Mod Pathol, 2016 Feb 27; 29(4). PMID: 26916072
A Comparison of Visual Assessment and Automated Digital Image Analysis of Ki67 Labeling Index in Breast Cancer.
Fangfang Zhong, Rui Bi, +3 authors, Ruohong Shui.
PLoS One, 2016 Mar 02; 11(2). PMID: 26928407    Free PMC article.
Manganese Superoxide Dismutase Acetylation and Dysregulation, Due to Loss of SIRT3 Activity, Promote a Luminal B-Like Breast Carcinogenic-Permissive Phenotype.
Xianghui Zou, Cesar Augusto Santa-Maria, +2 authors, Yueming Zhu.
Antioxid Redox Signal, 2016 Mar 05; 25(6). PMID: 26935174    Free PMC article.
Review.
Mifepristone Suppresses Basal Triple-Negative Breast Cancer Stem Cells by Down-regulating KLF5 Expression.
Rong Liu, Peiguo Shi, +8 authors, Ceshi Chen.
Theranostics, 2016 Mar 05; 6(4). PMID: 26941846    Free PMC article.
Highly Cited.
Association Between Insulin Resistance and Luminal B Subtype Breast Cancer in Postmenopausal Women.
Sanggeun Nam, Seho Park, +3 authors, Seung Il Kim.
Medicine (Baltimore), 2016 Mar 06; 95(9). PMID: 26945364    Free PMC article.
Current Trends in and Indications for Endoscopy-Assisted Breast Surgery for Breast Cancer: Results from a Six-Year Study Conducted by the Taiwan Endoscopic Breast Surgery Cooperative Group.
Hung-Wen Lai, Shou-Tung Chen, +5 authors, Chin-Sheng Hung.
PLoS One, 2016 Mar 08; 11(3). PMID: 26950469    Free PMC article.
Hsa-miR-375 is a predictor of local control in early stage breast cancer.
Franz Zehentmayr, Cornelia Hauser-Kronberger, +9 authors, Felix Sedlmayer.
Clin Epigenetics, 2016 Mar 11; 8. PMID: 26962366    Free PMC article.
Nomograms to estimate long-term overall survival and breast cancer-specific survival of patients with luminal breast cancer.
Wei Sun, Yi-Zhou Jiang, +2 authors, Zhi-Ming Shao.
Oncotarget, 2016 Mar 12; 7(15). PMID: 26967253    Free PMC article.
Molecular classification and prognostication of 300 node-negative breast cancer cases: A tertiary care experience.
K M Zuhara Shemin, N V Smitha, Annie Jojo, D K Vijaykumar.
South Asian J Cancer, 2016 Mar 17; 4(4). PMID: 26981506    Free PMC article.
Upregulation of E2F8 promotes cell proliferation and tumorigenicity in breast cancer by modulating G1/S phase transition.
Liping Ye, Ling Guo, +8 authors, Huanxin Lin.
Oncotarget, 2016 Mar 19; 7(17). PMID: 26992224    Free PMC article.
Ki-67 expression in luminal type breast cancer and its association with the clinicopathology of the cancer.
Peng Yuan, Benling Xu, +3 authors, Long Yuan.
Oncol Lett, 2016 Mar 22; 11(3). PMID: 26998129    Free PMC article.
Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort Study.
Se Hyun Kim, Kyung Hae Jung, +16 authors, Jee Hyun Kim.
Cancer Res Treat, 2016 Oct 19; 48(4). PMID: 27034147    Free PMC article.
Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy.
Chang Gon Kim, Joohyuk Sohn, +8 authors, Gun Min Kim.
J Breast Cancer, 2016 Apr 12; 19(1). PMID: 27064666    Free PMC article.
Diagnostic accuracy of MRI to evaluate tumour response and residual tumour size after neoadjuvant chemotherapy in breast cancer patients.
Alberto Bouzón, Benigno Acea, +6 authors, Alejandra García.
Radiol Oncol, 2016 Apr 14; 50(1). PMID: 27069452    Free PMC article.
Differential expression of the epigenetic methylation-related protein DNMT1 by breast cancer molecular subtype and stromal histology.
Eunah Shin, YuKyung Lee, Ja Seung Koo.
J Transl Med, 2016 Apr 14; 14. PMID: 27071379    Free PMC article.
Prognostic value of Ki67 and p53 in patients with estrogen receptor-positive and human epidermal growth factor receptor 2-negative breast cancer: Validation of the cut-off value of the Ki67 labeling index as a predictive factor.
Masahiro Ohara, Kazuo Matsuura, +5 authors, Toshiyuki Itamoto.
Mol Clin Oncol, 2016 Apr 14; 4(4). PMID: 27073684    Free PMC article.
Locoregional treatment of early breast cancer with isolated tumor cells or micrometastases on sentinel lymph node biopsy.
Agnès Tallet, Eric Lambaudie, +4 authors, Gilles Houvenaeghel.
World J Clin Oncol, 2016 Apr 16; 7(2). PMID: 27081647    Free PMC article.
Review.
Imaging methods for the local lymphatic system of the axilla in early breast cancer in patients qualified for sentinel lymph node biopsy.
Tomasz Nowikiewicz, Andrzej Kurylcio, Wojciech Polkowski, Wojciech Zegarski.
Prz Menopauzalny, 2016 Apr 21; 15(1). PMID: 27095960    Free PMC article.
Review.
The first case of POEMS syndrome with synchronous breast cancer: What are the associated diagnostic challenges?
Kazuhiro Hiyama, Hideo Terashima, +5 authors, Hisashi Horiguchi.
Clin Case Rep, 2016 Apr 22; 4(4). PMID: 27099730    Free PMC article.
The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters.
Barbara Brouwers, Sigrid Hatse, +15 authors, Hans Wildiers.
Oncotarget, 2016 Apr 23; 7(21). PMID: 27102154    Free PMC article.
A clinically applicable molecular classification for high-grade serous ovarian cancer based on hormone receptor expression.
Zheng Feng, Hao Wen, +4 authors, Xiaohua Wu.
Sci Rep, 2016 May 04; 6. PMID: 27139372    Free PMC article.
Change in bone mineral density during adjuvant chemotherapy for early-stage breast cancer.
Carina Ørts Christensen, Deirdre Cronin-Fenton, +2 authors, Marianne Ewertz.
Support Care Cancer, 2016 May 06; 24(10). PMID: 27146497    Free PMC article.
Molecular subtypes of breast carcinoma in Saudi Arabia. A retrospective study.
Norah A Alnegheimish, Razan A Alshatwi, +3 authors, Sufia Husain.
Saudi Med J, 2016 May 06; 37(5). PMID: 27146612    Free PMC article.
Value of Breast Cancer Molecular Subtypes and Ki67 Expression for the Prediction of Efficacy and Prognosis of Neoadjuvant Chemotherapy in a Chinese Population.
Jiayu Wang, Die Sang, +9 authors, Qiao Li.
Medicine (Baltimore), 2016 May 07; 95(18). PMID: 27149453    Free PMC article.
Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up.
Sara Bustreo, Simona Osella-Abate, +6 authors, Isabella Castellano.
Breast Cancer Res Treat, 2016 May 09; 157(2). PMID: 27155668    Free PMC article.
True Local Recurrences after Breast Conserving Surgery have Poor Prognosis in Patients with Early Breast Cancer.
Dauren Sarsenov, Serkan Ilgun, +9 authors, Vahit Ozmen.
Cureus, 2016 May 10; 8(3). PMID: 27158571    Free PMC article.
Overexpression of HIF1α and CAXI predicts poor outcome in early-stage triple negative breast cancer.
Min-Sun Jin, Hyebin Lee, +9 authors, Han Suk Ryu.
Virchows Arch, 2016 May 18; 469(2). PMID: 27184798
Intravoxel incoherent motion diffusion-weighted MR imaging of breast cancer: association with histopathological features and subtypes.
Yunju Kim, Kyounglan Ko, +4 authors, Boram Park.
Br J Radiol, 2016 May 21; 89(1063). PMID: 27197744    Free PMC article.
Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study.
Yi Chen, Kai Chen, +5 authors, Erwei Song.
BMC Cancer, 2016 May 21; 16. PMID: 27198767    Free PMC article.
High prevalence of luminal B breast cancer intrinsic subtype in Colombian women.
Silvia Juliana Serrano-Gomez, Maria Carolina Sanabria-Salas, +7 authors, Jovanny Zabaleta.
Carcinogenesis, 2016 May 22; 37(7). PMID: 27207651    Free PMC article.
Tumor-Infiltrating Lymphocytes: A Promising Biomarker in Breast Cancer.
Barbara Ingold Heppner, Sibylle Loibl, Carsten Denkert.
Breast Care (Basel), 2016 May 31; 11(2). PMID: 27239170    Free PMC article.
Review.
Appropriate Clinical Strategies for Breast Cancer Coexisting with Acute Myeloid Leukemia in the Genomic-Molecular Era: A Case Report.
Guangfu Hu, Dipendra K Mallik, +8 authors, Ziang Yang.
Breast Care (Basel), 2016 May 31; 11(2). PMID: 27239178    Free PMC article.
A single-center, randomized, parallel controlled study comparing the efficacy and safety aspects of three anthracycline-based regimens as neoadjuvant chemotherapy in primary breast cancer.
Yijun Zhou, Tao Ouyang, +6 authors, Jinfeng Li.
Breast Cancer Res Treat, 2016 Jun 03; 157(3). PMID: 27250001    Free PMC article.
Breast cancer subtype predictors revisited: from consensus to concordance?
Herman M J Sontrop, Marcel J T Reinders, Perry D Moerland.
BMC Med Genomics, 2016 Jun 05; 9(1). PMID: 27259591    Free PMC article.
Prolactin-induced protein as a potential therapy response marker of adjuvant chemotherapy in breast cancer patients.
Karolina Jablonska, Jedrzej Grzegrzolka, +10 authors, Piotr Dziegiel.
Am J Cancer Res, 2016 Jun 14; 6(5). PMID: 27293986    Free PMC article.
Tumor suppressor berberine binds VASP to inhibit cell migration in basal-like breast cancer.
Ke Su, Pengchao Hu, +7 authors, Jingwei Zhang.
Oncotarget, 2016 Jun 21; 7(29). PMID: 27322681    Free PMC article.
multiDE: a dimension reduced model based statistical method for differential expression analysis using RNA-sequencing data with multiple treatment conditions.
Guangliang Kang, Li Du, Hong Zhang.
BMC Bioinformatics, 2016 Jun 24; 17. PMID: 27334001    Free PMC article.
Therapeutic effect of taxanes on metastatic breast cancer of various immunohistochemical subtypes.
Ippei Fukada, Kazuhiro Araki, +6 authors, Yoshinori Ito.
Oncol Lett, 2016 Jun 28; 12(1). PMID: 27347197    Free PMC article.
The role of preoperative systemic treatment in patients with breast cancer.
Sylwia Dębska-Szmich, Magdalena Krakowska, +3 authors, Piotr Potemski.
Contemp Oncol (Pozn), 2016 Jul 01; 20(2). PMID: 27358586    Free PMC article.
Review.
Association between Ultrasound Features and the 21-Gene Recurrence Score Assays in Patients with Oestrogen Receptor-Positive, HER2-Negative, Invasive Breast Cancer.
Eun Young Chae, Woo Kyung Moon, +8 authors, Sei Hyun Ahn.
PLoS One, 2016 Jul 01; 11(6). PMID: 27362843    Free PMC article.
An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer.
Jelle Wesseling, Corrado Tinterri, +16 authors, Pino Cusumano.
Virchows Arch, 2016 Jul 06; 469(3). PMID: 27377889
The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression.
Pang-Kuo Lo, Ji Shin Lee, Xiaohui Liang, Saraswati Sukumar.
Cell Signal, 2016 Jul 06; 28(10). PMID: 27377963    Free PMC article.
Prognostically Distinctive Subgroup in Pathologic N3 Breast Cancer.
Yun Yeong Kim, Heung Kyu Park, +2 authors, Yong Soon Chun.
J Breast Cancer, 2016 Jul 07; 19(2). PMID: 27382392    Free PMC article.
2-(fluorine-18)-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography after breast conserving surgery: Correlation with molecular markers of breast cancer.
Salih Ozguven, Sabahat Inanir, +3 authors, Bahadir Gulluoglu.
Indian J Nucl Med, 2016 Jul 08; 31(3). PMID: 27385883    Free PMC article.
Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
Dvir Netanely, Ayelet Avraham, +2 authors, Ron Shamir.
Breast Cancer Res, 2016 Jul 09; 18(1). PMID: 27386846    Free PMC article.
Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens.
Mark Laible, Kornelia Schlombs, +8 authors, Ugur Sahin.
BMC Cancer, 2016 Jul 09; 16. PMID: 27389414    Free PMC article.
Functional impairment of activated protein C in breast cancer - relationship to survival outcomes.
Mario Roselli, Patrizia Ferroni, +9 authors, Fiorella Guadagni.
Am J Cancer Res, 2016 Jul 19; 6(6). PMID: 27429857    Free PMC article.
Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses.
Yaewon Yang, Seock-Ah Im, +11 authors, Dong-Young Noh.
BMC Cancer, 2016 Jul 23; 16. PMID: 27444430    Free PMC article.
Influence of delayed initiation of adjuvant chemotherapy on breast cancer survival is subtype-dependent.
Ke-Da Yu, Lei Fan, +3 authors, Zhi-Ming Shao.
Oncotarget, 2016 Jul 23; 8(28). PMID: 27447963    Free PMC article.
Assessment of dual-probe Her-2 fluorescent in situ hybridization in breast cancer by the 2013 ASCO/CAP guidelines produces more equivocal results than that by the 2007 ASCO/CAP guidelines.
Xiao-Long Qian, Hannah Y Wen, +6 authors, Li Fu.
Breast Cancer Res Treat, 2016 Jul 28; 159(1). PMID: 27455837    Free PMC article.
Workflow-driven clinical decision support for personalized oncology.
Anca Bucur, Jasper van Leeuwen, +5 authors, Georgios Stamatakos.
BMC Med Inform Decis Mak, 2016 Jul 28; 16 Suppl 2. PMID: 27460182    Free PMC article.
Classical pathology and mutational load of breast cancer - integration of two worlds.
Jan Budczies, Michael Bockmayr, +7 authors, Albrecht Stenzinger.
J Pathol Clin Res, 2016 Aug 09; 1(4). PMID: 27499907    Free PMC article.
Histogram analysis of apparent diffusion coefficients after neoadjuvant chemotherapy in breast cancer.
Yun Ju Kim, Sung Hun Kim, +3 authors, Byung Joo Song.
Jpn J Radiol, 2016 Aug 16; 34(10). PMID: 27517370
The Relationship Between Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor 2 Expression of Breast Cancer and the Retention Index in Dual Phase (18)F-FDG PET/CT.
Hansol Moon, Woo Chul Noh, +10 authors, Sang Moo Lim.
Nucl Med Mol Imaging, 2016 Aug 20; 50(3). PMID: 27540429    Free PMC article.
Luminal B breast cancer: patterns of recurrence and clinical outcome.
Zhi-Hua Li, Ping-Hua Hu, Jian-Hong Tu, Ni-Si Yu.
Oncotarget, 2016 Aug 20; 7(40). PMID: 27542253    Free PMC article.
The role of oncoplastic breast conserving treatment for locally advanced breast tumors. A matching case-control study.
René Aloisio da Costa Vieira, Guilherme Freire Angotti Carrara, +3 authors, Maria Aparecida Azevedo Koike Folgueira.
Ann Med Surg (Lond), 2016 Aug 23; 10. PMID: 27547399    Free PMC article.
Young Age Is Associated with Increased Locoregional Recurrence in Node-Positive Breast Cancer with Luminal Subtypes.
Sang-Won Kim, Mison Chun, +5 authors, Seung Hee Kang.
Cancer Res Treat, 2016 Aug 25; 49(2). PMID: 27554479    Free PMC article.
QSOX1 expression is associated with aggressive tumor features and reduced survival in breast carcinomas.
Gøril Knutsvik, Karin Collett, +2 authors, Ingunn M Stefansson.
Mod Pathol, 2016 Aug 27; 29(12). PMID: 27562495
Postdiagnosis Weight Change and Survival Following a Diagnosis of Early-Stage Breast Cancer.
Elizabeth M Cespedes Feliciano, Candyce H Kroenke, +5 authors, Bette J Caan.
Cancer Epidemiol Biomarkers Prev, 2016 Aug 28; 26(1). PMID: 27566419    Free PMC article.
Clinicopathological relevance of kinesin family member 18A expression in invasive breast cancer.
Mai Kasahara, Makoto Nagahara, +4 authors, Kenichi Sugihara.
Oncol Lett, 2016 Sep 03; 12(3). PMID: 27588139    Free PMC article.
Risk factors for seroma evacuation in breast cancer patients treated with intraoperative radiotherapy.
Michał Falco, Bartłomiej Masojć, +6 authors, Andrzej Kram.
Rep Pract Oncol Radiother, 2016 Sep 08; 21(3). PMID: 27601955    Free PMC article.
From High-Throughput Microarray-Based Screening to Clinical Application: The Development of a Second Generation Multigene Test for Breast Cancer Prognosis.
Jan C Brase, Ralf Kronenwett, +2 authors, Marcus Schmidt.
Microarrays (Basel), 2013 Jan 01; 2(3). PMID: 27605191    Free PMC article.
Review.
CITED2 in breast carcinoma as a potent prognostic predictor associated with proliferation, migration and chemoresistance.
Hiroyuki Minemura, Kiyoshi Takagi, +7 authors, Takashi Suzuki.
Cancer Sci, 2016 Sep 15; 107(12). PMID: 27627783    Free PMC article.
Tumor growth rate of invasive breast cancers during wait times for surgery assessed by ultrasonography.
Su Hyun Lee, Young-Seon Kim, +4 authors, Woo Kyung Moon.
Medicine (Baltimore), 2016 Sep 16; 95(37). PMID: 27631256    Free PMC article.
Predictive Factors and Value of ypN+ after Neoadjuvant Chemotherapy in Clinically Lymph Node-Negative Breast Cancer.
Ippei Fukada, Kazuhiro Araki, +10 authors, Yoshinori Ito.
PLoS One, 2016 Sep 16; 11(9). PMID: 27631393    Free PMC article.
Prevalence of persistent pain after breast cancer treatment by detection mode among participants in population-based screening programs.
Anabel Romero, Isabel Torà-Rocamora, +10 authors, CAMISS Study Group.
BMC Cancer, 2016 Sep 17; 16(1). PMID: 27632982    Free PMC article.
Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study.
André Hennigs, Fabian Riedel, +13 authors, Andreas Schneeweiss.
BMC Cancer, 2016 Sep 17; 16(1). PMID: 27634735    Free PMC article.
Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.
Vida Pourteimoor, Samira Mohammadi-Yeganeh, Mahdi Paryan.
Tumour Biol, 2016 Sep 22; 37(11). PMID: 27651157
Review.
Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker.
Lahong Zhang, Zhaojun Chen, +11 authors, Yun Yen.
Oncol Rep, 2016 Oct 26; 36(5). PMID: 27666119    Free PMC article.
Postmastectomy Radiation Therapy and Two-Stage Implant-Based Breast Reconstruction: Is There a Better Time to Irradiate?
Katherine B Santosa, Xiaoxue Chen, +6 authors, Edwin G Wilkins.
Plast Reconstr Surg, 2016 Sep 28; 138(4). PMID: 27673513    Free PMC article.
Comparison of the Ability of Different Clinical Treatment Scores to Estimate Prognosis in High-Risk Early Breast Cancer Patients: A Hellenic Cooperative Oncology Group Study.
Flora Stavridi, Konstantine T Kalogeras, +19 authors, George Fountzilas.
PLoS One, 2016 Oct 04; 11(10). PMID: 27695115    Free PMC article.
Decreased sirtuin 4 expression is associated with poor prognosis in patients with invasive breast cancer.
Qingyu Shi, Tong Liu, +4 authors, Da Pang.
Oncol Lett, 2016 Oct 05; 12(4). PMID: 27698834    Free PMC article.
FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort.
Jeff Johnson, Michael Choi, +9 authors, Xiaojiang Cui.
Oncotarget, 2016 Oct 07; 7(46). PMID: 27708239    Free PMC article.
Breast cancer molecular subtypes: from TNBC to QNBC.
Jane Date C Hon, Baljit Singh, +7 authors, Peng Lee.
Am J Cancer Res, 2016 Oct 12; 6(9). PMID: 27725895    Free PMC article.
Review.
Comparison of tumor-infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients.
Rin Ogiya, Naoki Niikura, +13 authors, Yutaka Tokuda.
Cancer Sci, 2016 Oct 12; 107(12). PMID: 27727484    Free PMC article.
The influence of breast cancer subtype on bone metastases development and survival in women with metastatic breast cancer.
R P Piggott, P S Waters, M J Kerin.
Ir J Med Sci, 2016 Oct 14; 186(1). PMID: 27734241
Analysis of genes involved in the PI3K/Akt pathway in radiation- and MNU-induced rat mammary carcinomas.
Kaye Showler, Mayumi Nishimura, +11 authors, Yoshiya Shimada.
J Radiat Res, 2016 Oct 16; 58(2). PMID: 27738081    Free PMC article.
Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade.
A Hennigs, F Riedel, +9 authors, A Schneeweiss.
Breast Cancer Res Treat, 2016 Nov 03; 160(3). PMID: 27744486    Free PMC article.
Incorporating Risk Factors to Identify the Indication of Post-mastectomy Radiotherapy in N1 Breast Cancer Treated with Optimal Systemic Therapy: A Multicenter Analysis in Korea (KROG 14-23).
Hae Jin Park, Kyung Hwan Shin, +12 authors, Suzy Kim.
Cancer Res Treat, 2016 Oct 22; 49(3). PMID: 27764904    Free PMC article.
Dissecting the Origin of Breast Cancer Subtype Stem Cell and the Potential Mechanism of Malignant Transformation.
Xinyi Liu, Dongfei Feng, +6 authors, Wei Jiang.
PLoS One, 2016 Oct 22; 11(10). PMID: 27768723    Free PMC article.
Correlating Tumor Stiffness with Immunohistochemical Subtypes of Breast Cancers: Prognostic Value of Comb-Push Ultrasound Shear Elastography for Differentiating Luminal Subtypes.
Max Denis, Adriana Gregory, +6 authors, Azra Alizad.
PLoS One, 2016 Oct 25; 11(10). PMID: 27776153    Free PMC article.
A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer.
Ying Liu, Ying Liao, +4 authors, Shilong Sun.
Int J Clin Oncol, 2016 Oct 26; 22(2). PMID: 27778118
Lgr6 labels a rare population of mammary gland progenitor cells that are able to originate luminal mammary tumours.
Leander Blaas, Fabio Pucci, +16 authors, Axel Behrens.
Nat Cell Biol, 2016 Nov 01; 18(12). PMID: 27798604    Free PMC article.
Assessment of early treatment response to neoadjuvant chemotherapy in breast cancer using non-mono-exponential diffusion models: a feasibility study comparing the baseline and mid-treatment MRI examinations.
Reem Bedair, Andrew N Priest, +7 authors, Fiona J Gilbert.
Eur Radiol, 2016 Nov 01; 27(7). PMID: 27798751    Free PMC article.
Associations of parity-related reproductive histories with ER± and HER2± receptor-specific breast cancer aetiology.
William F Anderson, Ruth M Pfeiffer, +3 authors, Niels Kroman.
Int J Epidemiol, 2016 Nov 08; 46(1). PMID: 27818374    Free PMC article.
Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells.
Polina Weitzenfeld, Tsipi Meshel, Adit Ben-Baruch.
Oncotarget, 2016 Nov 12; 7(49). PMID: 27835603    Free PMC article.
Association of PTP1B with Outcomes of Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy.
Monica M Rivera Franco, Eucario Leon Rodriguez, +3 authors, Alejandra Armengol Alonso.
Breast Cancer (Auckl), 2016 Nov 15; 10. PMID: 27840578    Free PMC article.
Progesterone Receptors, Pathological Complete Response and Early Outcome for Locally Advanced Breast Cancer - a Single Centre Study. (PPLB - 01).
Sanjit Agrawal, Lalit Banswal, +4 authors, Rosina Ahmed.
Indian J Surg Oncol, 2016 Nov 23; 7(4). PMID: 27872526    Free PMC article.
Immunohistochemical Subtypes of Breast Cancer: Correlation with Clinicopathological and Radiological Factors.
Yu-Mee Sohn, Kyunghwa Han, Mirinae Seo.
Iran J Radiol, 2016 Nov 30; 13(4). PMID: 27895868    Free PMC article.
FAT4 functions as a tumor suppressor in triple-negative breast cancer.
Lingmi Hou, Maoshan Chen, +5 authors, Jun Jiang.
Tumour Biol, 2016 Nov 30;. PMID: 27896700
Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.
Paul Gaß, Peter A Fasching, +47 authors, Christian R Löhberg.
Breast Care (Basel), 2016 Dec 07; 11(5). PMID: 27920623    Free PMC article.
BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
Hirokazu Tanino, Yoshimasa Kosaka, +11 authors, Masahiko Watanabe.
PLoS One, 2016 Dec 10; 11(12). PMID: 27935989    Free PMC article.
BRCAness as a Biomarker for Predicting Prognosis and Response to Anthracycline-Based Adjuvant Chemotherapy for Patients with Triple-Negative Breast Cancer.
Hitomi Mori, Makoto Kubo, +11 authors, Masafumi Nakamura.
PLoS One, 2016 Dec 16; 11(12). PMID: 27977696    Free PMC article.
Clinicopathological Significance of TARBP2, APP, and ZNF395 in Breast Cancer.
Ryoko Oi, Hirotaka Koizumi, +6 authors, Masayuki Takagi.
Breast Cancer (Auckl), 2016 Dec 17; 10. PMID: 27980417    Free PMC article.
Metabolic Tumor Burden Assessed by Dual Time Point [18F]FDG PET/CT in Locally Advanced Breast Cancer: Relation with Tumor Biology.
Ana María Garcia-Vicente, Julián Pérez-Beteta, +4 authors, Alicia Martínez-González.
Mol Imaging Biol, 2016 Dec 17; 19(4). PMID: 27981471
Cytochrome P-450 2D6 (CYP2D6) Genotype and Breast Cancer Recurrence in Tamoxifen-Treated Patients: Evaluating the Importance of Loss of Heterozygosity.
Thomas P Ahern, Daniel L Hertz, +7 authors, Deirdre P Cronin-Fenton.
Am J Epidemiol, 2016 Dec 19; 185(2). PMID: 27988492    Free PMC article.
Review.
A neuronal network of mitochondrial dynamics regulates metastasis.
M Cecilia Caino, Jae Ho Seo, +12 authors, Dario C Altieri.
Nat Commun, 2016 Dec 20; 7. PMID: 27991488    Free PMC article.
Highly Cited.
Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study.
Joachim Diessner, Manfred Wischnewsky, +8 authors, Achim Wöckel.
PLoS One, 2016 Dec 20; 11(12). PMID: 27992550    Free PMC article.
The prognostic value of node status in different breast cancer subtypes.
Zheng-Jun Yang, Yue Yu, +4 authors, Xu-Chen Cao.
Oncotarget, 2016 Dec 22; 8(3). PMID: 27999188    Free PMC article.
Evaluation of Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Experience in a Single Institution over a 10-Year Period.
Misun Choi, Yeon Hee Park, +4 authors, Eun Yoon Cho.
J Pathol Transl Med, 2016 Dec 26; 51(1). PMID: 28013533    Free PMC article.
Homeobox A11 hypermethylation indicates unfavorable prognosis in breast cancer.
Bingshu Xia, Ming Shan, +6 authors, Da Pang.
Oncotarget, 2016 Dec 31; 8(6). PMID: 28038461    Free PMC article.
Androgen Receptor Expression in Breast Carcinoma of Egyptian Patients.
Rehab Monir Samaka, Sheren Fouad Younes.
J Clin Diagn Res, 2017 Jan 05; 10(11). PMID: 28050375    Free PMC article.
Risk factors of locoregional relapse in locally advanced breast cancer treated with neoadjuvant chemotherapy following mastectomy and radiotherapy.
Liang Huang, Sheng Chen, Wentao T Yang, Zhiming Shao.
Oncotarget, 2017 Jan 06; 8(24). PMID: 28055977    Free PMC article.
Prognostic significance of Ki67 in Chinese women diagnosed with ER+/HER2- breast cancers by the 2015 St. Gallen consensus classification.
Yue Hu, Ran Gu, +9 authors, Weijuan Jia.
BMC Cancer, 2017 Jan 08; 17(1). PMID: 28061893    Free PMC article.
Fewer Reoperations After Lumpectomy for Breast Cancer with Neoadjuvant Rather than Adjuvant Chemotherapy: A Report from the National Cancer Database.
Jeffrey Landercasper, Barbara Bennie, +4 authors, Jared H Linebarger.
Ann Surg Oncol, 2017 Jan 08; 24(6). PMID: 28062931    Free PMC article.
Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer.
Yuka Asano, Shinichiro Kashiwagi, +8 authors, Masaichi Ohira.
Cancers (Basel), 2017 Jan 10; 9(1). PMID: 28067809    Free PMC article.
Comparison of Core Needle Biopsy and Excision Specimens for the Accurate Evaluation of Breast Cancer Molecular Markers: a Report of 1003 Cases.
Jie Chen, Zu Wang, +6 authors, Juxiang Gou.
Pathol Oncol Res, 2017 Jan 12; 23(4). PMID: 28074330
Correlation between the Ki-67 proliferation index and response to radiation therapy in small cell lung cancer.
Naoya Ishibashi, Toshiya Maebayashi, +3 authors, Shinobu Masuda.
Radiat Oncol, 2017 Jan 15; 12(1). PMID: 28086989    Free PMC article.
Discordance Rate in Estrogen Receptor, Progesterone Receptor, HER2 Status, and Ki67 Index Between Primary Unifocal and Multiple Homogenous Breast Carcinomas and Synchronous Axillary Lymph Node Metastases Have an Impact on Therapeutic Decision.
Rares Georgescu, Monica Boros, +6 authors, Simona Stolnicu.
Appl Immunohistochem Mol Morphol, 2017 Jan 19; 26(8). PMID: 28099174    Free PMC article.
Association of T-cadherin levels with the response to neoadjuvant chemotherapy in locally advanced breast cancer.
Dedi Kong, Mei-Hong Wang, Jie Yang, Liang Li.
Oncotarget, 2017 Jan 19; 8(8). PMID: 28099918    Free PMC article.
Breast carcinoma subtypes show different patterns of metastatic behavior.
István Artúr Molnár, Béla Ákos Molnár, +11 authors, Anna-Mária Tőkés.
Virchows Arch, 2017 Jan 20; 470(3). PMID: 28101678
The combination of PD-L1 expression and decreased tumor-infiltrating lymphocytes is associated with a poor prognosis in triple-negative breast cancer.
Hitomi Mori, Makoto Kubo, +10 authors, Masafumi Nakamura.
Oncotarget, 2017 Jan 21; 8(9). PMID: 28107186    Free PMC article.
Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics.
Jaime A Espinoza, Shakila Jabeen, +10 authors, Irina Gromova.
Oncoimmunology, 2017 Jan 27; 5(12). PMID: 28123884    Free PMC article.
Expression of Lipid Metabolism-Related Proteins Differs between Invasive Lobular Carcinoma and Invasive Ductal Carcinoma.
Yoon Jin Cha, Hye Min Kim, Ja Seung Koo.
Int J Mol Sci, 2017 Jan 27; 18(1). PMID: 28124996    Free PMC article.
Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer.
Ming Fan, Hui Li, +3 authors, Lihua Li.
PLoS One, 2017 Feb 07; 12(2). PMID: 28166261    Free PMC article.
Use of Tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer.
Shinichiro Kashiwagi, Yuka Asano, +9 authors, Masaichi Ohira.
PLoS One, 2017 Feb 07; 12(2). PMID: 28166544    Free PMC article.
Identifying relations between imaging phenotypes and molecular subtypes of breast cancer: Model discovery and external validation.
Jia Wu, Xiaoli Sun, +5 authors, Ruijiang Li.
J Magn Reson Imaging, 2017 Feb 09; 46(4). PMID: 28177554    Free PMC article.
A comparison of Ki-67 counting methods in luminal Breast Cancer: The Average Method vs. the Hot Spot Method.
Min Hye Jang, Hyun Jung Kim, +2 authors, So Yeon Park.
PLoS One, 2017 Feb 12; 12(2). PMID: 28187177    Free PMC article.
Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology.
E C Inwald, O Ortmann, +5 authors, M Klinkhammer-Schalke.
Breast Cancer Res Treat, 2017 Feb 17; 163(1). PMID: 28205042    Free PMC article.
BCL6 mRNA Expression Level in Invasive Duct Carcinoma not otherwise Specified.
Eman Badr, Eman Masoud, Asmaa Gaber Abdou, Marwa Serag Eldien.
J Clin Diagn Res, 2017 Feb 18; 10(12). PMID: 28208987    Free PMC article.
Selecting postoperative adjuvant systemic therapy for early stage breast cancer: A critical assessment of commercially available gene expression assays.
David M Hyams, Eric Schuur, +7 authors, Aníbal Nuñez De Pierro.
J Surg Oncol, 2017 Feb 18; 115(6). PMID: 28211064    Free PMC article.
Review.
Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy.
Balázs Ács, Veronika Zámbó, +9 authors, Anna-Mária Tőkés.
Diagn Pathol, 2017 Feb 23; 12(1). PMID: 28222768    Free PMC article.
Oncotype DX breast cancer recurrence score can be predicted with a novel nomogram using clinicopathologic data.
Amila Orucevic, John L Bell, Alison P McNabb, Robert E Heidel.
Breast Cancer Res Treat, 2017 Mar 01; 163(1). PMID: 28243897    Free PMC article.
Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor-Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors.
Koung Jin Suh, Se Hyun Kim, +13 authors, Jee Hyun Kim.
Cancer Res Treat, 2017 Mar 04; 49(4). PMID: 28253566    Free PMC article.
Differential Site-Based Expression of Pentose Phosphate Pathway-Related Proteins among Breast Cancer Metastases.
Yoon Jin Cha, Woo Hee Jung, Ja Seung Koo.
Dis Markers, 2017 Mar 07; 2017. PMID: 28260828    Free PMC article.
Prediction of years of life after diagnosis of breast cancer using omics and omic-by-treatment interactions.
Agustín González-Reymúndez, Gustavo de Los Campos, +2 authors, Ana I Vazquez.
Eur J Hum Genet, 2017 Mar 09; 25(5). PMID: 28272536    Free PMC article.
Clinical usefulness of the free web-based image analysis application ImmunoRatio for assessment of Ki-67 labelling index in breast cancer.
Min-Kyung Yeo, Hee Eun Kim, +3 authors, Ahwon Lee.
J Clin Pathol, 2017 Mar 17; 70(8). PMID: 28298390    Free PMC article.
LACTB is a tumour suppressor that modulates lipid metabolism and cell state.
Zuzana Keckesova, Joana Liu Donaher, +12 authors, Robert A Weinberg.
Nature, 2017 Mar 23; 543(7647). PMID: 28329758    Free PMC article.
Highly Cited.
Is Completion Axillary Dissection Necessary for This Patient?
Sadullah Girgin, Atilla Soran, +2 authors, Gökhan Demir.
J Breast Health, 2014 Jan 01; 10(3). PMID: 28331668    Free PMC article.
Cinical Significance of Androgen Receptor, CK-5/6, KI-67 and Molecular Subtypes in Breast Cancer.
Münire Kayahan, Ufuk Oğuz İdiz, +3 authors, Mahmut Müslümanoğlu.
J Breast Health, 2014 Jan 01; 10(4). PMID: 28331672    Free PMC article.
Autoimmune Thyroid Disease and Breast Cancer Prognosis.
Tolga Özmen, Bahadır Mahmut Güllüoğlu, Cumhur Şevket Yegen, Atilla Soran.
J Breast Health, 2015 Jan 01; 11(2). PMID: 28331694    Free PMC article.
Background Parenchymal Enhancement and Fibroglandular Tissue Proportion on Breast MRI: Correlation with Hormone Receptor Expression and Molecular Subtypes of Breast Cancer.
Mesut Öztürk, Ahmet Veysel Polat, +2 authors, Ayfer Kamalı Polat.
J Breast Health, 2017 Mar 24; 13(1). PMID: 28331765    Free PMC article.
High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer.
Danijel Sikic, Johannes Breyer, +10 authors, Wolfgang Otto.
Transl Oncol, 2017 Mar 28; 10(3). PMID: 28342317    Free PMC article.
ERCC1 Expression in Metastatic Triple Negative Breast Cancer Patients Treated with Platinum-Based Chemotherapy
Mohamed Ali EL Baiomy, Wagdi F El Kashef.
Asian Pac J Cancer Prev, 2017 Mar 28; 18(2). PMID: 28345838    Free PMC article.
Elevated microRNA-125b levels predict a worse prognosis in HER2-positive breast cancer patients.
Yanwei Luo, Xinye Wang, +12 authors, Ming Zhou.
Oncol Lett, 2017 Mar 31; 13(2). PMID: 28356971    Free PMC article.
Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer.
Matthew P Goetz, Krishna R Kalari, +25 authors, Judy C Boughey.
J Natl Cancer Inst, 2017 Apr 05; 109(7). PMID: 28376176    Free PMC article.
Differential impact of hormone receptor status on survival and recurrence for HER2 receptor-positive breast cancers treated with Trastuzumab.
Andrew McGuire, Olga Kalinina, +6 authors, Michael J Kerin.
Breast Cancer Res Treat, 2017 Apr 06; 164(1). PMID: 28378298    Free PMC article.
MicroRNA-222 Expression as a Predictive Marker for Tumor Progression in Hormone Receptor-Positive Breast Cancer.
Song-Hee Han, Hyun Jeong Kim, +3 authors, So Yeon Park.
J Breast Cancer, 2017 Apr 07; 20(1). PMID: 28382093    Free PMC article.
Prognostic Influence of BCL2 on Molecular Subtypes of Breast Cancer.
Ki-Tae Hwang, Wonshik Han, +6 authors, Dong-Young Noh.
J Breast Cancer, 2017 Apr 07; 20(1). PMID: 28382095    Free PMC article.
The Interleukin (IL)-1R1 pathway is a critical negative regulator of PyMT-mediated mammary tumorigenesis and pulmonary metastasis.
Maryse Dagenais, Jeremy Dupaul-Chicoine, +3 authors, Maya Saleh.
Oncoimmunology, 2017 Apr 14; 6(3). PMID: 28405519    Free PMC article.
Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10).
Bernhard C Pestalozzi, Christoph Tausch, +17 authors, Swiss Group for Clinical Cancer Research (SAKK).
BMC Cancer, 2017 Apr 15; 17(1). PMID: 28407750    Free PMC article.
Association Study Confirmed Three Breast Cancer-Specific Molecular Subtype-Associated Susceptibility Loci in Chinese Han Women.
Yihui Xu, Mengyun Chen, +7 authors, Bo Zhang.
Oncologist, 2017 Apr 15; 22(8). PMID: 28408616    Free PMC article.
Differences in subtype distribution between screen-detected and symptomatic invasive breast cancer and their impact on survival.
N Kobayashi, M Hikichi, +4 authors, T Utsumi.
Clin Transl Oncol, 2017 Apr 15; 19(10). PMID: 28409323
Surgical treatment in Paget's disease with invasive ductal carcinoma: an observational study based on SEER.
Qi Wu, Xiaojun Ding, +6 authors, Shengrong Sun.
Sci Rep, 2017 Apr 20; 7. PMID: 28422090    Free PMC article.
Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance.
Jae Moon Gwak, Milim Kim, +2 authors, So Yeon Park.
Oncotarget, 2017 Apr 20; 8(22). PMID: 28422735    Free PMC article.
Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer.
Aranzazu Fernandez-Martinez, Tomás Pascual, +30 authors, Miguel Martin.
Oncotarget, 2017 Apr 21; 8(13). PMID: 28423537    Free PMC article.
Isoform expression patterns of EPHA10 protein mediate breast cancer progression by regulating the E-Cadherin and β-catenin complex.
Ye Li, Lu Jin, +6 authors, Qinglei Gao.
Oncotarget, 2017 Apr 22; 8(18). PMID: 28427223    Free PMC article.
Chemokine (C-C motif) receptor 7 (CCR7) associates with the tumour immune microenvironment but not progression in invasive breast carcinoma.
Sultan N Sonbul, Kylie L Gorringe, +4 authors, Emad A Rakha.
J Pathol Clin Res, 2017 Apr 30; 3(2). PMID: 28451459    Free PMC article.
Molecular Signaling of Progesterone, Growth Hormone, Wnt, and HER in Mammary Glands of Dogs, Rodents, and Humans: New Treatment Target Identification.
Elpetra P M Timmermans-Sprang, Ana Gracanin, Jan A Mol.
Front Vet Sci, 2017 Apr 30; 4. PMID: 28451590    Free PMC article.
Review.
Phenotypic characterisation of breast cancer: the role of CDC42.
Eleni Chrysanthou, Kylie L Gorringe, +7 authors, Abhik Mukherjee.
Breast Cancer Res Treat, 2017 Apr 30; 164(2). PMID: 28451966    Free PMC article.
Expression and function of MutT homolog 1 in distinct subtypes of breast cancer.
Xiaohui Zhang, Wei Song, +4 authors, Qiang Sun.
Oncol Lett, 2017 Apr 30; 13(4). PMID: 28454376    Free PMC article.
A high-fat diet increases the incidence of mammary cancer inc-Ha-ras proto-oncogene transgenic rats.
Mie Magaki, Hiroko Ishii, +6 authors, Takamasa Ohnishi.
J Toxicol Pathol, 2017 May 02; 30(2). PMID: 28458452    Free PMC article.
Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections.
Abir A Muftah, Mohammed A Aleskandarany, +7 authors, Andrew R Green.
Breast Cancer Res Treat, 2017 May 10; 164(2). PMID: 28478613    Free PMC article.
Clinicopathological and Molecular Study of Triple-Negative Breast Cancer in Algerian Patients.
Hadjer Gaceb, Farid Cherbal, +2 authors, Hassen Mahfouf.
Pathol Oncol Res, 2017 May 10; 24(2). PMID: 28478614
Molecular characterization of circulating tumor cells from patients with metastatic breast cancer reflects evolutionary changes in gene expression under the pressure of systemic therapy.
Kristina E Aaltonen, Vendula Novosadová, +3 authors, Lisa Rydén.
Oncotarget, 2017 May 11; 8(28). PMID: 28489591    Free PMC article.
Comparison of the prognostic values of preoperative inflammation-based parameters in patients with breast cancer.
Hideya Takeuchi, Hirohumi Kawanaka, +3 authors, Tokujiro Yano.
PLoS One, 2017 May 11; 12(5). PMID: 28489884    Free PMC article.
Effect of macrophages on breast cancer cell proliferation, and on expression of hormone receptors, uPAR and HER-2.
Therése Lindsten, Alexander Hedbrant, +5 authors, Ann Erlandsson.
Int J Oncol, 2017 May 13; 51(1). PMID: 28498427    Free PMC article.
Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer.
Wataru Goto, Shinichiro Kashiwagi, +9 authors, Masaichi Ohira.
Biomark Res, 2017 May 17; 5. PMID: 28507762    Free PMC article.
Epithelial Mesenchymal Transition (EMT) in Metastatic Breast Cancer in Omani Women.
Ritu Lakhtakia, Adil Aljarrah, Muhammad Furrukh, Shyam S Ganguly.
Cancer Microenviron, 2017 May 21; 10(1-3). PMID: 28526992    Free PMC article.
Adjuvant endocrine therapy alone in patients with node-positive, luminal A type breast cancer.
Sungmin Park, Se Kyung Lee, +7 authors, Seok Jin Nam.
Medicine (Baltimore), 2017 Jun 01; 96(22). PMID: 28562530    Free PMC article.
High density of CD204-positive macrophages predicts worse clinical prognosis in patients with breast cancer.
Yuko Miyasato, Takuya Shiota, +8 authors, Yoshihiro Komohara.
Cancer Sci, 2017 Jun 03; 108(8). PMID: 28574667    Free PMC article.
Molecular characterization of breast cancer cell lines by clinical immunohistochemical markers.
André de Lima Mota, Adriane Feijo Evangelista, +4 authors, Marcia Maria Chiquitelli Marques.
Oncol Lett, 2017 Jun 08; 13(6). PMID: 28588725    Free PMC article.
Prognostic Significance of a Micropapillary Pattern in Pure Mucinous Carcinoma of the Breast: Comparative Analysis with Micropapillary Carcinoma.
Hyun-Jung Kim, Kyeongmee Park, +3 authors, Inseok Park.
J Pathol Transl Med, 2017 Jun 10; 51(4). PMID: 28597867    Free PMC article.
Prognostic Value of Clinicopathological Factors for Indonesian Breast Carcinomas of Different Molecular Subtypes
Irianiwati Widodo, Ery Kus Dwianingsih, +4 authors, Soeripto.
Asian Pac J Cancer Prev, 2017 Jun 15; 18(5). PMID: 28610410    Free PMC article.
Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer.
Rodrigo Goncalves, Katherine DeSchryver, +11 authors, Matthew J Ellis.
Breast Cancer Res Treat, 2017 Jun 15; 165(2). PMID: 28612227    Free PMC article.
Clinical use of the Oncotype DX genomic test to guide treatment decisions for patients with invasive breast cancer.
Terri P McVeigh, Michael J Kerin.
Breast Cancer (Dove Med Press), 2017 Jun 16; 9. PMID: 28615971    Free PMC article.
Review.
Neoadjuvant Therapy for Breast Cancer: Established Concepts and Emerging Strategies.
Tessa G Steenbruggen, Mette S van Ramshorst, +3 authors, Gabe S Sonke.
Drugs, 2017 Jun 16; 77(12). PMID: 28616845
Review.
miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
Jin Wang, Cailu Song, +5 authors, Xiaoming Xie.
Breast Cancer Res, 2017 Jun 21; 19(1). PMID: 28629464    Free PMC article.
Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis.
Danijel Sikic, Bastian Keck, +10 authors, Bridge Consortium.
PLoS One, 2017 Jun 21; 12(6). PMID: 28632777    Free PMC article.
Downregulation of antigen presentation-associated pathway proteins is linked to poor outcome in triple-negative breast cancer patient tumors.
Martin H Pedersen, Brian L Hood, +3 authors, Rikke Leth-Larsen.
Oncoimmunology, 2017 Jun 24; 6(5). PMID: 28638726    Free PMC article.
Sentinel node biopsy for axillary management after neoadjuvant therapy for breast cancer: a single-center retrospective analysis with long follow-up.
Yoshinari Ogawa, Katsumi Ikeda, +6 authors, Makoto Ichiki.
Surg Today, 2017 Jun 26; 48(1). PMID: 28647776
Insertional mutagenesis identifies drivers of a novel oncogenic pathway in invasive lobular breast carcinoma.
Sjors M Kas, Julian R de Ruiter, +13 authors, Jos Jonkers.
Nat Genet, 2017 Jun 27; 49(8). PMID: 28650484
Cone-beam Breast Computed Tomography: CT Density Does Not Reflect Proliferation Potential and Receptor Expression of Breast Carcinoma.
Susanne Wienbeck, Uwe Fischer, +4 authors, Alexey Surov.
Transl Oncol, 2017 Jul 01; 10(4). PMID: 28666188    Free PMC article.
Younger age is an independent predictor of worse prognosis among Lebanese nonmetastatic breast cancer patients: analysis of a prospective cohort.
Alissar El Chediak, Raafat S Alameddine, +7 authors, Ali Shamseddine.
Breast Cancer (Dove Med Press), 2017 Jul 04; 9. PMID: 28670139    Free PMC article.
Vasohibin 2 as a potential predictor of aggressive behavior of triple-negative breast cancer.
Bin Wang, Liang Yang, Qian Zhao, Liping Zhu.
Am J Transl Res, 2017 Jul 04; 9(6). PMID: 28670379    Free PMC article.
Molecular genetics complexity impeding research progress in breast and ovarian cancers.
Ishita Gupta, Ikram Burney, Mansour S Al-Moundhri, Yahya Tamimi.
Mol Clin Oncol, 2017 Jul 08; 7(1). PMID: 28685067    Free PMC article.
Overexpression of sphingosine kinase 1 is predictive of poor prognosis in human breast cancer.
Ya-Jing Zhu, Hua You, +6 authors, Guo-Sheng Ren.
Oncol Lett, 2017 Jul 12; 14(1). PMID: 28693136    Free PMC article.
Clinical outcome of brain metastases differs significantly among breast cancer subtypes.
Nadja E Oehrlich, Loukia M Spineli, Frank Papendorf, Tjoung-Won Park-Simon.
Oncol Lett, 2017 Jul 12; 14(1). PMID: 28693153    Free PMC article.
Comparison of Oncotype DX® Recurrence Score® with other risk assessment tools including the Nottingham Prognostic Index in the identification of patients with low-risk invasive breast cancer.
Maura Bríd Cotter, Alex Dakin, +5 authors, Cecily M Quinn.
Virchows Arch, 2017 Jul 15; 471(3). PMID: 28707056
Comparative diagnostic accuracy of 18F-FDG PET/CT for breast cancer recurrence.
Roberta Piva, Flavia Ticconi, +7 authors, Silvia Morbelli.
Breast Cancer (Dove Med Press), 2017 Jul 26; 9. PMID: 28740429    Free PMC article.
Review.
Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy.
Vienna Ludovini, Cinzia Antognelli, +13 authors, Stefania Gori.
BMC Cancer, 2017 Jul 28; 17(1). PMID: 28747156    Free PMC article.
The Epigenetic Landscape of Promoter Genome-wide Analysis in Breast Cancer.
Seher Karsli-Ceppioglu, Aslihan Dagdemir, +4 authors, Dominique Bernard-Gallon.
Sci Rep, 2017 Jul 28; 7(1). PMID: 28747748    Free PMC article.
Increased Tumour Infiltration of CD4+ and CD8+ T-Lymphocytes in Patients with Triple Negative Breast Cancer Suggests Susceptibility to Immune Therapy
Bushra Sikandar, Muhammad Asif Qureshi, +2 authors, Talat Mirza.
Asian Pac J Cancer Prev, 2017 Jul 28; 18(7). PMID: 28749113    Free PMC article.
Ganoderma spp.: A Promising Adjuvant Treatment for Breast Cancer.
Ivette J Suárez-Arroyo, Yaliz Loperena-Alvarez, Raysa Rosario-Acevedo, Michelle M Martínez-Montemayor.
Medicines (Basel), 2017 Aug 02; 4(1). PMID: 28758107    Free PMC article.
A Retrospective Survival Analysis of Anatomic and Prognostic Stage Group Based on the American Joint Committee on Cancer 8th Edition Cancer Staging Manual in Luminal B Human Epidermal Growth Factor Receptor 2-negative Breast Cancer.
Ling Xu, Jiang-Hong Li, +6 authors, Yin-Hua Liu.
Chin Med J (Engl), 2017 Aug 05; 130(16). PMID: 28776547    Free PMC article.
Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapy.
C Marín Hernández, A Piñero Madrona, +4 authors, P Parrilla Paricio.
Clin Transl Oncol, 2017 Aug 09; 20(4). PMID: 28785911
Bcl-2 antigen expression in luminal A and triple-negative breast cancer.
Carla Solange Escórcio-Dourado, Luana Mota Martins, +8 authors, Benedito Borges da Silva.
Med Oncol, 2017 Aug 13; 34(9). PMID: 28801774
HOXB9 Expression Correlates with Histological Grade and Prognosis in LSCC.
Chuanhui Sun, Changsong Han, +3 authors, Lingmei Qu.
Biomed Res Int, 2017 Aug 16; 2017. PMID: 28808656    Free PMC article.
Breast cancer subtype discrimination using standardized 4-IHC and digital image analysis.
Marina Gándara-Cortes, Ángel Vázquez-Boquete, +10 authors, Tomás García-Caballero.
Virchows Arch, 2017 Aug 22; 472(2). PMID: 28825136
Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast.
Marion Lavigne, Emmanuelle Menet, +10 authors, Anne Vincent-Salomon.
Mod Pathol, 2017 Sep 09; 31(1). PMID: 28884749
Prognostic role of progesterone receptor expression in a population-based analysis.
Adele Caldarella, Alessandro Barchielli.
J Cancer Res Clin Oncol, 2017 Sep 11; 143(12). PMID: 28889189
Distinct molecular subtypes of uterine leiomyosarcoma respond differently to chemotherapy treatment.
Yang An, Shuzhen Wang, +9 authors, Xiangqian Guo.
BMC Cancer, 2017 Sep 13; 17(1). PMID: 28893210    Free PMC article.
Therapeutic Implications of the Molecular and Immune Landscape of Triple-Negative Breast Cancer.
Ana C Gregório, Manuela Lacerda, +3 authors, João Nuno Moreira.
Pathol Oncol Res, 2017 Sep 16; 24(4). PMID: 28913723
Review.
Predictive factors of pathologic complete response in HER2-positive and axillary lymph node positive breast cancer after neoadjuvant paclitaxel, carboplatin plus with trastuzumab.
Jinhua Ding, Yinlong Yang, +2 authors, Zhiming Shao.
Oncotarget, 2017 Sep 17; 8(34). PMID: 28915617    Free PMC article.
Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification.
Soichiro Takase, Satoshi Kano, +24 authors, Toshitaka Nagao.
Oncotarget, 2017 Sep 25; 8(35). PMID: 28938615    Free PMC article.
Contrast Enhancement on Cone-Beam Breast-CT for Discrimination of Breast Cancer Immunohistochemical Subtypes.
Johannes Uhlig, Uwe Fischer, +4 authors, Susanne Wienbeck.
Transl Oncol, 2017 Sep 26; 10(6). PMID: 28946110    Free PMC article.
A retrospective prognostic evaluation analysis using the 8th edition of American Joint Committee on Cancer (AJCC) cancer staging system for luminal A breast cancer.
Jingming Ye, Wenjun Wang, +7 authors, Yinhua Liu.
Chin J Cancer Res, 2017 Sep 28; 29(4). PMID: 28947867    Free PMC article.
Breast cancer survival by molecular subtype: a population-based analysis of cancer registry data.
Saber Fallahpour, Tanya Navaneelan, Prithwish De, Alessia Borgo.
CMAJ Open, 2017 Sep 28; 5(3). PMID: 28951445    Free PMC article.
Magnetic resonance metabolic profiling of estrogen receptor-positive breast cancer: correlation with currently used molecular markers.
Ji Soo Choi, Dahye Yoon, +5 authors, Min Jung Kim.
Oncotarget, 2017 Oct 04; 8(38). PMID: 28969000    Free PMC article.
Serum CA125 is a predictive marker for breast cancer outcomes and correlates with molecular subtypes.
Cheng Fang, Yue Cao, +2 authors, Yirong Li.
Oncotarget, 2017 Oct 04; 8(38). PMID: 28969044    Free PMC article.
Comparison of Core Needle Biopsy and Surgical Specimens in Determining Intrinsic Biological Subtypes of Breast Cancer with Immunohistochemistry.
Kiho You, Sungmin Park, +6 authors, Jeong Eon Lee.
J Breast Cancer, 2017 Oct 04; 20(3). PMID: 28970856    Free PMC article.
Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors.
Stephan Bernhardt, Michaela Bayerlová, +15 authors, Eva Johanna Kantelhardt.
Breast Cancer Res, 2017 Oct 13; 19(1). PMID: 29020998    Free PMC article.
The clinicopathological significance of UBE2C in breast cancer: a study based on immunohistochemistry, microarray and RNA-sequencing data.
Chao-Hua Mo, Li Gao, +4 authors, Zhen-Bo Feng.
Cancer Cell Int, 2017 Oct 13; 17. PMID: 29021715    Free PMC article.
The value of phosphohistone H3 as a proliferation marker for evaluating invasive breast cancers: A comparative study with Ki67.
Ji-Ye Kim, Hyang Sook Jeong, +4 authors, Ja Seung Koo.
Oncotarget, 2017 Oct 17; 8(39). PMID: 29029412    Free PMC article.
Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents.
Nehad M Ayoub, Kamal M Al-Shami, Mohammad A Alqudah, Nizar M Mhaidat.
Onco Targets Ther, 2017 Oct 19; 10. PMID: 29042798    Free PMC article.
Breast Cancer in Latinas: A Focus on Intrinsic Subtypes Distribution.
Silvia J Serrano-Gómez, Laura Fejerman, Jovanny Zabaleta.
Cancer Epidemiol Biomarkers Prev, 2017 Oct 22; 27(1). PMID: 29054978    Free PMC article.
Review.
Computer-aided evaluation of the correlation between MRI morphology and immunohistochemical biomarkers or molecular subtypes in breast cancer.
Sen Jiang, You-Jia Hong, Fan Zhang, Yang-Kang Li.
Sci Rep, 2017 Oct 25; 7(1). PMID: 29062076    Free PMC article.
Comparison of quality of life between 2-year and 3-or-more-year administration of leuprorelin acetate every-3-months depot in combination with tamoxifen as adjuvant endocrine treatment in premenopausal patients with endocrine-responsive breast cancer: a randomized controlled trial.
Yasuo Ohashi, Eiichi Shiba, +5 authors, Tsukasa Fujimoto.
Support Care Cancer, 2017 Oct 25; 26(3). PMID: 29063390    Free PMC article.
Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis.
Valentina Cocciolone, Katia Cannita, +11 authors, Corrado Ficorella.
Oncotarget, 2017 Oct 27; 8(42). PMID: 29069766    Free PMC article.
Persistent homology index as a robust quantitative measure of immunohistochemical scoring.
Akihiro Takiyama, Takashi Teramoto, +2 authors, Shinya Tanaka.
Sci Rep, 2017 Oct 27; 7(1). PMID: 29070862    Free PMC article.
Anti-Phosphohistone H3-Positive Mitoses Are Linked to Pathological Response in Neoadjuvantly Treated Breast Cancer.
Sylvia Timme, Martin Sillem, +5 authors, Elmar Stickeler.
Breast Care (Basel), 2017 Oct 27; 12(4). PMID: 29070988    Free PMC article.
Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer.
Charles Johannessen, Line Moi, +4 authors, Lill-Tove Busund.
PLoS One, 2017 Oct 27; 12(10). PMID: 29073169    Free PMC article.
PTTG1-interacting protein (PTTG1IP/PBF) predicts breast cancer survival.
Heli Repo, Natalia Gurvits, +8 authors, Pauliina Kronqvist.
BMC Cancer, 2017 Oct 29; 17(1). PMID: 29078751    Free PMC article.
Prognostic significance of lymphatic vessel invasion diagnosed by D2-40 in Chinese invasive breast cancers.
Ke-Wen He, Ju-Jie Sun, +4 authors, Zhi-Yong Yu.
Medicine (Baltimore), 2017 Nov 03; 96(44). PMID: 29095309    Free PMC article.
Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study.
Olivier Brouckaert, Anja Rudolph, +74 authors, Patrick Neven.
Breast Cancer Res, 2017 Nov 09; 19(1). PMID: 29116004    Free PMC article.
The Predictive Value of PITX2 DNA Methylation for High-Risk Breast Cancer Therapy: Current Guidelines, Medical Needs, and Challenges.
Michaela Aubele, Manfred Schmitt, +8 authors, Marion Kiechle.
Dis Markers, 2017 Nov 16; 2017. PMID: 29138528    Free PMC article.
Review.
A Retrospective Analysis of Clinical Utility of AJCC 8th Edition Cancer Staging System for Breast Cancer.
Hui Hu, Wei Wei, +2 authors, Yinhua Liu.
World J Oncol, 2017 Nov 18; 8(3). PMID: 29147438    Free PMC article.
Role of Taxanes in Triple-Negative Breast Cancer: A Study From Tertiary Cancer Center in South India.
K C Lakshmaiah, Abhishek Anand, +9 authors, Deepak Koppaka.
World J Oncol, 2017 Nov 18; 8(4). PMID: 29147445    Free PMC article.
Near-infrared photothermal therapy using anti-EGFR-gold nanorod conjugates for triple negative breast cancer.
Meihua Zhang, Hoe Suk Kim, +3 authors, Woo Kyung Moon.
Oncotarget, 2017 Nov 22; 8(49). PMID: 29156817    Free PMC article.
Overexpression of suppressive microRNAs, miR-30a and miR-200c are associated with improved survival of breast cancer patients.
Tsutomu Kawaguchi, Li Yan, +5 authors, Kazuaki Takabe.
Sci Rep, 2017 Nov 23; 7(1). PMID: 29162923    Free PMC article.
Feasibility analysis of early temporal kinetics as a surrogate marker for breast tumor type, grade, and aggressiveness.
Laura Heacock, Alana A Lewin, +6 authors, Linda Moy.
J Magn Reson Imaging, 2017 Nov 28; 47(6). PMID: 29178258    Free PMC article.
Application of artificial neural networks for predicting presence of non-sentinel lymph node metastases in breast cancer patients with positive sentinel lymph node biopsies.
Tomasz Nowikiewicz, Paweł Wnuk, +3 authors, Wojciech Zegarski.
Arch Med Sci, 2017 Nov 29; 13(6). PMID: 29181071    Free PMC article.
Adjuvant chemotherapeutic treatment of 1650 patients with early breast cancer in routine care in Germany: data from the prospective TMK cohort study.
Steffen Dörfel, Claus-Christoph Steffens, +6 authors, TMK-Group (Tumour Registry Breast Cancer).
Breast Cancer, 2017 Dec 06; 25(3). PMID: 29204847    Free PMC article.
Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study.
Jia Yu, Bo Qin, +27 authors, Liewei Wang.
Breast Cancer Res, 2017 Dec 08; 19(1). PMID: 29212525    Free PMC article.
The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer.
Hideya Takeuchi, Miyuki Abe, +6 authors, Kenji Sugio.
PLoS One, 2017 Dec 08; 12(12). PMID: 29216259    Free PMC article.
Ki-67 Expression by Immunohistochemistry and Quantitative Real-Time Polymerase Chain Reaction as Predictor of Clinical Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.
Prihantono Prihantono, Mochammad Hatta, +5 authors, Andi Nilawati Usman.
J Oncol, 2017 Dec 12; 2017. PMID: 29225623    Free PMC article.
Diversity index as a novel prognostic factor in breast cancer.
Yul Ri Chung, Hyun Jeong Kim, +3 authors, So Yeon Park.
Oncotarget, 2017 Dec 13; 8(57). PMID: 29228597    Free PMC article.
Tamoxifen sensitivity-related microRNA-342 is a useful biomarker for breast cancer survival.
Jessica Young, Tsutomu Kawaguchi, +3 authors, Kazuaki Takabe.
Oncotarget, 2017 Dec 17; 8(59). PMID: 29245954    Free PMC article.
Evaluation of the Expression of Amine Oxidase Proteins in Breast Cancer.
Woo Young Sun, Junjeong Choi, Yoon Jin Cha, Ja Seung Koo.
Int J Mol Sci, 2017 Dec 21; 18(12). PMID: 29261141    Free PMC article.
Discordant correlation of breast adenoid cystic carcinoma on imaging and pathology: A case report and literature review on surgical management.
Zhiyan Yan, May Ying Leong, Geok Hoon Lim.
Int J Surg Case Rep, 2017 Dec 22; 42. PMID: 29268125    Free PMC article.
Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes and residual cancer burden.
Yuka Asano, Shinichiro Kashiwagi, +11 authors, Masaichi Ohira.
BMC Cancer, 2017 Dec 29; 17(1). PMID: 29282021    Free PMC article.
MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes - a feasibility study.
Kirsi Holli-Helenius, Annukka Salminen, +4 authors, Riitta Parkkola.
BMC Med Imaging, 2017 Dec 30; 17(1). PMID: 29284425    Free PMC article.
Wnt7a Deficiency Could Predict Worse Disease-Free and Overall Survival in Estrogen Receptor-Positive Breast Cancer.
Kijong Yi, Kyueng-Whan Min, +5 authors, Seung Sam Paik.
J Breast Cancer, 2017 Dec 30; 20(4). PMID: 29285041    Free PMC article.
GSTT1, GSTP1, and GSTM1 genetic variants are associated with survival in previously untreated metastatic breast cancer.
Jian Zhang, Ying Wu, +5 authors, Zhonghua Wang.
Oncotarget, 2017 Dec 30; 8(62). PMID: 29285301    Free PMC article.
The use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer.
Satbir Singh Thakur, Haocheng Li, +5 authors, Hua Yang.
PLoS One, 2018 Jan 06; 13(1). PMID: 29304138    Free PMC article.
Prognostic Significance of Activated Leukocyte Cell Adhesion Molecule (ALCAM) in Association with Promoter Methylation of the ALCAM Gene in Breast Cancer.
Young Ju Jeong, Hoon Kyu Oh, Sung Hwan Park, Jin Gu Bong.
Molecules, 2018 Jan 10; 23(1). PMID: 29315254    Free PMC article.
Engrailed 1 overexpression as a potential prognostic marker in quintuple-negative breast cancer.
Yu Jin Kim, Minjung Sung, +4 authors, Yoon-La Choi.
Cancer Biol Ther, 2018 Jan 16; 19(4). PMID: 29333926    Free PMC article.
Effect of dihydropyrimidine dehydrogenase single nucleotide polymorphisms on prognosis of breast cancer patients with chemotherapy.
Fengxia Qin, Huikun Zhang, +6 authors, Yongjie Ma.
Oncotarget, 2018 Jan 18; 8(67). PMID: 29340111    Free PMC article.
Mithramycin A suppresses basal triple-negative breast cancer cell survival partially via down-regulating Krüppel-like factor 5 transcription by Sp1.
Rong Liu, Xu Zhi, +4 authors, Ceshi Chen.
Sci Rep, 2018 Jan 20; 8(1). PMID: 29348684    Free PMC article.
Negative Conversion of Progesterone Receptor Status after Primary Systemic Therapy Is Associated with Poor Clinical Outcome in Patients with Breast Cancer.
Soomin Ahn, Hyun Jeong Kim, +8 authors, So Yeon Park.
Cancer Res Treat, 2018 Jan 25; 50(4). PMID: 29361816    Free PMC article.
Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to paclitaxel.
Ying Jin, Wenquan Hu, +16 authors, Qing Robert Miao.
Cancer Lett, 2018 Jan 27; 419. PMID: 29373839    Free PMC article.
Molecular Subtypes of Indonesian Breast Carcinomas - Lack of Association with Patient Age and Tumor Size
Yeni Rahmawati, Yunita Setyawati, +2 authors, Dewajani Purnomosari.
Asian Pac J Cancer Prev, 2018 Jan 28; 19(1). PMID: 29373908    Free PMC article.
Validity of St Gallen risk categories in prognostication of breast cancer patients in Southern Sri Lanka.
Harshini Peiris, Lakmini Mudduwa, Neil Thalagala, Kamani Jayatilake.
BMC Womens Health, 2018 Feb 02; 18(1). PMID: 29385991    Free PMC article.
A retrospective prognostic evaluation analysis using the 8th edition of the American Joint Committee on Cancer staging system for breast cancer.
Sae Byul Lee, Guiyun Sohn, +6 authors, Sei-Hyun Ahn.
Breast Cancer Res Treat, 2018 Feb 02; 169(2). PMID: 29388016    Free PMC article.
Ki-67 labeling index is a predictive marker for a pathological complete response to neoadjuvant chemotherapy in breast cancer: A meta-analysis.
Miaomiao Tao, Shu Chen, Xianquan Zhang, Qi Zhou.
Medicine (Baltimore), 2018 Feb 03; 96(51). PMID: 29390540    Free PMC article.
Review.
Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ.
Marie Beguinot, Marie-Melanie Dauplat, +5 authors, Nina Radosevic-Robin.
BMC Cancer, 2018 Feb 06; 18(1). PMID: 29394917    Free PMC article.
Predicting the Efficacy of HER2-Targeted Therapies: A Look at the Host.
Martina Di Modica, Elda Tagliabue, Tiziana Triulzi.
Dis Markers, 2018 Feb 07; 2017. PMID: 29403144    Free PMC article.
Review.
Roles of MALAT1 in development and migration of triple negative and Her-2 positive breast cancer.
Zhang Xiping, Chen Bo, +4 authors, Tang Binbin.
Oncotarget, 2018 Feb 09; 9(2). PMID: 29416769    Free PMC article.
Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.
Michiko Imamura, Takashi Morimoto, +13 authors, Yasuo Miyoshi.
World J Surg Oncol, 2018 Feb 13; 16(1). PMID: 29433529    Free PMC article.
Prognostic Significance of Low Claudin3 Expression in Luminal Breast Cancers.
Lakmini Mudduwa, Harshini Peiris, +2 authors, Thusharie Liyanage.
Breast Cancer (Auckl), 2018 Feb 13; 11. PMID: 29434471    Free PMC article.
Targeting breast cancer cells with a CuInS2/ZnS quantum dot-labeled Ki-67 bioprobe.
Guang Sun, Wanying Xing, +3 authors, Siyao Yu.
Oncol Lett, 2018 Feb 13; 15(2). PMID: 29434960    Free PMC article.
Kallikrein-related peptidase 6 (KLK6) expression differentiates tumor subtypes and predicts clinical outcome in breast cancer patients.
Christoforos Haritos, Kleita Michaelidou, +4 authors, Andreas Scorilas.
Clin Exp Med, 2018 Feb 13; 18(2). PMID: 29435805
Effects of core needle biopsy and subsequent neoadjuvant chemotherapy on molecular alterations and outcome in breast cancer.
Lingmin Xie, Xiaolei Li, +5 authors, Linbo Wang.
Onco Targets Ther, 2018 Feb 15; 11. PMID: 29440915    Free PMC article.
Breast cancer in Ethiopia: evidence for geographic difference in the distribution of molecular subtypes in Africa.
Endale Hadgu, Daniel Seifu, +7 authors, Mats G Karlsson.
BMC Womens Health, 2018 Feb 16; 18(1). PMID: 29444670    Free PMC article.
Luminal A Breast Cancer and Molecular Assays: A Review.
Jennifer J Gao, Sandra M Swain.
Oncologist, 2018 Feb 24; 23(5). PMID: 29472313    Free PMC article.
Review.
[Metastatic breast cancer in the spine : Molecular predictors for choosing adequate treatment strategies].
D Adler, M Kriegsmann, +4 authors, M Akbar.
Orthopade, 2018 Mar 01; 47(7). PMID: 29487982
Review.
Prognostic & predictive factors for planning adjuvant chemotherapy of early-stage breast cancer.
Onur Esbah, Berna Oksuzoglu.
Indian J Med Res, 2018 Mar 08; 146(5). PMID: 29512598    Free PMC article.
Review.
Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling.
Pernilla Roswall, Matteo Bocci, +24 authors, Kristian Pietras.
Nat Med, 2018 Mar 13; 24(4). PMID: 29529015    Free PMC article.
Highly Cited.
A novel computational approach for drug repurposing using systems biology.
Azam Peyvandipour, Nafiseh Saberian, +2 authors, Sorin Draghici.
Bioinformatics, 2018 Mar 14; 34(16). PMID: 29534151    Free PMC article.
Using computer assisted image analysis to determine the optimal Ki67 threshold for predicting outcome of invasive breast cancer.
Timothy Kwang Yong Tay, Aye Aye Thike, +12 authors, Puay Hoon Tan.
Oncotarget, 2018 Mar 17; 9(14). PMID: 29545924    Free PMC article.
DCE-MRI Pharmacokinetic-Based Phenotyping of Invasive Ductal Carcinoma: A Radiomic Study for Prediction of Histological Outcomes.
Serena Monti, Marco Aiello, +6 authors, Marco Salvatore.
Contrast Media Mol Imaging, 2018 Mar 28; 2018. PMID: 29581709    Free PMC article.
The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer.
Xin An, Fei Xu, +8 authors, Shusen Wang.
BMC Cancer, 2018 Mar 29; 18(1). PMID: 29587760    Free PMC article.
Morphology of Immunomodulation in Breast Cancer Tumor Draining Lymph Nodes Depends on Stage and Intrinsic Subtype.
Maximilian Seidl, Moritz Bader, +13 authors, Peter Bronsert.
Sci Rep, 2018 Mar 30; 8(1). PMID: 29593307    Free PMC article.
Analysis of membranous Ki-67 staining in breast cancer and surrounding breast epithelium.
Gábor Cserni.
Virchows Arch, 2018 Mar 30; 473(2). PMID: 29594352
Prediction of treatment responses to neoadjuvant chemotherapy in triple-negative breast cancer by analysis of immune checkpoint protein expression.
Yuka Asano, Shinichiro Kashiwagi, +9 authors, Masaichi Ohira.
J Transl Med, 2018 Apr 05; 16(1). PMID: 29615063    Free PMC article.
Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancer.
David Groheux, L Biard, +9 authors, P de Cremoux.
Eur J Nucl Med Mol Imaging, 2018 Apr 05; 45(8). PMID: 29616304
Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients.
Li Chen, Liu Yang, +13 authors, Zhi-Ming Shao.
Nat Commun, 2018 Apr 11; 9(1). PMID: 29636477    Free PMC article.
Evidence-based approaches to reduce cancer health disparities: Discover, develop, deliver, and disseminate.
Priyanka P Desai, Jana B Lampe, +3 authors, Jamboor K Vishwanatha.
J Carcinog, 2018 Apr 13; 17. PMID: 29643743    Free PMC article.
Patterns of breast cancer relapse in accordance to biological subtype.
Atanas Ignatov, Holm Eggemann, Elke Burger, Tanja Ignatov.
J Cancer Res Clin Oncol, 2018 Apr 21; 144(7). PMID: 29675790
Expression of Pentose Phosphate Pathway-Related Proteins in Breast Cancer.
Junjeong Choi, Eun-Sol Kim, Ja Seung Koo.
Dis Markers, 2018 Apr 24; 2018. PMID: 29682102    Free PMC article.
Stromal immunoglobulin κC expression is associated with initiation of breast cancer in TA2 mice and human breast cancer.
Shiwu Zhang, Fei Fei, +5 authors, Yuwei Li.
Cancer Sci, 2018 Apr 24; 109(6). PMID: 29683229    Free PMC article.
The Impact of Hormonal Contraceptives on Breast Cancer Pathology.
Jesse A Dorchak, Sifat Maria, +8 authors, Paula A Witt-Enderby.
Horm Cancer, 2018 Apr 25; 9(4). PMID: 29687205    Free PMC article.
Evaluation of survivin immunoexpression in the differentiation of high- and low-grade breast ductal carcinoma in situ.
Milca Cezar Chade, Sebastião Piato, +4 authors, Enio Martins Medeiros.
Einstein (Sao Paulo), 2018 Apr 26; 16(1). PMID: 29694611    Free PMC article.
Clinical Significance of the Neutrophil-to-Lymphocyte Ratio in Endocrine Therapy for Stage IV Breast Cancer.
Nozomi Iimori, Shinichiro Kashiwagi, +9 authors, Masaichi Ohira.
In Vivo, 2018 Apr 27; 32(3). PMID: 29695577    Free PMC article.
Relationship between functional imaging and immunohistochemical markers and prediction of breast cancer subtype: a PET/MRI study.
Mariarosaria Incoronato, Anna Maria Grimaldi, +9 authors, Marco Salvatore.
Eur J Nucl Med Mol Imaging, 2018 Apr 27; 45(10). PMID: 29696443
A nomogram for predicting survival in patients with breast cancer brain metastasis.
Zhou Huang, Bing Sun, +4 authors, Santai Song.
Oncol Lett, 2018 May 05; 15(5). PMID: 29725432    Free PMC article.
Effect of neoadjuvant chemotherapy on the expression of hormone receptors and Ki-67 in Chinese breast cancer patients: A retrospective study of 525 patients.
Yu-Tuan Wu, Xin Li, +6 authors, Ling-Quan Kong.
J Biomed Res, 2018 May 18;. PMID: 29770779    Free PMC article.
Conventional Pathology Versus Gene Signatures for Assessing Luminal A and B Type Breast Cancers: Results of a Prospective Cohort Study.
Julia E C van Steenhoven, Anne Kuijer, +12 authors, Thijs van Dalen.
Genes (Basel), 2018 May 19; 9(5). PMID: 29772837    Free PMC article.
Novel evaluation scale for QOL (QOL-ACD-BP) in preoperative chemotherapy for breast cancer.
Koji Takada, Shinichiro Kashiwagi, +7 authors, Masaichi Ohira.
J Cancer Res Clin Oncol, 2018 May 21; 144(8). PMID: 29779135    Free PMC article.
The Association between Molecular Subtypes of Breast Cancer with Histological Grade and Lymph Node Metastases in Indonesian Woman
Yunita Setyawati, Yeni Rahmawati, +2 authors, Dewajani Purnomosari.
Asian Pac J Cancer Prev, 2018 May 29; 19(5). PMID: 29801411    Free PMC article.
The Screening, Diagnosis, Treatment, and Follow-Up of Breast Cancer.
Achim Wöckel, Ute-Susann Albert, +3 authors, Tanja Stüber.
Dtsch Arztebl Int, 2018 May 29; 115(18). PMID: 29807560    Free PMC article.
Systematic Review.
The clinicopathological significance of Ki67 in papillary thyroid carcinoma: a suitable indicator?
Jingdong Tang, Chunyi Gui, Shenglong Qiu, Min Wang.
World J Surg Oncol, 2018 Jun 02; 16(1). PMID: 29855303    Free PMC article.
Relationship Between ADAMTS8, ADAMTS18, and ADAMTS20 (A Disintegrin and Metalloproteinase with Thrombospondin Motifs) Expressions and Tumor Molecular Classification, Clinical Pathological Parameters, and Prognosis in Breast Invasive Ductal Carcinoma.
Xuhui Guo, Juntao Li, +3 authors, Xudong Wei.
Med Sci Monit, 2018 Jun 04; 24. PMID: 29860265    Free PMC article.
Electrically Guided DNA Immobilization and Multiplexed DNA Detection with Nanoporous Gold Electrodes.
Jovana Veselinovic, Zidong Li, Pallavi Daggumati, Erkin Seker.
Nanomaterials (Basel), 2018 Jun 09; 8(5). PMID: 29883441    Free PMC article.
Whole-body 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET/CT) for staging locally advanced breast cancer: A prospective study from a tertiary cancer centre in south India.
Sivanath Reddy Gajjala, Narendra Hulikal, +2 authors, Tekchand Kalawat.
Indian J Med Res, 2018 Jun 21; 147(3). PMID: 29923514    Free PMC article.
Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-κB signaling.
Rui Han, Shanzhi Gu, +5 authors, Lingxiao Zhang.
Sci Rep, 2018 Jun 24; 8(1). PMID: 29934505    Free PMC article.
Imaging and the completion of the omics paradigm in breast cancer.
D Leithner, J V Horvat, +5 authors, K Pinker.
Radiologe, 2018 Jun 28; 58(Suppl 1). PMID: 29947931    Free PMC article.
Review.
High serum vascular endothelial growth factor C predicts better relapse-free survival in early clinically node-negative breast cancer.
José Maañón, Diego Perez, +9 authors, Antonio Rueda.
Oncotarget, 2018 Jul 03; 9(46). PMID: 29963266    Free PMC article.
FOXA1 and AR in invasive breast cancer: new findings on their co-expression and impact on prognosis in ER-positive patients.
Nelson Rangel, Nicoletta Fortunati, +12 authors, Isabella Castellano.
BMC Cancer, 2018 Jul 05; 18(1). PMID: 29970021    Free PMC article.
Metastatic and triple-negative breast cancer: challenges and treatment options.
Sumayah Al-Mahmood, Justin Sapiezynski, Olga B Garbuzenko, Tamara Minko.
Drug Deliv Transl Res, 2018 Jul 07; 8(5). PMID: 29978332    Free PMC article.
Highly Cited. Review.
Gene expression assay and Watson for Oncology for optimization of treatment in ER-positive, HER2-negative breast cancer.
Yun Yeong Kim, Se Jeong Oh, +2 authors, Heung Kyu Park.
PLoS One, 2018 Jul 07; 13(7). PMID: 29979736    Free PMC article.
Expression of tumor suppressors miR-195 and let-7a as potential biomarkers of invasive breast cancer.
Marcia M Marques, Adriane F Evangelista, +5 authors, Ismael Dale Cotrim Guerreiro da Silva.
Clinics (Sao Paulo), 2018 Jul 12; 73. PMID: 29995098    Free PMC article.
Impact of sentinel lymph node biopsy in newly diagnosed invasive breast cancer patients with suspicious node: a comparative accuracy survey of fine-needle aspiration biopsy versus core-needle biopsy.
Adheesh Bhandari, Erjie Xia, +7 authors, Ouchen Wang.
Am J Transl Res, 2018 Jul 19; 10(6). PMID: 30018726    Free PMC article.
A fine-needle aspiration-based protein signature discriminates benign from malignant breast lesions.
Bo Franzén, Masood Kamali-Moghaddam, +9 authors, Rolf Lewensohn.
Mol Oncol, 2018 Jul 19; 12(9). PMID: 30019538    Free PMC article.
Triple-negative and HER2 positive ductal carcinoma in situ of the breast: characteristics, behavior, and biomarker profile.
Satoshi Takahashi, Aye Aye Thike, +2 authors, Puay Hoon Tan.
Virchows Arch, 2018 Jul 24; 473(3). PMID: 30033510
The TGFα-EGFR-Akt signaling axis plays a role in enhancing proinflammatory chemokines in triple-negative breast cancer cells.
Rosa Mistica C Ignacio, Carla R Gibbs, Eun-Sook Lee, Deok-Soo Son.
Oncotarget, 2018 Jul 24; 9(50). PMID: 30034618    Free PMC article.
Prognostic value of systemic inflammatory markers and development of a nomogram in breast cancer.
Uiju Cho, Hong Sik Park, +4 authors, Hyun Joo Choi.
PLoS One, 2018 Jul 27; 13(7). PMID: 30048474    Free PMC article.
Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark.
Lindsay J Collin, Deirdre P Cronin-Fenton, +8 authors, Timothy L Lash.
BMJ Open, 2018 Aug 03; 8(7). PMID: 30068618    Free PMC article.
Survival Study of Triple-Negative and Non-Triple-Negative Breast Cancer in a Brazilian Cohort.
Homero Gonçalves, Maximiliano Ribeiro Guerra, +3 authors, Maria Teresa Bustamante Teixeira.
Clin Med Insights Oncol, 2018 Aug 08; 12. PMID: 30083066    Free PMC article.
Clonal relatedness in tumour pairs of breast cancer patients.
Jana Biermann, Toshima Z Parris, +7 authors, Khalil Helou.
Breast Cancer Res, 2018 Aug 11; 20(1). PMID: 30092821    Free PMC article.
Influence of age on radiomic features in 18F-FDG PET in normal breast tissue and in breast cancer tumors.
Sarah Boughdad, Christophe Nioche, +3 authors, Irène Buvat.
Oncotarget, 2018 Aug 17; 9(56). PMID: 30112113    Free PMC article.
Practical Consequences Resulting from the Analysis of a 21-Multigene Array in the Interdisciplinary Conference of a Breast Cancer Center.
Hans-Ullrich Voelker, Lea Frey, Annette Strehl, Michael Weigel.
Int J Breast Cancer, 2018 Aug 17; 2018. PMID: 30112216    Free PMC article.
Establishment and external validation of a prognostic model for predicting disease-free survival and risk stratification in breast cancer patients treated with neoadjuvant chemotherapy.
Jianguo Lai, Hongli Wang, +2 authors, Zihao Pan.
Cancer Manag Res, 2018 Aug 21; 10. PMID: 30122984    Free PMC article.
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material.
Shawn Baldacchino, Christian Saliba, +2 authors, Godfrey Grech.
J Vis Exp, 2018 Aug 21; (138). PMID: 30124640    Free PMC article.
An integrated bioinformatical analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer.
Dan Xue, Pu Cheng, +5 authors, Jian Huang.
Onco Targets Ther, 2018 Aug 22; 11. PMID: 30127624    Free PMC article.
Ki 67 assessment in breast cancer in an Egyptian population: a comparative study between manual assessment on optical microscopy and digital quantitative assessment.
Essam Ayad, Ahmed Soliman, +3 authors, Youhong Dong.
Diagn Pathol, 2018 Aug 30; 13(1). PMID: 30153851    Free PMC article.
Formin Proteins FHOD1 and INF2 in Triple-Negative Breast Cancer: Association With Basal Markers and Functional Activities.
Vanina D Heuser, Naziha Mansuri, +5 authors, Maria Gardberg.
Breast Cancer (Auckl), 2018 Aug 31; 12. PMID: 30158824    Free PMC article.
A Machine Learning Approach for the Association of ki-67 Scoring with Prognostic Factors.
E Dirican, E Kiliç.
J Oncol, 2018 Aug 31; 2018. PMID: 30158977    Free PMC article.
Could local surgery improve survival in de novo stage IV breast cancer?
Zhenchong Xiong, Guangzheng Deng, +4 authors, Xi Wang.
BMC Cancer, 2018 Sep 12; 18(1). PMID: 30200932    Free PMC article.
Distribution and prognostic value of tumor‑infiltrating T cells in breast cancer.
Shaoda Meng, Li Li, +3 authors, Kunxian Yang.
Mol Med Rep, 2018 Sep 18; 18(5). PMID: 30221739    Free PMC article.
Predictive value of improvement in the immune tumour microenvironment in patients with breast cancer treated with neoadjuvant chemotherapy.
Wataru Goto, Shinichiro Kashiwagi, +9 authors, Masaichi Ohira.
ESMO Open, 2018 Sep 21; 3(6). PMID: 30233820    Free PMC article.
Comparison of Receptor-Defined Breast Cancer Subtypes Between German and Sudanese Women: A Facility-Based Cohort Study.
Asmerom Tesfamariam Sengal, Nada Suliman Haj Mukhtar, +7 authors, Eva Johanna Kantelhardt.
J Glob Oncol, 2018 Sep 23; 4. PMID: 30241184    Free PMC article.
Breast Cancer Staging: Is TNM Ready to Evolve?
Fernando Cadiz, Juan G Gormaz, Mauricio Burotto.
J Glob Oncol, 2018 Sep 23; 4. PMID: 30241210    Free PMC article.
Intravoxel incoherent motion magnetic resonance imaging for breast cancer: A comparison with benign lesions and evaluation of heterogeneity in different tumor regions with prognostic factors and molecular classification.
Ming Zhao, Kuang Fu, +6 authors, Jiawei Tian.
Oncol Lett, 2018 Sep 27; 16(4). PMID: 30250578    Free PMC article.
Establishment and Characterization of gc-006-03, a Novel Human Signet Ring Cell Gastric Cancer Cell Line Derived from Metastatic Ascites.
Xinyu Su, Yiqi Xue, +7 authors, Jinfei Chen.
J Cancer, 2018 Oct 03; 9(18). PMID: 30271482    Free PMC article.
High RNA-binding Motif Protein 3 Expression Is Associated with Improved Clinical Outcomes in Invasive Breast Cancer.
Sun Hee Kang, Jihyoung Cho, Hasong Jeong, Sun Young Kwon.
J Breast Cancer, 2018 Oct 03; 21(3). PMID: 30275857    Free PMC article.
Assessing the efficacy of androgen receptor and Sox10 as independent markers of the triple-negative breast cancer subtype by transcriptome profiling.
Khalid N Al-Zahrani, David P Cook, Barbara C Vanderhyden, Luc A Sabourin.
Oncotarget, 2018 Oct 04; 9(70). PMID: 30279965    Free PMC article.
Validation of CPS+EG, Neo-Bioscore, and modified Neo-Bioscore staging systems after preoperative systemic therapy of breast cancer: Protocol of a retrospective multicenter cohort study in China.
Ling Xu, Zhuo Zhang, +6 authors, Yimin Cui.
Thorac Cancer, 2018 Oct 09; 9(11). PMID: 30296013    Free PMC article.
Efficacy and cardiac safety of the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: a systematic review and meta-analysis.
Yu-Tuan Wu, Zhou Xu, +8 authors, Ling-Quan Kong.
Ther Clin Risk Manag, 2018 Oct 13; 14. PMID: 30310287    Free PMC article.
Review.
Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer.
Tstutomu Kawaguchi, Li Yan, +7 authors, Kazuaki Takabe.
Ann Surg Oncol, 2018 Oct 13; 25(13). PMID: 30311168    Free PMC article.
Elevated expression of POLD1 is associated with poor prognosis in breast cancer.
Qinghong Qin, Qixing Tan, +4 authors, Changyuan Wei.
Oncol Lett, 2018 Oct 23; 16(5). PMID: 30344713    Free PMC article.
The Prognostic Impact of Synchronous Ipsilateral Multiple Breast Cancer: Survival Outcomes according to the Eighth American Joint Committee on Cancer Staging and Molecular Subtype.
Jinah Chu, Hyunsik Bae, +3 authors, Eun Yoon Cho.
J Pathol Transl Med, 2018 Oct 24; 52(6). PMID: 30347971    Free PMC article.
Cancer stem cell markers ALDH1 and CD44+/CD24- phenotype and their prognosis impact in invasive ductal carcinoma.
Iris Rabinovich, Ana Paula Martins Sebastião, +6 authors, Andréa Novais Moreno-Amaral.
Eur J Histochem, 2018 Oct 27; 62(3). PMID: 30362671    Free PMC article.
Positive non-sentinel axillary lymph nodes in breast cancer with 1-2 sentinel lymph node metastases.
Jianwei Zheng, Shuyan Cai, +5 authors, Fanrong Qiu.
Medicine (Baltimore), 2018 Nov 02; 97(44). PMID: 30383658    Free PMC article.
Expression of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, and Ki-67 in ductal carcinoma in situ (DCIS) and DCIS with microinvasion.
Zhi-Bin Wan, Hong-Yi Gao, +5 authors, Yan Zhang.
Medicine (Baltimore), 2018 Nov 02; 97(44). PMID: 30383678    Free PMC article.
Targeting the Hippo Pathway for Breast Cancer Therapy.
Liqing Wu, Xiaolong Yang.
Cancers (Basel), 2018 Nov 08; 10(11). PMID: 30400599    Free PMC article.
Review.
Lymph node metastasis and high serum CEA are important prognostic factors in hormone receptor positive and HER2 negative breast cancer.
Yoshimasa Kosaka, Naoko Minatani, +10 authors, Masahiko Watanabe.
Mol Clin Oncol, 2018 Nov 08; 9(5). PMID: 30402236    Free PMC article.
Menopausal Hormone Therapy use and breast cancer risk by receptor subtypes: Results from the New South Wales Cancer Lifestyle and EvaluAtion of Risk (CLEAR) study.
Usha Salagame, Emily Banks, +2 authors, Karen Canfell.
PLoS One, 2018 Nov 08; 13(11). PMID: 30403669    Free PMC article.
Quantitative assessment of metabolic tumor burden in molecular subtypes of primary breast cancer with FDG PET/CT.
Wei Chen, Lei Zhu, +3 authors, Ping Wang.
Diagn Interv Radiol, 2018 Nov 09; 24(6). PMID: 30406761    Free PMC article.
Significance of intrinsic breast cancer subtypes on the long-term prognosis after neoadjuvant chemotherapy.
Wataru Goto, Shinichiro Kashiwagi, +7 authors, Masaichi Ohira.
J Transl Med, 2018 Nov 11; 16(1). PMID: 30413161    Free PMC article.
Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer.
Yoshikazu Johmura, Ichiro Maeda, +17 authors, Makoto Nakanishi.
J Clin Invest, 2018 Nov 13; 128(12). PMID: 30418174    Free PMC article.
Clinical implications of changes in the diversity of c-MYC copy number variation after neoadjuvant chemotherapy in breast cancer.
Yul Ri Chung, Hyun Jeong Kim, +2 authors, So Yeon Park.
Sci Rep, 2018 Nov 14; 8(1). PMID: 30420657    Free PMC article.
Clinical performance of an analytically validated assay in comparison to microarray technology to assess PITX2 DNA-methylation in breast cancer.
Gabriele Schricker, Rudolf Napieralski, +12 authors, Olaf G Wilhelm.
Sci Rep, 2018 Nov 18; 8(1). PMID: 30442983    Free PMC article.
Predictive value of lymphocyte-to-monocyte ratio in the preoperative setting for progression of patients with breast cancer.
Wataru Goto, Shinichiro Kashiwagi, +8 authors, Masaichi Ohira.
BMC Cancer, 2018 Nov 21; 18(1). PMID: 30453914    Free PMC article.
Possibility of avoiding axillary lymph node dissection by immune microenvironment monitoring in preoperative chemotherapy for breast cancer.
Koji Takada, Shinichiro Kashiwagi, +7 authors, Masaichi Ohira.
J Transl Med, 2018 Nov 21; 16(1). PMID: 30454008    Free PMC article.
What Is the Best Management of cN0pN1(sn) Breast Cancer Patients?
Jana de Boniface, Marcus Schmidt, +3 authors, Toralf Reimer.
Breast Care (Basel), 2018 Dec 01; 13(5). PMID: 30498417    Free PMC article.
Review.
Inhibitors targeting CDK4/6, PARP and PI3K in breast cancer: a review.
Siti Muhamad Nur Husna, Hern-Tze Tina Tan, +2 authors, Kah Keng Wong.
Ther Adv Med Oncol, 2018 Dec 14; 10. PMID: 30542378    Free PMC article.
Review.
Circulating uPA as a potential prognostic biomarker for resectable esophageal squamous cell carcinoma.
Xiao He, Xiaoling Xu, Guanxia Zhu, Hong Ye.
Medicine (Baltimore), 2019 Mar 01; 98(9). PMID: 30817615    Free PMC article.
The association of five preoperative serum tumor markers and pathological features in patients with breast cancer.
Mingjian Lian, Cuixia Zhang, +5 authors, Guolin Hong.
J Clin Lab Anal, 2019 Mar 08; 33(5). PMID: 30843272    Free PMC article.
Association between rs2188380 and the risk of breast cancer in southwest Chinese population.
Lin Huang, Jinling Liao, Yang Chen, Zengnan Mo.
J Clin Lab Anal, 2019 Mar 30; 33(5). PMID: 30924556    Free PMC article.
Evaluation of the Incorporation of Recurrence Score into the American Joint Committee on Cancer Eighth Edition Staging System in Patients with T1-2N0M0, Estrogen Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Invasive Breast Cancer: A Population-Based Analysis.
Shuning Ding, Jiayi Wu, +6 authors, Li Zhu.
Oncologist, 2019 Apr 26; 24(11). PMID: 31019021    Free PMC article.
SIGN: similarity identification in gene expression.
Seyed Ali Madani Tonekaboni, Venkata Satya Kumar Manem, Nehme El-Hachem, Benjamin Haibe-Kains.
Bioinformatics, 2019 Jun 15; 35(22). PMID: 31198954    Free PMC article.
An integrative bioinformatics analysis identified miR-375 as a candidate key regulator of malignant breast cancer.
Jiaxuan Liu, Ping Wang, +11 authors, Daya Luo.
J Appl Genet, 2019 Aug 03; 60(3-4). PMID: 31372832
Quantifying Risk Pathway Crosstalk Mediated by miRNA to Screen Precision drugs for Breast Cancer Patients.
Yingqi Xu, Shuting Lin, +7 authors, Yanjun Xu.
Genes (Basel), 2019 Aug 31; 10(9). PMID: 31466383    Free PMC article.
Changing patterns and survival improvements of young breast cancer in China and SEER database, 1999-2017.
Rong Guo, Jing Si, +7 authors, Jiong Wu.
Chin J Cancer Res, 2019 Oct 01; 31(4). PMID: 31564808    Free PMC article.
Added value of histogram analysis of apparent diffusion coefficient maps for differentiating triple-negative breast cancer from other subtypes of breast cancer on standard MRI.
Hong-Li Liu, Min Zong, +5 authors, Yan-Ni Jiang.
Cancer Manag Res, 2019 Oct 01; 11. PMID: 31564982    Free PMC article.
21-Gene recurrence score influences the chemotherapy decision for patients with breast cancer of different luminal subtypes.
Wei Wang, Lin Lin, +11 authors, Kunwei Shen.
Oncol Lett, 2019 Oct 04; 18(4). PMID: 31579428    Free PMC article.
Potential Benefits of Neoadjuvant Chemotherapy in Clinically Node-Positive Luminal Subtype- Breast Cancer.
Hyung Suk Kim, Tae Kyung Yoo, Woo Chan Park, Byung Joo Chae.
J Breast Cancer, 2019 Oct 11; 22(3). PMID: 31598341    Free PMC article.
Changes in Biomarker Status in Metastatic Breast Cancer and Their Prognostic Value.
Ji Won Woo, Yul Ri Chung, +6 authors, So Yeon Park.
J Breast Cancer, 2019 Oct 11; 22(3). PMID: 31598343    Free PMC article.
Higher underestimation of tumour size post-neoadjuvant chemotherapy with breast magnetic resonance imaging (MRI)-A concordance comparison cohort analysis.
Wen-Pei Wu, Hwa-Koon Wu, +6 authors, Hung-Wen Lai.
PLoS One, 2019 Oct 11; 14(10). PMID: 31600220    Free PMC article.
Hsa-miR-210-3p expression in breast cancer and its putative association with worse outcome in patients treated with Docetaxel.
Barbara Pasculli, Raffaela Barbano, +11 authors, Paola Parrella.
Sci Rep, 2019 Oct 19; 9(1). PMID: 31624308    Free PMC article.
Two Distinct Subtypes Revealed in Blood Transcriptome of Breast Cancer Patients With an Unsupervised Analysis.
Wenlong Ming, Hui Xie, +7 authors, Wanjun Gu.
Front Oncol, 2019 Oct 22; 9. PMID: 31632916    Free PMC article.
Timescale of tumor volume of a young breast cancer patient with luminal B subtype: A case report.
Xiaoyun Mao, Ming Zhou, +2 authors, Feng Jin.
Medicine (Baltimore), 2019 Oct 28; 98(43). PMID: 31651890    Free PMC article.
Impact of Docetaxel on blood-brain barrier function and formation of breast cancer brain metastases.
Simon Bernatz, Elena I Ilina, +13 authors, Michel Mittelbronn.
J Exp Clin Cancer Res, 2019 Oct 31; 38(1). PMID: 31665089    Free PMC article.
Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis.
Qiang Wu, Guangzhi Ma, +4 authors, Qinghua Zhou.
Front Oncol, 2019 Nov 05; 9. PMID: 31681601    Free PMC article.
Systematic Review.
Apparent diffusion coefficient cannot predict molecular subtype and lymph node metastases in invasive breast cancer: a multicenter analysis.
Alexey Surov, Yun-Woo Chang, +4 authors, Andreas Wienke.
BMC Cancer, 2019 Nov 07; 19(1). PMID: 31690273    Free PMC article.
Association between the degree of fibrosis in fibrotic focus and the unfavorable clinicopathological prognostic features of breast cancer.
Yongfu Li, Yuhan Wei, +7 authors, Qin Li.
PeerJ, 2019 Nov 20; 7. PMID: 31741805    Free PMC article.
Identifying breast cancer patients who require a double-check of preoperative core needle biopsy and postoperative surgical specimens to determine the molecular subtype of their tumor.
Je Hyung Park, Hyun Yul Kim, +3 authors, Hyun-June Paik.
Ann Surg Treat Res, 2019 Nov 20; 97(5). PMID: 31742206    Free PMC article.
Luminal B is the Most Common Intrinsic Molecular Subtypes of Invasive Ductal Breast Carcinoma Patients in East Kalimantan, Indonesia.
Swandari Paramita, Eko Nugroho Raharjo, +2 authors, Nur Ahlina Hanifah.
Asian Pac J Cancer Prev, 2019 Aug 28; 20(8). PMID: 31450891    Free PMC article.
Factors associated with readmissions in women participating in screening programs and treated for breast cancer: a retrospective cohort study.
Carme Miret, Laia Domingo, +6 authors, Maria Sala.
BMC Health Serv Res, 2019 Dec 07; 19(1). PMID: 31805926    Free PMC article.
Strong association of fascin expression with triple negative breast cancer and basal-like phenotype in African-American women.
Ashwini K Esnakula, Luisel Ricks-Santi, +6 authors, Tammey J Naab.
J Clin Pathol, 2013 Aug 30; 67(2). PMID: 23986556    Free PMC article.
Clinical Validation of BCT Scores With Prognostic Factors in Hormone Receptor-positive, HER2-negative Early Breast Cancer.
Jeeyeon Lee, Won Hwa Kim, +9 authors, Ho Yong Park.
In Vivo, 2019 Oct 31; 33(6). PMID: 31662548    Free PMC article.
Decision of Adjuvant Systemic Treatment in HR+ HER2- Early Invasive Breast Cancer: Which Biomarkers Could Help?
Marie Alexandre, Aurélie Maran-Gonzalez, +6 authors, Séverine Guiu.
Cancer Manag Res, 2019 Dec 19; 11. PMID: 31849525    Free PMC article.
Review.
ki67 nuclei detection and ki67-index estimation: a novel automatic approach based on human vision modeling.
Barbara Rita Barricelli, Elena Casiraghi, +4 authors, Barbara Vergani.
BMC Bioinformatics, 2019 Dec 29; 20(1). PMID: 31881821    Free PMC article.
Exploring the Role of Breast Density on Cancer Prognosis among Women Attending Population-Based Screening Programmes.
Laia Domingo, Maria Sala, +7 authors, Camiss Study Group.
J Oncol, 2019 Dec 31; 2019. PMID: 31885567    Free PMC article.
Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence.
Fabio Conforti, Laura Pala, +12 authors, Aron Goldhirsch.
Breast Cancer Res, 2020 Jan 01; 21(1). PMID: 31888717    Free PMC article.
Molecular classification of breast cancer: A retrospective cohort study.
Fatma Khinaifis Al-Thoubaity.
Ann Med Surg (Lond), 2020 Jan 01; 49. PMID: 31890196    Free PMC article.
Predictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant Chemotherapy.
Xinyan Li, Mozhi Wang, +6 authors, Yingying Xu.
J Breast Cancer, 2020 Jan 04; 22(4). PMID: 31897326    Free PMC article.
Review.
Theranostic application of miR-429 in HER2+ breast cancer.
Claudia Cava, Chiara Novello, +7 authors, Isabella Castiglioni.
Theranostics, 2020 Jan 07; 10(1). PMID: 31903105    Free PMC article.
The expressions of autotaxin-lysophosphatidate signaling-related proteins in metastatic breast cancer.
Su Jung Shim, Eunah Shin, Choong-Sik Lee, Ja Seung Koo.
Int J Clin Exp Pathol, 2020 Jan 15; 12(8). PMID: 31934128    Free PMC article.
Correlation of expression of WWOX and JNK with clinicopathologic features in human breast carcinoma.
Sai Huang, Chenggang Wang, +3 authors, Xiao Wang.
Int J Clin Exp Pathol, 2018 Feb 01; 11(2). PMID: 31938155    Free PMC article.
Renalase overexpression in ER-positive breast cancer.
Xuewen Yu, Pengxun Han, +2 authors, Mumin Shao.
Int J Clin Exp Pathol, 2018 Mar 01; 11(3). PMID: 31938225    Free PMC article.
The clinicopathological significance of ZNF10 in invasive ductal carcinoma of the breast.
Jing Duan, Tiantian Zhen, +7 authors, Anjia Han.
Int J Clin Exp Pathol, 2018 Jun 01; 11(6). PMID: 31938422    Free PMC article.
The discordance pattern of molecular sub-types between primary and metastatic sites in Chinese breast cancer patients.
Gaoda Ju, Rongxuan Zhu, +9 authors, Hongxia Wang.
Int J Clin Exp Pathol, 2020 Jan 18; 11(12). PMID: 31949681    Free PMC article.
High expression of soluble CD155 in estrogen receptor-negative breast cancer.
Akiko Iguchi-Manaka, Genki Okumura, +5 authors, Kazuko Shibuya.
Breast Cancer, 2019 Aug 03; 27(1). PMID: 31372841    Free PMC article.
Correlation of epidermal growth factor receptor (EGFR), androgen receptor (AR) and 14-3-3 sigma expression in breast cancer.
Zhimin Ji, Lili Yang, Qiurong Ruan.
Int J Clin Exp Pathol, 2017 Oct 01; 10(10). PMID: 31966379    Free PMC article.
Ki-67 Expression is a Significant Prognostic Factor Only When Progesterone Receptor Expression is Low in Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer.
Young-Joon Kang, Han-Byoel Lee, +7 authors, Wonshik Han.
J Oncol, 2020 Jan 25; 2019. PMID: 31975992    Free PMC article.
Response to immunohistochemical markers' conversion after neoadjuvant chemotherapy in breast cancer patients: association between imaging and histopathologic analysis.
Y Zhao, X Wang, +2 authors, D Zhang.
Clin Transl Oncol, 2019 Apr 22; 22(1). PMID: 31006089
Invasive ductal breast cancer: preoperative predict Ki-67 index based on radiomics of ADC maps.
Yu Zhang, Yifeng Zhu, +5 authors, Shaowu Wang.
Radiol Med, 2019 Nov 07; 125(2). PMID: 31696388
Analysis of Copy-Number Variations and Feline Mammary Carcinoma Survival.
José Luis Granados-Soler, Kirsten Bornemann-Kolatzki, +7 authors, Ingo Nolte.
Sci Rep, 2020 Jan 24; 10(1). PMID: 31969654    Free PMC article.
The F-Box Domain-Dependent Activity of EMI1 Regulates PARPi Sensitivity in Triple-Negative Breast Cancers.
Antonio Marzio, Joseph Puccini, +5 authors, Michele Pagano.
Mol Cell, 2018 Dec 18; 73(2). PMID: 30554948    Free PMC article.
Analysis of the molecular subtypes of preoperative core needle biopsy and surgical specimens in invasive breast cancer.
Ye Sul Jeong, Jun Kang, +3 authors, Ahwon Lee.
J Pathol Transl Med, 2019 Nov 14; 54(1). PMID: 31718121    Free PMC article.
RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
Hiroko Toda, Naohiko Seki, +10 authors, Shoji Natsugoe.
Mol Oncol, 2019 Nov 23; 14(2). PMID: 31755218    Free PMC article.
Integration of Ki-67 index into AJCC 2018 staging provides additional prognostic information in breast tumours candidate for genomic profiling.
Elena Vissio, Jasna Metovic, +7 authors, Isabella Castellano.
Br J Cancer, 2019 Nov 30; 122(3). PMID: 31780778    Free PMC article.